Yaya tsawon lokacin da waɗannan alamomi ke faruwa?
Ya kamata a bi da dukan ciwon zuciya a cikin wannan hanya musamman ma lokacin da kake da shekaru.
tare da zazzabi
Bugu da ƙari, dole ne a bincika yawan jini na cholesterol.
Yanzu kuna da zazzabi?
Kuna da wannan ciwon kirji a yanzu?
Kuna da wahalar numfashi.
Kuna iya gaya mini waɗanne alamomin da kuke da su tare da wannan?
Yaya zazzabinka ya kasance mai girma?
Ni ma ina da ma'aurata.
Ina da ƙananan sanyi da nau'i nau'i.
Ina da mummunan ciwon zuciya a yau.
Wannan shine lokacin da ya dace don zafin jiki.
Yana da ciwon kirji.
Ina tsammanin ina da ƙananan zazzabi.
Ina so in bayyana inda zafin jiki yake.
Har ila yau, suna da ƙananan zafi.
Tare da tarihin ciwon sukari.
Kuna jin kamar kirjina ya zama kamar zane.
Kuma kun san mutane suna shan wahala a gare ni koyaushe.
Kuna da ciwon kirji.
Kuma kun ce wannan matsa lamba ne a cikin ƙirjinku.
Kowane mutum a cikin iyali yana da matsala na ciwon zuciya da ciwon zuciya mai tsananin cholesterol.
Akwai wasu alamu ko matsaloli da kake lura da ciwon tsoka?
Shin akwai wasu marasa lafiya kamar ku a gida tare da alamunku iri ɗaya?
Shin kuna da wasu alamu?
Shin kuna da gajeren numfashi?
Har yanzu kuna da ciwon zuciya.
Saboda wannan shine rigakafin rigakafi.
Har ila yau, ba za mu iya jurewa ba don ciwon zuciya na zuciya.
Amma matsala mafi muhimmanci a yanzu ita ce ciwon kirji.
Ina da wahalar numfashi.
Na san mutane da yawa suna jin dadi a kan ni.
Amma muna buƙatar kula da kowane ciwon kirji tare da mafi tsanani.
Yanzu kuna numfashi sosai a yanzu?
Saboda wannan ciwon kirji na manta sosai.
Kuna jin kamar wani ya buge zuciyar ku.
Har ila yau, yana jin kamar ɗan gajeren numfashi.
Shin suna yin gunaguni game da irin wannan cututtuka?
Kuna da wani abu mai ban sha'awa kamar babban jini ko wani abu kamar haka?
Shin kuna da wasu cututtuka na cututtuka kamar ciwon sukari?
Shin kuna jin dadin numfashi tare da wannan ciwon kirji?
Kuna da matsa lamba mai yawa na jini?
Kuna da ɗan gajeren numfashi tare da wannan?
Shin kun san abin da alamun da ta samu?
Kuna ganin hoton?
A yau mun sha ruwa mai yawa.
Duk da haka, ina amfani da gwaje-gwaje don ciwon sukari.
Duk da haka, yana da alamun kama da na.
Yaya zazzabi yake da yawa?
Ta yaya matsi na jini?
Idan ka ci gaba da ci gaba da ciwon zafi.
Idan kana da zazzabi fiye da ɗari biyu ko fiye.
Idan kun yi tunanin cewa alamunku ko matsalolinku suna da kyau a dubawa.
Ina da zazzabi a jiya.
Hakanan ina da ƙananan zazzabi.
Ina da zazzabi a jiya.
Ina da ciwo mai tsanani a cikin zuciya.
Ina da wahalar numfashi ma.
Zan aiko muku da wani hoto.
Ina jin dadi a yau.
A yau na dauki nauyin zafin jiki da kuma ciwon zafi.
Ina tsammanin wannan shine flu.
Ina tsammanin wannan ƙananan ƙananan ƙananan ƙananan.
Shin yana kama da wani mutum mai nauyi da ke zaune a kan kirji?
Komai ya fara da ciwon kai da zazzabi a lokaci guda.
Yana da rauni a tsakiyar zuciyata.
Yana da matsa lamba kamar ciwon kirji.
Yana cikin kirjina.
Yana cikin tsakiyar zuciyata.
Yana cikin tsakiyar kirji.
Ina da ciwo a cikin zuciyata.
Ina damu sosai game da wannan ciwon kirji.
Ina so in gaya muku a cikin bayanin wannan ciwon kirji.
kamar high jini matsa lamba ko ciwon sukari
Kamar yadda yake a cikin tsakiyar kirji.
Yanzu don zazzabi za ku iya ɗaukar tachipirine mai dadi.
Yanzu nawa kwanakin da kake da alamun cututtuka?
Yanzu ka ce kana da ciwon kirji.
Wani lokaci ina da ciwon kirji.
Kuna da wasu alamomi tare da wannan ba kawai ciwo ba.
Ko wani yana zaune a kan kirji?
Yawancin zafin jiki da ciwon kai da ciwon tsoka.
A tsakiyar kirjina.
Ka nuna mini a kan wannan hoton inda kake ji da ciwo.
Tun da kake da zazzabi.
Kuna tsammanin wasu daga cikin wadannan alamomi na iya dangantawa da ciki?
Yaranku suna da alamun cututtuka iri ɗaya?
Ka gaya mini game da ciwon kirji.
Zazzabi ya karu da dare.
Kwanaki biyu da suka gabata suna da zazzabi.
Kwayar cutar ta fara karuwar dare.
Wannan shine likita mai ɗaukar hoto a cikin ɗakin triage na gaggawa.
Kuna iya gaya mani ƙarin bayani game da ciwon kirji?
Ina jin ciwo a gaban jikina a cikin zuciyata.
Ina da ciwo mai tsanani a cikin zuciyata.
Lokacin da nake da wannan ciwo a cikin zuciyata.
Wane irin ciwon da kake da shi a cikin kirji?
Yaushe wannan ciwon kirji ya fara?
A ina za ku ji ciwo a cikin kirji?
inda ka ji wannan ciwon kirji eel wannan kirji t
Kuna jin kamar ƙarfi a cikin ƙirjinku.
Ka san ina da ciwon sukari da abubuwa.
Ka ce kana da wannan ciwon kirji.
Ciwon cututtukan cutar coronavirus (COVID-19) a cikin Tarayyar Turai / Yankin Tattalin Arziki da Burtaniya, daga 1 ga Janairu zuwa 15 ga Maris 2020
Ciwon cutar coronavirus (COVID-19) yana nuna irin wannan yanayin a ƙasashen Tarayyar Turai / Yankin Tattalin Arziki da Burtaniya suna tabbatar da cewa, yayin da a mataki dabam dabam dangane da kasar, cutar COVID-19 tana ci gaba da sauri a duk ƙasashe.
Dangane da kwarewar daga Italiya, ƙasashe, asibitoci da ƙungiyoyin kulawa masu tsanani ya kamata su kara shirye-shiryen su don haɓaka marasa lafiya tare da COVID-19 wanda zai buƙaci kiwon lafiya, musamman kulawa mai tsanani.
A ranar 31 ga watan Disamba 2019, an ba da rahoton rahoton rahoton rahoton cututtukan huhu da ba a sani ba a Wuhan, lardin Hubei, China.
A ranar 9 ga Janairu 2020, Cibiyar Kula da Cututtuka ta kasar Sin ta ba da rahoton wakilin da ke haifar da cutar coronavirus a matsayin sabon coronavirus wanda yanzu ake kira ciwon numfashi mai tsanani na coronavirus 2 (SARS-CoV-2).
Tun daga lokacin, cutar da ke haifar da kamuwa da cutar SARS-CoV-2 an kira shi cutar coronavirus (COVID-19).
A bayyane har zuwa yau shine cewa kashi 80% na mutanen da ke da cutar COVID-19 suna da cutar mai sauƙi, watau kamuwa da cutar numfashi tare da ko ba tare da ciwon huhu ba, kuma yawancin waɗannan sun warke.
A cikin kashi 14 cikin dari, COVID-19 ya zama cuta mafi tsanani da ke buƙatar asibiti yayin da sauran kashi 6 cikin dari ke fuskantar cututtuka masu muhimmanci da ke buƙatar kulawa mai tsanani.
Rashin mutuwar marasa lafiya a asibiti saboda COVID-19 shine kusan 4%.
A cikin wannan binciken, muna tantance yanayin da ke cikin haɗarin COVID-19 a kowane ƙasashen Tarayyar Turai / Yankin Tattalin Arziki (EU / EEA) da Birtaniya (UK) kuma mun kwatanta su da na lardin Hubei, China.
Mun kuma kwatanta adadin cututtukan COVID-19 na yanzu a ƙasashen EU / EEA da Birtaniya da wannan a Italiya a lokacin 31 Janairu-15 Maris 2020.
Cutar COVID-19 a kasashen EU / EEA da Birtaniya
Bayan kasar Sin, COVID-19 ya kara yaduwar yanki kuma yanayin cutar COVID-19 a sauran duniya a halin yanzu ya biyo baya na wannan kasar.
A ranar 11 ga Maris 2020, Darakta Janar na Hukumar Lafiya ta Duniya (WHO) ya bayyana COVID-19 annobar.
A cikin 5 Maris na Eurosurveillance 2020, Spiteri et al. ya ba da rahoto kan farkon cututtukan COVID-19 na Turai da aka tabbatar bisa ga ma'anar shari'ar WHO.
A cikin EU / EEA, Faransa ta ba da rahoton shari'o'in uku na farko a ranar 24 ga Janairun 2020 a cikin mutanen da suka dawo daga Wuhan, lardin Hubei, China.
A ranar 15 ga Maris 2020, an gano shari'ar COVID-19 a duk ƙasashe 30 na EU / EEA da Birtaniya (UK), inda tsakanin 31 ga Disamba 2019 da wannan rana sun haɗa da, an ba da rahoton mutane 39,768 da mutuwar mutane 1,727, tare da mutane 17,750 da mutuwar mutane 1,441 daga Italiya kawai.
Samun adadin haɗin gwiwa da kuma haɗarin cutar COVID-19
A Cibiyar Kula da Cututtuka ta Turai (ECDC), ana sabunta lamarin COVID-19 da aka sanar a kowace ƙasa a duniya, wanda aka samu daga tushen hukuma kawai kamar ma'aikatar kiwon lafiya ta ƙasa, hukumomin kiwon lafiya na kasa da na yanki da WHO, kowace rana a karfe 8:00 na safe.
An yi amfani da waɗannan bayanai don tantance yanayin COVID-19 a EU / EEA da Birtaniya, da kuma kwatanta su da wannan a Italiya.
A matsayin dan wasan kwaikwayo na yawan lokuta masu aiki na COVID-19, mun lissafa tashin hankali na kwanaki 14 na lokuta na COVID-19, don haka la'akari da yanayin halitta na COVID-19, a kowane ƙasashen EU / EEA da Birtaniya, a lokacin 1 Janairu - 15 Maris 2020.
Mun kuma gabatar da adadin adadin kararraki na kowane ƙasa da aka sanar a ranar 15 ga Maris 2020 8:00 na safe idan aka kwatanta da na Italiya na lokacin 31 ga Janairu - 15 ga Maris 2020.
Hanyoyin COVID-19 a kasashen EU / EEA da Birtaniya
Trends a cikin kwanaki 14 na tattalin arzikin cutar COVID-19 a kasashen EU / EEA da Birtaniya gabaɗaya bi na lardin Hubei (China) (Figura 1).
Ga EU / EEA da Birtaniya gabaɗaya, haɗarin COVID-19 ya fara haɓaka a kusa da 21 Fabrairu sannan ya karu sosai a kusa da 28 Fabrairu 2020 (Kayan abu).
Wannan galibi ya haifar da karuwa mai sauri a yawan lokuta da aka ruwaito daga Italiya, amma duk sauran ƙasashe EU / EEA da Birtaniya sun nuna irin wannan haɓaka yanayin haɗin gwiwa na COVID-19 (kayan abu).
Halin 2 ya nuna adadin cututtukan COVID-19, a ƙasashen EU / EEA da Birtaniya idan aka kwatanta da wannan a Italiya na lokacin 31 ga Janairu - 15 ga Maris 2020.
Ya bayyana cewa, a ranar 15 ga watan Maris da misalin karfe 8 na yamma, wasu kasashe 15 na EU / EEA da Birtaniya sun riga sun bayar da rahoton adadin mutane da aka yi kama da na Italiya makonni 3 kafin ko kasa.
Sakamakonmu ya nuna cewa adadin cututtukan COVID-19 da aka sanar da su sun karu da sauri a EU / EEA da Birtaniya.
Hanyoyin da aka lura a cikin haɗarin haɗari na COVID-19 sun nuna cewa annobar tana ci gaba da daidaitawa a cikin dukkan ƙasashe.
Wannan yana faruwa ne duk da ƙasashe suna cikin matakai daban-daban, bambance-bambance a cikin amsoshin kiwon lafiyar jama'a na kasa, da kuma yiwuwar ma'anar shari'a daban-daban a ƙasashe da kuma ka'idoji daban-daban don zaɓar marasa lafiya waɗanda dole ne a gwada su don tabbatar da COVID-19, ciki har da gwajin kama.
A farkon Maris 2020, likitoci a yankunan da suka shafa a Italiya sun bayyana yanayin da kashi 10 cikin 100 na marasa lafiya da ke da cutar COVID-19 ke buƙatar kulawa mai tsanani kuma kafofin watsa labarai sun ba da rahoton cewa asibitoci da ƙungiyoyin kulawa masu tsanani a wadannan yankuna sun riga sun kai iyakarsu.
A halin yanzu ana samuwa a matakin EU / EEA bayanan 6% da 1%, bi da bi (ba a nuna bayanai ba).
Ya kamata, duk da haka, a tattara su a cikin tsari don kara bayanan sa ido na yanzu wanda ke mai da hankali kan yawan lokuta da kuma adadin mutuwar.
Wani binciken da aka yi a 2010-11 ya nuna bambanci mai yawa akan samuwar kulawa mai tsanani da gado na tsaka-tsaki a Turai, daga 29.2 a Jamus zuwa 4.2 gado da yawan jama'a 100,000 a Portugal.
Wannan yana nufin cewa ƙasashe na iya samun albarkatu fiye da Italiya (12.5 kulawa mai tsanani da gado mai tsaka-tsaki na kowane 100,000 na yawan jama'a a 2010-11).
Abubuwan da ke da alaƙa da samar da ikon kiwon lafiya, tare da kimantawa ga kowane ƙasashen EU / EEA da Birtaniya na yawan lokuta na asibiti na COVID-19 da ke da alaƙa da haɗarin 90% na wucewa damar kula da lafiya, an bayar da su a cikin sabuntawar shida na kimanta haɗari mai sauri na ECDC akan COVID-19.
Tun da lokuta sun kasance har zuwa yau a wasu yankuna a cikin ƙasashen EU / EEA da Birtaniya, da asibitoci da sassan kulawa masu tsanani yawanci suna bauta wa yawan jama'a na yanki, ya kamata ya fi kyau a samar da bayanai game da lokuta da gado masu tsanani a cikin Nomenclate na yanki na raka'a don kididdiga 2 (NUTS-2).
Kwarewa daga Italiya da kuma halin yanzu a wasu ƙasashe sun nuna cewa cutar COVID-19 tana ci gaba da sauri a EU / EEA da Birtaniya.
Kasashe, asibitoci da rukunin kulawa mai tsanani ya kamata su shirya kansu don yanayin watsawa na al'umma na ci gaba da SARS-CoV-2 da kuma ƙara yawan marasa lafiya da ke dauke da cutar COVID-19 da ke buƙatar kiwon lafiya, musamman kulawa mai tsanani, kamar wanda ke faruwa a yankunan Italiya.
Kamar yadda aka nuna a cikin kimanta haɗari mai sauri na ECDC na kwanan nan, hangen nesa, m da kuma cikakken tsari yana da muhimmanci don jinkirin yaduwar SARS-COV-2, tare da sauyawa daga rikewa zuwa tsarin rage-rage, kamar yadda ake sa ran karuwar sauri a yawan lokuta bazai samar da masu yanke shawara da asibitoci da lokaci ya isa don fahimtar, karɓaɓɓensu, kar ku da kuma ku amsa.
Kimantawar haɗari mai sauri kuma ta lissafa matakan kiwon lafiyar jama'a don rage tasirin annobar.
Akwai gajeren taga na dama a lokacin da kasashe suna da damar kara kara kokarin sarrafa su don rage yaduwar SARS-CoV-2 da rage matsin lamba a kan kiwon lafiya.
Idan ba haka ba, yana yiwuwa cewa tsarin kiwon lafiya na wasu ƙasashe na EU / EEA zai fuskanci haɓaka marasa lafiya da ke buƙatar kulawa mai tsanani a cikin kwanaki ko makonni masu zuwa.
Barkewar cutar Coronavirus ta 2019 (COVID-19), wanda ke haifar da mummunan cututtukan numfashi (SARS) coronavirus 2 (SARS-CoV-2), ya kashe mutane sama da 3,000 kuma ya kamuwa da cutar sama da 80,000 a kasar Sin da sauran wuraren duniya, wanda ya haifar da bala'i ga mutane.
Kamar SARS-CoV, wanda ya haifar da SARS a dubban mutane a 2003, ana iya watsa SARS-CoV-2 daga bukukuwa kuma yana haifar da alamun kama da irin wannan hanyar.
Koyaya, COVID-19 yana da ƙananan tsanani da mutuwa fiye da SARS amma ya fi watsawa kuma yana shafar tsofaffi fiye da matasa da maza fiye da mata.
A mayar da martani ga yawan adadin wallafe-wallafen da ke haɓaka cututtuka, wannan labarin yana ƙoƙarin samar da sake dubawa da cikakken bincike na batun da ke haɓaka da sauri.
Za mu rufe asali game da cututtukan cututtuka, ilimin halittu, virology, ganowa, magani, ra'ayi, da kuma rigakafin cututtuka.
Kodayake tambayoyi da yawa har yanzu suna buƙatar amsoshin, muna fatan wannan bita zai taimaka wajen fahimtar da kuma kawar da cutar da ta yi barazana.
Bikin bazara a ranar 25 ga Janairu, 2020 ya zama abin tunawa da ba a taɓa mantawa ba ga duk China waɗanda aka bukaci su kasance a cikin gida don duk hutu da kuma makonni da yawa bayan barkewar cutar kwayar cutar.
Ciwon kwayar cutar yana da tasiri sosai ga coronavirus (CoV) wanda ya haifar da barkewar cutar numfashi mai tsanani (SARS) a shekarar 2003; don haka, Hukumar Lafiya ta Duniya (WHO) ta kira shi SARS-CoV-2 a ranar 11 ga Fabrairu, 2020, kuma cutar da ke da alaka da cutar CoV-19 (COVID-19).
Annobar ta fara ne a Wuhan, China, kuma ta yadu da sauri a duk fadin kasar kuma zuwa kusan wasu 50 a duk faɗin duniya.
Tun daga ranar 2 ga watan Maris, 2020, cutar ta haifar da shari'o'in COVID-19 sama da 80,000, tare da fiye da marasa lafiya 40,000 da marasa lafiya 3,000 suka mutu.
WHO ta yi gargadin cewa COVID-19 "maƙiyi na jama'a ne 1" kuma zai iya zama mafi iko fiye da ta'addanci.
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin kasa da watanni biyu, an buga fiye da takardu 200 akan COVID-19 ciki har da kwayar cutar COVID-19, cututtuka, ilimin cututtuka, ganowa, da kuma magani tun bayan rahoton farko a ranar 7 ga Janairu, 2020 wanda ya ƙaddarin kwayar cutar da cutar cutar.
Wannan nazarin yana ƙoƙarin taƙaita ci gaban bincike a sabuwar batun da sauri ke haɓaka batun.
Duk lokacin da zai yiwu, za mu yi kokarin kwatanta COVID-19 da SARS da wani cuta da ke haifar da CoV, ciwon numfashi na Gabas ta Tsakiya (MERS, barkewar a 2012).
Za mu kuma tattauna abin da muka koya har zuwa yanzu game da rigakafin da tsinkaya na cutar, da kuma wasu tambayoyi da ake bukata har yanzu gaggawa.
An yi la'akari da CoVs a al'adance marasa cututtuka ga mutane, galibi suna haifar da kimanin 15% na sanyi na yau da kullun 4.
Duk da haka, a cikin wannan karni, mun haɗu da cututtukan cututtuka na ɗan adam sau biyu, wato, SARS-CoV da MERS-CoV, wanda ya haifar da barkewa a farkon China a 2003 da Saudi Arabia a 2012, bi da bi, kuma ba da daɗewa ba yadawa zuwa wasu ƙasashe da yawa tare da mummunan cututtuka da mutuwa.
Saboda haka, COVID-19 na yanzu shine cutar CoV ta uku a tarihin mutane.
Kamar yadda aka nuna a Fig. Fig.1,1, an bayar da rahoton farko daga Wuhan a ranar 31 ga Disamba, 2019 zuwa Hukumar Kiwon Lafiya ta China.
Bayan kwana bakwai, an saki jerin CoV.
A ranar 15 ga watan Janairu, 2020 an ba da rahoton shari'ar farko da aka kashe daga Wuhan.
A halin yanzu, annobar ta yadu da sauri zuwa garuruwan makwabta, larduna, da ƙasashe.
A ranar 20 ga watan Janairu, an ba da rahoton kamuwa da cutar na masu kula da lafiya, wanda ya nuna cewa yaduwar mutum zuwa ɗan adam yana yiwuwa.
A ranar 23 ga watan Janairu, an kulle birnin Wuhan tare da duk sufuri na jama'a dakatar da su.
A ranar 24 ga Janairu, binciken asibiti na farko akan cutar ya ba da rahoton cewa, daga cikin marasa lafiya 41 da ke da cutar da aka tabbatar, 21 ne kawai ke da alaƙa kai tsaye da kasuwar abincin teku ta Wuhan wanda aka yi la'akari da wurin fara kamuwa da cutar daga tushen dabbobi.
A ranar 30 ga watan Janairu, WHO ta bayyana barkewar cutar ta zama gaggawa ga lafiyar duniya.
A lokacin wannan rahoton, cutar ta riga ta yadu a ko'ina cikin kasar Sin da kusan wasu kasashe 50 a duk faɗin duniya (Fig. 2).
Yayin da yanayin ke ci gaba da sauri, har yanzu ba a yanke shawarar girman ƙarshe da tsananin barkewar barkewar barkewa.
A ranar 11 ga Fabrairu, 2020, wani bincike mai yawa akan marasa lafiya 8,866 ciki har da marasa lafiya 4,021 sun tabbatar da COVID-19 sun gabatar da ƙarin bayani game da annoba kamar haka (https://mp.weixin.q.q.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 ya kamu da cutar mutane daban-daban, amma galibi yana da shekaru 30-65.
Kusan rabin (47.7%) na mutanen da suka kamu da cutar sun fi shekaru 50, ƙananan kaɗan ne a ƙasa da 20, kuma kawai mutane 14 da suka kamu da cutar sun kai shekaru 10.
SARS-CoV-2 ya kamu da mutane (0.31 / 100,000) fiye da mata (0.27 / 100,000).
COVID-19 ya fadada a cikin ƙungiyoyi galibi a cikin da kewaye da Hubei.
COVID-19 ya ɗauki matsakaicin kwanaki 5 (2-9) daga farkon zuwa ganowa.
Matsakaicin lokacin ciki shine kwanaki 4.8 (3.0-7.2).
Matsakaicin lokacin daga farkon zuwa mutuwa shine kwanaki 9.5 (4.8-13).
Lambar haihuwa na asali (R0) shine 3.77 (95% CI: 3.51-4.05), kuma daidaita R0 shine 2.23-4.82.
Adadin mutanen da aka kamu da cutar ya karu da yawa kafin 23 ga Janairu 2020, wanda ya dace da lokacin sufuri mai girma kafin bikin bazara a kasar Sin.
Mutuwar marasa lafiya da aka tabbatar da cututtuka ya kasance 1.44% (95% CI: 1.10-1.86%), kuma daidaita mutuwar duk marasa lafiya ya kasance 3.06% (95% CI: 2.02-4.59%).
Abubuwan haɗari guda uku na COVID-19 sune jima'i (maza), shekaru (<0xE2><0x89><0xA5>60), da kuma ciwon huhu mai tsanani.
CoVs ƙananan iyali ne na manyan ƙwayoyin cuta da ke dauke da rami guda ɗaya na RNA.
Ana iya raba su zuwa hudu, wato, alpha, beta, gamma, da delta, wanda aka sani da alpha- da beta-CoVs don kamuwa da mutane.
Glycoprotein (S) yana da alaƙa da masu karɓar kwayoyin kwayoyin angiotensin-converting enzyme 2 (ACE2) da dipeptidyl peptidase 4 (DPP4) don SARS-CoV da MERS-CoV, bi da bi, sa'an nan kuma nau'i-nau'i na membrane ya faru.
Ana saki kwayar halittar RNA a cikin cytoplasm; bayan maimaita kwayar halittar kwayar halitta, genomic RNA tare da ƙwayar glycoproteins da furotin nucleocapside suna samar da ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar cuta, wanda daga baya ya haɗa tare da ƙwayar kwayar kwayar cuta don sakin kwayar cutar.
An bayar da rahoton jerin genomic na farko na SARS-CoV-2 a ranar 10 ga Janairu, 2020.
An gano SARS-CoV-2 wani sabon nau'in beta-CoV tare da fiye da 99.98% ainihin kwayoyin halitta a tsakanin samfuran 10 da aka tattara daga asalin shafin barkewar, kasuwar abincin teku ta Huanan a Wuhan.
SARS-CoV-2 ya fi kama da SARS-CoV fiye da MERS-CoV.
Ta hanyar watsa microscopy na lantarki, an gano ɓangarorin SARS-CoV-2 a cikin sassan ultratin na mutum iska epithelium.
An gano cewa mutum ACE2 ne mai karɓar SARS-CoV-2 da SARS-CoV.
Koyaya, furotin S na SARS-CoV-2 yana da alaƙa da ACE2 na ɗan adam fiye da na SARS-CoV, wanda ya haɗa da gaskiyar cewa SARS-CoV-2 yana haifar da kamuwa da kamuwa da cuta a cikin marasa lafiya fiye da SARS-CoV.
SARS-CoV-2 na iya samar da sabon ɗan gajeren furotin da aka tsara ta hanyar orf3b da furotin da aka ɓoye ta hanyar orf8.
Orf3b na SARS-CoV-2 na iya taka muhimmiyar rawa a cikin kwayar cuta kuma yana hana maganganun IFN<0xCE><0xB2>; duk da haka, orf8 ba ya ƙunshi wani yanki da aka sani ko motif.
A ranar 18 ga Fabrairu, 2020, Zhou, et al., ya ba da rahoton tsarin crio-EM na cikakken tsawon ɗan adam ACE2 a 2.9 <0xC3><0x85> ƙuduri a cikin hadaddun tare da mai ɗaukar amino acid B0AT1.
Sun gano cewa hadaddun, wanda ya budewa da rufewa, an tattara shi azaman dimer kuma hadaddun ACE2-B0AT1 na iya ɗaga furotin S guda biyu, wanda ke ba da shaida ganewa da kamuwa da cuta.
B0AT1 na iya zama manufar magani don bincika miyagun ƙwayoyi don hana kamuwa da cutar SARS-CoV-2.
asali da tsaka-tsaki host
An san cewa duka SARS-CoV da MERS-CoV sun samo asali ne daga bats kuma an watsa su ga mutane ta hanyar cats da raƙuma, bi da bi.
Ta hanyar kwatanta phylogenetic na SARS-CoV-2 tare da sauran CoVs, an dauki bats na asalin SARS-CoV-2 kamar yadda sabon kwayar cutar yayi daidai da 96% CoVs biyu kamar SARS daga bats da ake kira bat-SL-CoVZX45 da bat-SL-CoVZX21.
Duk da haka, wane mai watsa shiri na tsakiya ya taimaka wa kwayar cutar ta wuce shinge na jinsunan cutar mutane har yanzu ba a san shi ba, kuma har yanzu ba a bayyana hanyar watsawa ba.
Ji, et al., macizai sun ba da shawara a matsayin mai ɗaukar kwayar cutar daga kwayar cuta zuwa mutane waɗanda suka haɗa da sake hadewa a cikin furotin S.
Bisa ga wani binciken, masu bincike a Guangzhou, China, sun ba da shawarar cewa pangolins - daɗewa, dabbobi masu cin abinci da aka saba amfani da su a cikin magani na gargajiya na kasar Sin - sune mai yiwuwa mai tsaka-tsaki na SARS-CoV-2 bisa 99% homology na kwayoyin halitta a cikin CoV wanda aka gano a cikin pangolin da SARS-CoV-2.
Duk da haka, bambancin 1% yada duk a kan genomes biyu har yanzu babban bambanci; don haka, ana jiran sakamakon cikakken shaida (Fig. (Fig.33).
Har yanzu ba a san kayayyakin kimiyyar jiki na SARS-CoV-2 ba.
SARS-CoV da MERS-CoV na iya tsira a cikin injiniya na sa'o'i 48 a cikin yanayin bushe da kuma har zuwa kwanaki 5 a karkashin 20 <0xC2><0xB0>C da 40%-50% zafi.
SARS-CoV-2 na iya samun irin wannan kayayyaki.
An ba da rahoton cewa SARS-CoV-2 yana da hankali ga raguwa na ultraviolet da zafi a 56 <0xC2><0xB0>C na minti 30; Ether, 75% ethanol, chlorine-containing disinfectant, peracetic acid, chloroform, da sauran magunguna, amma ba chlorhexidine, zai iya hana kwayar.
Gabaɗaya, yawan jama'a ba su da rigakafin SARS-CoV-2 kuma saboda haka yana fuskantar sabon kwayar cutar.
A halin yanzu, ba a bayar da rahoton cikakken bincike game da amsawar rigakafi ga SARS-CoV-2 ba.
Saboda haka, zamu iya komawa ne kawai nazarin da suka gabata akan wasu CoVs, musamman SARS-CoV da MERS-CoV (Fig. (Fig.4).4).
Gabaɗaya, bayan kwayar cutar ta mamaye mai karɓar rigakafi, an fara gane shi ta hanyar tsarin rigakafi na rigakafi ta hanyar gane tsarin (PRRs) ciki har da masu karɓar C-type-lectin-like, masu karɓar Kaya (TLR), mai karɓar NOD-like (NLR), da kuma RIG-I-like karɓaɓɓe (R).
Ta hanyar hanyoyi daban-daban, kwayar cutar ta haifar da bayyanar dalilai masu inflammatory, matura na sel dendritic, da kuma haɗin nau'i na I interferons (IFNs) wanda ke iyakance yaduwar kwayar cutar da kuma gaggawa macrophage phagocytosis na antigenes.
Duk da haka, furotin N na SARS-CoV na iya taimakawa kwayar cutar ta tsere daga amsoshin rigakafi.
Ba da daɗewa ba, maganin rigakafi mai dacewa ya haɗu da yaƙi da kwayar cutar.
Lymphocytes T ciki har da CD4 + da CD8 + T sel suna taka muhimmiyar rawa a tsaro.
CD4+ T sel suna motsa sel B don samar da kwayoyin kwayoyin cuta, kuma CD8+ T sel kai tsaye ya kashe kwayoyin cutar.
<0xC6><0x98>ungiyoyin taimako na T suna samar da cytokines na proinflammatory don taimakawa sel masu kare.
Koyaya, CoV na iya hana ayyukan T ta hanyar haifar da apoptosis na T sel.
<0xC6><0x98>arfin ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwa wanda ya haɗa da ƙarin ƙwayoyin cuta kamar C3a da C5a da kwayoyin cuta yana da mahimmanci a yaki da kamuwa da cutar.
Alal misali, kwayoyin cuta sun ware daga mai haƙuri da aka warkar da MERS-CoV.
A gefe guda, overreaction na tsarin rigakafi yana haifar da adadi mai yawa na 'yanci a cikin gida wanda zai iya haifar da mummunan lalacewa ga huhu da sauran ƙwayoyin, kuma, a cikin mummunan yanayi, gazawar ƙungiyoyi masu yawa har ma da mutuwa.
Cutar SARS-CoV-2, wanda aka nuna ta hanyar haɗin gwiwa, tana iya shafar tsofaffi da cututtuka da kuma mata masu ciki.
Yana da yau da kullum cewa ga mutanen da aka fallasa ga adadin kwayoyin cuta ko wanda aka lalata ayyuka na rigakafi, suna da damar samun kamuwa da cutar fiye da wasu.
An kiyasta ma'anar lokacin daukar ciki na SARS-CoV-2 shine kwanaki 1-14, galibi kwanaki 3-7 bisa nazarin shari'ar 425 na farko a Wuhan.
Duk da haka, binciken da aka yi game da lokuta 1,099 ya nuna cewa lokacin daukar ciki ya kasance kwanaki 3 a matsakaici kuma ya kasance daga kwanaki 0 zuwa 24.
Bincike na kwanan nan, kamar yadda aka bayyana a sama, ya nuna cewa lokacin da ake ciki ya kasance kwanaki 4.8 (3.0-7.2) bisa ga asalin lokuta 8,866.
Yana da muhimmanci sosai ga hukumomin kiwon lafiya su daidaita lokacin keɓewa mai inganci dangane da lokacin da aka fi dacewa, don haka hana mutane masu kamuwa da cutar amma marasa alama daga watsa kwayar cutar zuwa wasu.
A matsayin al'ada na yau da kullum, mutane da aka fallasa, ko kuma cutar, yawanci ana buƙatar a keɓe su na kwanaki 14.
Ya kamata a tsawon lokacin gwajin zuwa kwanaki 24?
Ciwon daji sau da yawa shine babban alama na COVID-19, wanda ba za a iya haɗa shi da wata alama ko wasu alamu kamar busassun ciwo, gajeren numfashi, ciwon tsoka, ciwon kai, ciwon kai, ciwon makogwaro, ciwon kirji, ciwon daji, nauyi, daji, da kuma ciwo.
Wasu marasa lafiya sun fuskanci dyspnea da / ko hypoxemia mako guda bayan farawar cutar.
A lokuta masu tsanani, marasa lafiya sun ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ciwon numfashi mai tsanani, short septic, acidosis metabolic, da coagulopathy.
marasa lafiya da zazzabi da / ko alamun numfashi da zazzabi mai tsanani, ko da ba tare da rashin daidaituwa na zahiri ba, ya kamata a bincika kwayar don gano farkon.
Wani binciken da aka yi a ƙarshen Disamba na 2019 ya nuna cewa adadin alamun cutar sun kasance 98% don zazzabi, 76% don bushewa, 55% don dyspnea, da 3% don ciwon daji; kashi 8% na marasa lafiya suna buƙatar goyon bayan ventilation.
An ba da rahoto irin wannan binciken a cikin binciken kwanan nan guda biyu na rukuni na iyali da kuma rukuni wanda ya haifar da watsawa daga mutum mara alama.
Hakazalika, binciken da aka yi a shekara ta 2012 ya nuna cewa marasa lafiyar MERS-CoV suna da zazzabi (98%), bushewa (47%), da dyspnea (55%) a matsayin babban alamun su.
Duk da haka, kashi 80% daga cikinsu suna buƙatar goyon bayan iska, fiye da marasa lafiya na COVID-19 kuma daidai da mafi yawan MERS fiye da COVID-19.
An kuma lura da ciwon daji (26%) da ciwon makogwaro (21%) tare da marasa lafiya na MERS.
A cikin marasa lafiyar SARS, an nuna cewa zazzabi (99%-100%), bushe-shuke (29%-75%), dyspnea (40%-42%), ciwo (20-25%), da ciwon makogwaro (13-25%) sune manyan alamun da ake buƙatar goyon baya na iska don kimanin 14%-20% na marasa lafiya.
A ranar 14 ga Fabrairu, mutuwar COVID-19 ya kai kashi 2% lokacin da aka tabbatar da cutar ta kai 66,576 a duniya.
Hakazalika, mutuwar SARS a watan Nuwamba 2002 ta kasance 10% na lokuta 8,096 da aka tabbatar.
Ga MERS, dangane da binciken da aka gudanar a watan Yunin 2012, mutuwar ta kasance kashi 37% na 2,494 da aka tabbatar.
Wani binciken da ya gabata ya ruwaito cewa R0 na SARS-CoV-2 ya kasance mai girma kamar 6.47 tare da tsawon 95% na amincewa (CI) na 5.71-7.23, yayin da R0 na SARS-CoV ya kasance daga 2 zuwa 4.
An gabatar da kwatanta SARS-CoV-2 tare da MERS-CoV da SARA-CoV game da alamun su, mutuwarsu, da R0 a cikin Table1.1.
Lambobin da ke sama sun nuna cewa SARS-CoV-2 yana da ikon yadu fiye da MERS-CoV da SARS-CoV, amma yana da matukar mutuwa fiye da na karshe biyu.
Saboda haka, yana da kalubale sosai don sarrafa annobar SARS-CoV-2 fiye da na MERS-CoV da SARS-CoV.
Sau da yawa farawa yana faruwa a cikin iyali ɗaya ko daga taron ɗaya ko motar kamar jirgin ruwa na yawon bude ido.
Yawancin marasa lafiya suna da tarihin tafiya ko zama a Wuhan ko wasu yankunan da suka shafi ko tuntuɓar mutane ko marasa lafiya a cikin makonni biyu da suka gabata kafin farawa.
Duk da haka, an ba da rahoton cewa mutane na iya ɗaukar kwayar cutar ba tare da alamun cutar ba fiye da makonni biyu kuma marasa lafiya da aka warkar da su daga asibitoci za su iya ɗaukar kwayar cutar, wanda ke aika ƙararrawa don ƙara lokacin keɓewa.
Masu haƙuri suna da yawan al'ada ko rage yawan ƙwayoyin farin jini (musamman limfocytes) a farkon mataki.
Alal misali, limfopenija tare da fararen kwayoyin jini &lt; 4 <0xC3><0x97> 109/L ciki har da ƙidayar limfocyte &lt; 1 <0xC3><0x97> 109/L, da matakan aspartate aminotransferase da viremia an samu a 1,099 marasa lafiya na COVID-19.
Matakan enzymes na hanta da tsoka da myoglobin sun karu a cikin jinin wasu marasa lafiya, kuma C-reactive furotin da erythrocyte sedimentation sun karu a cikin jini na mafi yawan marasa lafiya.
A cikin marasa lafiya da ke da mummunan shari'a, matakin D-dimer, samfurin lalata fibrin da ke cikin jini, an haɓaka, kuma an rage yawan limfocyte a hankali.
An gano rashin daidaituwa a cikin radiography na kirji a cikin mafi yawan marasa lafiya na COVID-19 kuma an nuna ta hanyar inuwa na biyu ko ƙananan gilashin ƙasa a cikin huhu.
Sau da yawa marasa lafiya suna haifar da ciwon huhu, raunin huhu mai tsanani, da kuma cutar numfashi mai tsanani (ARDS).
Lokacin da ARDS ke faruwa, ƙwayar wuta ba tare da sarrafawa ba, tarin ruwa, da ci gaba da fibrosis suna haifar da musayar gas.
Raunin nau'i-I da nau'i nau'i-II pneumocytes yana rage matakin surfactant kuma yana ƙara tashin hankali na surface, don haka ya rage ikon huhu don fadada da haɓaka haɗarin rushewa.
Sabili da haka, mafi munin binciken radiographic na kirji sau da yawa daidai da mafi tsanani na cutar.
A ranar 18 ga Fabrairu, 2020, bincike na farko na cututtukan COVID-19 ya nuna lalacewar ƙwayoyin cuta, ƙirƙirar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar cuta, da ƙwayar ƙwayar cuta ta ƙwayar cuta da ARDS da kuma kama da na marasa lafiyar SARS da MERS.
An yi amfani da ganowar SARS-CoV-2 RNA ta hanyar sarkar sarkar polymerase ta baya-transcriptase (RT-PCR) a matsayin manyan ka'idoji don gano COVID-19.
Duk da haka, saboda babban ƙimar ƙarya, wanda zai iya gaggauta annobar cutar, an fara amfani da bayyanar asibiti don ganowa (wanda ba kawai ya dogara da RT-PCR) a China a ranar 13 ga Fabrairu, 2020.
Har ila yau, irin wannan yanayin ya faru ne tare da ganewar SARS.
Saboda haka, hadewar tarihin cututtuka, bayyanar asibiti, gwaje-gwajen gwaje-gwaje, da kuma binciken radiological yana da muhimmanci kuma yana da muhimmanci don yin bincike mai tasiri.
A ranar 14 ga Fabrairu, 2020, ƙungiyar Feng Zhang ta bayyana yarjejeniya ta yin amfani da fasahar SARS-CoV-2 ta CRISPR, wanda ke gano sassan SARS-CoV-2 RNA a 20 <0xC3><0x97> 10-18 mol / L zuwa 200 <0xC3><0x97> 10-18 mol / L (10-100 kwafin microliter na shigarwa) ta amfani da dipstick ba tare da sa'a ba.
Da fatan, sabon fasahar zai iya haɓaka jin dadi da jin dadi idan an tabbatar da shi a cikin samfurori na asibiti.
Saboda rashin kwarewa tare da sabon sabon CoV, likitoci na iya ba da taimako ga marasa lafiya na COVID-19, yayin da ake ƙoƙarin magani daban-daban waɗanda aka yi amfani da su ko kuma an gabatar da su kafin don maganin sauran CoVs kamar SARS-CoV da MERS-CoV da sauran cututtukan kwayar halitta (Table 2).
Wadannan magani sun haɗa da magani na yanzu da kuma yiwuwar magani tare da kwayoyi na kwayoyin cuta, immunosuppressants, steroids, plasma daga marasa lafiya da aka warke, magani na kasar Sin, da goyon bayan tunani.
Ko da plasma daga marasa lafiya da aka warke an ba da shawarar a yi amfani da su don magani.
Kamfanonin magunguna suna tsere don haɓaka kwayoyin cuta da allurar rigakafin cutar.
SARS-CoV-2 yafi kai hari ga huhu a farkon kuma mai yiwuwa hari, a karamin digiri, wasu ƙungiyoyi da ke bayyana ACE2, irin su tsarin gastrointestinal da kirji.
Duk da haka, rashin lafiyar numfashi da gazawar sune babban barazana ga marasa lafiya da kuma babban dalilin mutuwa.
Don haka, goyon baya na numfashi yana da mahimmanci don warkar da alamun da kuma ceton rayuka kuma ya haɗa da maganin oxygen na gaba ɗaya, oxygen mai kwarara, iska mai laushi, da kuma iska mai laushi dangane da tsananin cutar.
marasa lafiya da ke da alamun numfashi mai tsanani dole ne su goyi bayan oxygenation na membrane extracorporeal (ECMO), fasaha da aka gyara ta hanyar wucewar zuciya da aka yi amfani da ita don maganin cututtukan zuciya da ke barazanar rai ko rashin lafiyar numfashi.
Bugu da ƙari, kiyaye ma'auni na lantarki, rigakafin da maganin kamuwa da kamuwa da cuta na sakandare, da kuma kare ayyukan gabobin mahimman magunguna suna da mahimmanci ga marasa lafiyar SARS-CoV-2.
An san cewa hadarin cytokine ya haifar da mummunan sakamako na tsarin rigakafi a cikin marasa lafiyar SARS da MERS.
Cytokine guguwa wani nau'i ne na mayar da martani na tsarin da aka nuna ta hanyar saki jerin cytokines ciki har da TNF<0xCE><0xB1>, IL-1<0xCE><0xB2>, IL-2, IL-6, IFN<0xCE><0xB1>, IFN<0xCE><0xB2>, IFNγ, da MCP-1.
Wadannan cytokines suna haifar da ƙwayoyin rigakafi don saki adadi mai yawa na free radicals wanda shine babban dalilin ARDS da gazawar jiki da yawa.
Immunosuppression yana da muhimmanci a magance guguwa na cytokine, musamman a cikin marasa lafiya.
Corticosteroids da tocilizumab, anti-IL6 monoklonal antibody, an yi amfani da su don magance guguwa na cytokine.
Sauran maganin rigakafi na cytokine hada da gyare-gyare na rigakafi na T-cell-directed rigakafi; kulle IFN-γ, IL-1, da TNF; hana JAK; blinatumomab; m na cytokine siginar 4; da kuma HDAC inhibitors.
Steroids, a matsayin immunosuppressants, an yi amfani da su sosai a cikin maganin SARS don rage tsananin lalacewar wutar lantarki.
Duk da haka, steroids a cikin manyan allurai ba su da amfani ga mummunan rauni na huhu a cikin marasa lafiya SARS da COVID-19.
Maimakon haka, suna iya haifar da mummunan sakamako, musamman avascular osteonecrosis, wanda ke shafar tsinkayen.
Duk da haka, an ba da shawarar a yi amfani da gajerun kwayoyi na corticosteroids a cikin ƙananan ƙananan zuwa matsakaici don marasa lafiya na COVID-19.
A lokacin rubutun, ba a tabbatar da maganin antivirus mai inganci ba.
Duk da haka, gudanar da intravenous tare da remdesivir, analog na nucleotide, an gano cewa yana da tasiri a cikin mai haƙuri na Amurka tare da COVID-19.
Remdesivir wani sabon magani ne na maganin kwayar cuta da Gilead ta samar da farko don maganin cututtukan da cututtukan Ebola da Marlburg suka haifar.
Daga baya, remdesivir ya kuma nuna yiwuwar hana sauran kwayoyin RNA guda ɗaya da suka rage ciki har da kwayoyin MERS da SARS.
Dangane da wadannan, Gilead ya samar da filin zuwa China don gudanar da gwaje-gwaje biyu akan mutane masu kamuwa da cutar SARS-CoV-2, kuma ana sa ran sakamakon.
Bugu da ƙari, baricitinb, interferon-<0xCE><0xB1>, lopinavir / ritonavir, da ribavirin an ba da shawarar a matsayin magani mai yiwuwa ga marasa lafiya da ke da alamun numfashi mai tsanani.
Diarrhea, ciwon daji, ciwon zuciya, lalacewar hanta, da sauran mummunan sakamako na iya faruwa bayan hade magani tare da lopinavir / ritonavir.
Ya kamata a bincika hulɗar waɗannan magani tare da sauran magungunan da aka yi amfani da su a cikin marasa lafiya.
Plasma daga marasa lafiya da kuma antibody tsara
Tarin jini daga marasa lafiya da suka warke daga cutar kwayar cuta don magance wasu marasa lafiya da ke fama da cutar guda ko don kare marasa lafiya daga kama cutar yana da dogon tarihi.
Hakika, marasa lafiya da aka warke sau da yawa suna da babban matakin antibody akan kwayoyin cuta a cikin jininsu.
<0xC6><0x98>ungiyoyin kwayoyin halitta sune ƙwayar immunoglobulin (Ig) da B Lymphocytes ke samar don yaki da ƙwayoyin cuta da sauran abubuwa na kasashen waje kuma suna gane kwayoyin musamman a cikin kwayoyin cuta kuma suna tsabtace su kai tsaye.
Dangane da wannan, an tattara plasma daga jinin wani rukuni na marasa lafiya waɗanda suka warke daga COVID-19 kuma an allura shi zuwa marasa lafiya 10 masu tsanani.
Alamun su sun inganta a cikin awanni 24, tare da rage kumburi da nau'ikan kwayar cutar da kuma inganta ciwon oxygen a cikin jini.
Duk da haka, tabbatarwa da bayani suna buƙatar bayar da hanyar amfani da yawa kafin a ci gaba da takamaiman magani.
Bugu da ƙari, idan aka ba da tasirin magani, ya kamata a yi la'akari da wasu rashin amfani da plasma.
Alal misali, kwayoyin cuta na iya ƙaruwa da amsar rigakafi kuma suna haifar da ciwon cytokine saki, wanda zai iya zama mummunar guba mai haɗari ga rayuwa.
Yawan kwayoyin halitta a cikin jini yawanci yana da ƙananan, kuma buƙatar plasma yana da girma don magance marasa lafiya.
Yana da wuya a haɓaka da samar da takamaiman kwayoyin halitta da sauri don yaki da cutar ta duniya.
Don haka, yana da mahimmanci kuma mai amfani don ware ƙwayoyin B daga marasa lafiya da aka warke da su kuma gano lambobin kwayoyin halitta waɗanda ke yin la'akari da ƙwayoyin cuta ko allo don ƙwayoyin ƙwayoyin cuta masu inganci da ƙwayoyin cuta.
A wannan yanayin, zamu iya haɓaka ƙwayoyin cuta da sauri.
An yi amfani da TCM don magance cututtuka iri-iri a China na dubban shekaru.
Duk da haka, tasirinsa ya dogara ne akan haɗuwa da abubuwa da yawa a cikin tsari wanda ya bambanta dangane da ganewar cutar dangane da ka'idojin TCM.
Yawancin abubuwan da suka dace ba a san su ba ko kuma ba su da maras kyau saboda yana da wuyar cirewa da tabbatar da irin waɗannan abubuwan ko haɗuwa da su.
A halin yanzu, saboda rashin inganci da takamaiman magani na COVID-19, TCM ya zama daya daga cikin manyan madadin magani ga marasa lafiya da ke da alamun haske zuwa matsakaici ko ga waɗanda suka warke daga matsanancin matakai.
Alal misali, Shu Feng Jie Du capsules da Lian Hua Qing Wen capsules sun kasance masu tasiri don maganin COVID-19.
An lura da manyan adadin magani a cikin maganin marasa lafiyar COVID-19 a larduna da dama a kasar Sin waɗanda ke amfani da TCM a 87% na marasa lafiyar su, ciki har da Gansu (63.7%), Ningxia (50%), da Hunan (50%), yayin da lardin Hubei, wanda ke amfani da TCM a cikin kusan kashi 30% na marasa lafiyar COVID-19, yana da mafi ƙarancin magani (13%).
Duk da haka, wannan alama ce mai ban mamaki kamar yadda wasu dalilai masu yawa kamar adadin da kuma tsananin marasa lafiya ya kamata a hada a cikin kimantawa.
A ranar 18 ga Fabrairu, 2020, Boli Zhang da abokan aiki sun wallafa wani nazari don kwatanta magani na yamma (WM) kawai tare da haɗin magani na WM da TCM.
Sun gano cewa lokuta da ake buƙata don dawo da zafin jiki, ɓacewa, da kuma asibiti sun fi gajeren lokaci a cikin ƙungiyar WM + TCM fiye da ƙungiyar WM kawai.
Mafi ban sha'awa, kudirin na mummunan cututtuka (daga haske zuwa tsanani) ya kasance mafi ƙasƙanci ga ƙungiyar WM + TCM fiye da ƙungiyar WM kawai (7.4% da 46.2%) kuma mutuwar ta kasance mafi ƙasƙanci a cikin ƙungiyar WM + TCM fiye da ƙungiyar WM kawai (8.8% da 39%).
Duk da haka, ingancin da aminci na TCM har yanzu jiran ƙarin gwaji da aka sarrafa sosai a manyan ma'auni da kuma a ƙarin cibiyoyi.
Har ila yau, yana da ban sha'awa don bayyana tsarin ayyuka da kuma bayyana abubuwan da ke da tasiri na maganin TCM ko haɗuwa da su idan ya yiwu.
Masu haƙuri da ake zargin ko tabbatar da COVID-19 galibi suna fuskantar tsoro mai yawa game da cutar da ke ciwo har ma da kisa, kuma mutane masu keɓewa suna fuskantar baƙin ciki, kaɗaici, da fushi.
Bugu da ƙari, alamun kamuwa da cutar kamar zazzabi, hypoxia, da kuma nau'i-nau'i da mummunar tasiri na jiyya kamar rashin barci da corticosteroids ke haifar da ƙarin damuwa da damuwa na tunani.
A farkon mataki na barkewar SARS, an ba da rahoton wasu cututtuka na ruhaniya waɗanda suka haɗa da ci gaba da damuwa, damuwa, hare-hare, jin tsoro, jin daɗin psychomotor, alamun psychotic, delirium, har ma da kisan kai.
Binciken haɗin gwiwa da keɓewa, a matsayin wani ɓangare na amsa kiwon lafiyar jama'a ga barkewar COVID-19, zai iya sa mutane su ƙara damuwa da laifi game da tasirin cutar, keɓewa, da kuma azabtar da iyalansu da abokai.
Saboda haka, ya kamata a bayar da kulawar lafiyar tunani ga marasa lafiya na COVID-19, wadanda ake zargin mutane, da kuma mutanen da ke tuntuɓar su da kuma jama'a da suke bukata.
Taimakon tunani ya kamata ya haɗa da kafa ƙungiyoyin kiwon lafiyar tunani masu yawa, sadarwa mai haske tare da sabuntawa na yau da kullun da daidai game da barkewar SARS-CoV-2 da shirye-shiryen magani da kuma amfani da na'urorin lantarki masu sana'a da aikace-aikace don kauce wa tuntuɓar kusa da juna.
<0xC6><0x98>ungiyoyin rigakafi masu tasiri suna da muhimmanci don dakatar da sarkar watsawa daga tafkunan dabbobi da kuma kamuwa da mutane zuwa masu karɓar ƙwayar cuta kuma galibi suna da haɗin kai ga maganin magani a cikin sarrafa annoba da cututtukan da ke faruwa.
An yi ƙoƙari don haɓaka alluran rigakafi na S don samar da tsawon lokaci da kuma iko da tsare-tsaren kwayoyin halitta da / ko rigakafin kariya daga SARS-CoV.
An kimanta allurar rigakafi mai rai a cikin samfuran dabbobi don SARS.
Duk da haka, ingancin in vivo na waɗannan 'yan takarar allurar rigakafin a cikin tsofaffin mutane da kuma samfurori masu lalata da kariya da su daga kamuwa da cutar zoonotic har yanzu ba a ƙayyade su ba kafin a fara binciken asibiti.
Wannan yana yiwuwa saboda SARS ya mutu shekaru 17 da suka gabata kuma babu wani sabon lamari tun daga lokacin.
Akasin haka, lokuta masu yawa da ƙungiyoyi na MERS suna ci gaba da faruwa a Gabas ta Tsakiya kuma sun yadu zuwa wasu yankuna saboda ci gaba da tushen zoonotic a yankunan da ke ci gaba.
An kirkiro dabarun allurar rigakafi don MERS ta amfani da kwayar cutar da ba a kunnawa ba, Plasmids DNA, Vectors na kwayar cutar, nanoparticles, kwayoyin kwayar cutar da subo da kuma wasu an kimanta su a cikin samfuran dabbobi.
Ci gaban rigakafi mai lafiya da inganci akan SARS-CoV-2 ga mutane marasa lafiya shine aikin gaggawa da muhimmanci don sarrafa annobar da ke ci gaba.
Duk da haka, yana da kalubale don shawo kan matsalar saboda tsawon lokaci (matsakaicin watanni 18) da ake buƙata don haɓaka allurar rigakafi da kuma bambance-bambancen na CoVs.
A matsayin sabon cutar, COVID-19 ya fara bayyana cikakken kwarewar asibiti a cikin dubban marasa lafiya.
A mafi yawan lokuta, marasa lafiya zasu iya warkewa a hankali ba tare da ciwo ba.
Koyaya, kama da SARS da MERS, COVID-19 yana da alaƙa da mummunan cututtuka da mutuwar marasa lafiya tare da mummunan yanayi.
Saboda haka, gina samfurin samfurin don cutar yana da muhimmanci ga hukumomin kiwon lafiya su ba da fifiko ga ayyukansu, musamman a yankunan da ke da iyakancewar albarkatun.
Dangane da nazarin asibiti da aka ruwaito har zuwa yanzu, abubuwan da ke gaba na iya shafar ko za a haɗa su da tsinkayen marasa lafiya na COVID-19 (Table (Table33):
Age: Shekaru shine mafi muhimmanci ga hasashen SARS, wanda kuma gaskiya ne ga COVID-19.
COVID-19 yafi faruwa a cikin shekaru 30-65 tare da 47.7% na wadanda marasa lafiya suna sama da 50 a cikin binciken na lokuta 8,866 kamar yadda aka bayyana a sama.
Masu lafiya da suke buƙatar kulawa mai tsanani sun fi yiwuwar samun cututtuka da rikice-rikice kuma sun tsufa sosai fiye da waɗanda ba su yi ba (a tsakiyar shekarun 66 da 51), suna nuna shekaru a matsayin abin da ke faruwa don sakamakon marasa lafiya na COVID-19.
Jima'i: SARS-CoV-2 ya kamuwa da mutane fiye da mata (0.31 / 100,000 da 0.27 / 100,000), kamar yadda aka bayyana a sama.
Cututtuka da rikice-rikice: marasa lafiya da COVID-19 waɗanda ke buƙatar kulawa mai tsanani sun fi sha wahala daga raunin zuciya da rashin lafiya.
Abubuwan da ke faruwa a cikin zuciya sune kuma babban dalilin mutuwar marasa lafiya na SARS.
An ba da rahoton cewa SARS-CoV-2 na iya haɗa cholangiocytes na ACE2, wanda zai iya haifar da raunin hanta a cikin marasa lafiya na COVID-19.
Yana da kyau a lura cewa shekaru da cututtuka suna da alaƙa sosai kuma suna iya tsabtace juna.
Sakamakon binciken gwaje-gwaje: matakin furotin C-reactive (CRP) a cikin jini yana nuna tsananin ciwon kumburi ko rauni nama kuma an ba da shawarar zama mai yiwuwar haifar da cututtuka, amsawa ga magani, da kuma karshen dawowa.
Hakanan an gabatar da dangantakar matakin CRP zuwa tsananin da tsinkaya na COVID-19.
Bugu da ƙari, lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), da creatine kinase (CK) na iya taimakawa hasashen sakamakon.
Ana bayyana waɗannan enzymes sosai a cikin gabobin da yawa, musamman a cikin zuciya da hanta, kuma ana sake su a lokacin lalacewar nama.
Saboda haka, su ne alamomin gargajiya don zuciya ko raunin hanta.
Babban alamun asibiti: Radiography na Chest da ci gaba na lokaci na cututtukan asibiti ya kamata a yi la'akari tare da sauran matsaloli don tsinkaye sakamakon da rikice-rikice na COVID-19.
Amfani da steroids: Kamar yadda aka bayyana a sama, steroids sune immunosuppressant wanda aka saba amfani dashi a matsayin magani na haɗin gwiwa ga cututtuka masu kamuwa da cututtuka don rage tsananin lalacewa.
Tun da aka yi amfani da babban sashi na corticosteroids a cikin marasa lafiya SARS mai tsanani, yawancin wadanda suka tsira sun sha wahala daga osteonecrosis na avascular tare da nakasa tsawon rayuwa da ingancin rayuwa mara kyau.
Don haka, idan an buƙata, ya kamata a yi amfani da steroids a cikin ƙananan sashi kuma don ɗan gajeren lokaci a cikin marasa lafiya na COVID-19.
Matsalar tunani: Kamar yadda aka bayyana a sama, a lokacin barkewar COVID-19, marasa lafiya da yawa sun sha wahala daga damuwa mai ban mamaki kamar yadda sau da yawa suka jimre tsawon lokuta na keɓewa da rashin tabbas sosai kuma sun ga mutuwar dangi masu kusa da ’yan’uwansu marasa lafiya.
Yana da muhimmanci a samar da shawarwari na tunani da goyon baya na dogon lokaci don taimaka wa waɗannan marasa lafiya su dawo daga damuwa kuma su koma rayuwar al'ada.
A cewar binciken zamani har zuwa yanzu, COVID-19 alama yana da fasali daban-daban na annobar daga SARS.
Baya ga maimaitawa a cikin ƙananan hanyoyin numfashi, SARS-CoV-2 na iya yin maimaitawa sosai a cikin hanyoyin numfashi na sama kuma yana haifar da cututtuka masu sauƙi ko babu alamomi a farkon mataki na kamuwa da cutar, kama da sauran CoVs waɗanda ke haifar da sanyi na kowa.
Saboda haka, marasa lafiya da ke kamuwa da cutar a farkon lokaci ko lokacin daukar ciki na iya haifar da adadin ƙwayoyin cuta a yayin ayyukan yau da kullum, yana haifar da matsala mai yawa don sarrafa annobar.
Duk da haka, an yi la'akari da watsawar SARS-CoV yana faruwa lokacin da marasa lafiya ke ciwo sosai, yayin da yawancin watsawa basu faru ba a farkon lokaci.
Saboda haka, barkewar COVID-19 na yanzu ya fi tsanani kuma yana da wuya a kula da shi fiye da barkewar SARS.
A halin yanzu, manyan kokarin suna gudana a kasar Sin ciki har da kulle Wuhan da garuruwan da ke kewaye da su da kuma ci gaba da kewaye kusan dukkanin jama'a cikin fatan dakatar da watsawar SARS-CoV-2.
Kodayake wadannan ayyukan sun yi mummunan lahani ga tattalin arziki da sauran sassan kasar, yawan sababbin marasa lafiya suna raguwa, yana nuna raguwar annobar.
Mafi kyawun ra'ayi shine cewa barkewar cutar za ta ƙare a watan Maris, kuma lokacin raguwa zai wuce watanni 3-4.
Duk da haka, wasu masana ba su da irin wannan tsammanin.
Paul Hunter, et al., ya kiyasta cewa COVID-19, wanda ya fi kama da SARS, ba zai ƙare ba a shekarar 2020.
Ira Longini, et al., ya kafa samfurin don hasashen sakamakon annobar kuma ya ba da shawarar cewa SARS-CoV-2 na iya kamuwa da kashi biyu bisa uku na yawan jama'ar duniya.
Wani rukuni na Kanada ya ba da rahoton cewa an gano SARS-CoV-2 a cikin tsakiyar turbinate da magunguna na marasa lafiya waɗanda suka warke kuma suka bar asibiti makonni 2 da suka gabata, wanda ke nuna cewa sabon kwayar cutar da aka gano na iya zama annoba mai kama da cutar.
Duk da haka, alamomi masu alkawari sun faru a kasar Sin dangane da raguwar sababbin lokuta, wanda ke nuna dabarun da za a yi aiki a yanzu.
Da farko an yi hasashen cewa cutar Ebola ta haifar da cutar har zuwa miliyan ɗaya tare da rabin rabin mutuwar miliyan.
Duk da haka, ta hanyar tsare-tsaren tsare-tsaren da warewa, a ƙarshe an sarrafa cutar.
Yana yiwuwa, kama da SARS-CoV, cewa SARS-CoV-2 na iya zama mai rauni a cikin kamuwa da cuta kuma a ƙarshe ya mutu a kasa ko ya zama ƙwayar cuta da ba ta kasance tare da mutane ba.
An kwatanta annobar COVID-19 da SARS da MERS a ƙasa (Fig. (Fig. 55).
SARS-CoV-2 yana da matukar watsawa ta hanyar ciwo ko ciwo, kuma mai yiwuwa ta hanyar tuntuɓar kai tsaye tare da kayan da cutar ta gurbata.
An kuma gano kwayar cutar a cikin feces, wanda ke haifar da sabon yiwuwar yaduwa daga fece-to-moth.
Wani bincike na kwanan nan game da cututtukan 138 ya ruwaito cewa kashi 41% na cututtuka na iya haifar da kamuwa da cututtuka na nosocomial, ciki har da marasa lafiya 17 da wasu cututtuka na baya da kuma masu ba da kiwon lafiya 40.
Saboda haka, ya kamata a yi amfani da babban kariya don kare mutane, musamman ma'aikatan kiwon lafiya, ma'aikatan zamantakewa, membobin iyali, abokan aiki, har ma da masu zuwa tare da marasa lafiya ko mutanen da ke da cutar.
Line na farko na kariya wanda za'a iya amfani dashi don rage haɗarin kamuwa da cutar shine ta hanyar saka masks fuska; Dukansu amfani da abin rufe fuska na kiwon lafiya da N95 mask (series # 1860s) yana taimakawa wajen sarrafa yaduwar kwayoyin cuta.
Masks na Surgical fuska hana ruwa droplets daga wani wanda zai iya kamuwa da cutar daga tafiya ta cikin iska ko tsayawa a kan surface na kayan, inda za a iya miƙa su ga wasu.
Koyaya, N95 kawai (series # 1860s) masks zai iya karewa daga kwantar da virions kamar kananan 10 zuwa 80 nm, tare da kawai 5% na virions suna iya shiga gaba ɗaya; SARS-CoV-2 yana kama da SARS-CoV a size kuma duka biyu suna kimanin 85 nm.
Tun da ɓangarorin na iya shiga har ma da abin rufe fuska guda biyar da aka haɗa tare, masu kula da lafiya a kai tsaye tare da marasa lafiya dole ne su sanya abin rufe fuska N95 (series # 1860s) amma ba abin rufe fuska ba.
Baya ga masks, masu kula da lafiya ya kamata su sa tufafi masu ɗaurewa don ƙarin rage hulɗa tare da ƙwayoyin cuta.
Ciwon kwayar cutar na iya cutar da mutum ta hanyar idanu.
A ranar 22 ga Janairu, 2020, wani likita ya kamuwa da SARS-CoV-2 duk da cewa ya saka mask N95; ƙwayar cuta ta iya shiga jikinsa ta hanyar idanunsa.
Saboda haka, masu kula da lafiyar ya kamata su kuma saka garkuwa da fuska mai haske ko ganye yayin aiki tare da marasa lafiya.
Ga jama'a a cikin yankuna da suka shafi ko masu yiwuwa, ana ba da shawarar cewa kowa ya wanke hannunsa tare da sabulu masu tsabta fiye da sau da yawa, ya yi kokarin kasancewa cikin gida don kiwon lafiya da kuma iyakance hulɗa tare da mutane masu yiwuwar kamuwa da cutar.
Ana ɗaukar ƙafafu uku nesa mai dacewa don mutane su guje wa mai haƙuri.
Wadannan ayyukan sune hanyoyi masu tasiri don rage haɗarin kamuwa da cuta da kuma hana yaduwar kwayar cutar.
Kodayake SARS-CoV-2 ya zo a matsayin sabon kwayar cutar zuwa duniyar ɗan adam, babban homology zuwa SARS-CoV kamar yadda aka ruwaito a ranar 7 ga Janairu 2020 ya kamata ya haifar da babban gargadi ga China bisa zurfin tunawarta game da barkewar SARS a 2003.
Duk da haka, ba sai 19 Janairu 2020 darektan Cibiyar Kula da Cututtukan Wuhan ya yi ta'aziyya ga 'yan ƙasa ta hanyar cewa sabon kwayar cutar yana da ƙananan kamuwa da cuta da iyakancin haihuwa daga ɗan adam zuwa ɗan adam kuma ba matsala ba ne don hana cutar da ƙunshewa.
Wannan saƙon ya shawo kan gargaɗin jama'a, musamman lokacin da kasar ke shirin bikin bazara, kuma lokacin da aka rasa muhimmiyar lokaci don ɗaukar cutar a ƙarami a Wuhan.
Hukumomin kula da cututtuka a kasar Sin na iya ɗaukar wannan darasi mai tsanani kuma suna yin ingantawa a nan gaba.
Alal misali, waɗannan hukumomi ya kamata su kasance (1) mafi hankali a lokacin yin sanarwar jama'a kamar yadda kowane kalma ya ƙidaya ga 'yan ƙasa kuma zasu iya canza halinsu da yanke shawara; (2) mafi m da kuma m bayanai daga asibitoci maimakon jiran rahotanni na yau da kullun daga likitoci ko jami'an.
Barkewar COVID-19 da sabon kwayar cutar SARS-CoV-2 ta fara a karshen Disamba 2019.
A cikin kasa da watanni biyu, ya yada duk fadin kasar Sin da kuma kusa da sauran kasashe 50 a duniya a lokacin wannan rubutun.
Tun da kwayar cutar tana kama da SARS-CoV kuma alamun alamun suna kama da tsakanin COVID-19 da SARS, barkewar COVID-19 ta haifar da maimaita SARS.
Duk da haka, akwai wasu bambance-bambance tsakanin COVID-19 da SARS, waɗanda suke da muhimmanci don ɗaukar annobar da kuma magance marasa lafiya.
COVID-19 yana shafar tsofaffi fiye da matasa da maza fiye da mata, kuma tsananin mutuwa da mutuwa sun fi girma a cikin tsofaffi fiye da matasa.
SARS yana da mafi yawan mutuwa fiye da COVID-19 (10.91% da 1.44%).
Masu cutar COVID-19 suna watsa kwayar cutar ko da lokacin da ba su da alama yayin da marasa lafiyar SARS ke yin hakan sau da yawa lokacin da suke da ciwo mai tsanani, wanda ke haifar da matsala mai yawa don ɗaukar yaduwar COVID-19 fiye da SARS.
Wannan ya bayyana dalilin da ya sa SARS-CoV-2 ya yadu da sauri da kuma fadada fiye da SARS-CoV.
Nazarin RNA na yau da kullun na SARS-CoV-2 na iya zama mara kyau a wasu marasa lafiya na COVID-19.
A gefe guda, marasa lafiya zasu iya sake warkar da cutar.
Wadannan binciken suna kara yawan haɗarin yaduwar kwayar cutar.
Saboda irin wannan ci gaba mai sauri a cikin bincike akan COVID-19, batutuwan da dama da dama ba za a magance su ba, kamar haka:
A ina ne SARS-CoV-2 ya fito?
Kodayake an samu kashi 96% na kwayoyin halitta tsakanin SARS-CoV-2 da kwayoyin SARS-kamar CoVs guda biyu, har yanzu ba za mu iya kammala cewa SARS-CoV-2 daga kwayar cutar ba.
Wane nau'i ne nau'i na tsaka-tsaki don watsa kwayar cutar daga mai karɓa na asali, ya ce baths, ga mutane?
Ba tare da sanin amsoshin # 1 da 2 ba za mu iya yanke watsawa yadda ya dace ba, kuma barkewar barkewa na iya sake faruwa a kowane lokaci.
Kodayake samfurin kwayoyin halitta da gwaje-gwaje na biochemical sun nuna cewa SARS-CoV-2 yana da alaƙa da ACE2, ta yaya daidai kwayar cutar ta shiga cikin kwayoyin iska kuma ta haifar da canje-canje na ƙwayar cuta?
Shin kwayar cutar ma ta haɗu da kwayoyin ACE2-expressing a wasu gabobin?
Ba tare da amsoshin amsoshin waɗannan tambayoyin ba, ba za mu iya samun ganewa da sauri da daidaituwa da magani mai kyau ba.
Har yaushe annobar za ta wuce?
Ta yaya kwayar cutar ta ci gaba a lokacin watsawa tsakanin mutane?
Shin zai zama annobar a duk duniya, ta mutu kamar SARS ko kuma ta dawo a lokaci-lokaci kamar influence?
Yana da muhimmanci, amma yana iya ɗaukar lokaci don neman amsoshin abubuwan da ke sama da sauran tambayoyi.
Duk da haka, tare da duk wani kudin da zai iya buƙata, ba mu da wani zaɓi sai dai mu dakatar da annobar nan da nan da nan kuma mu dawo da rayuwarmu ta al’ada.
Asalin zoonotic na coronavirus na mutum
Maye gurbin da daidaitawa sun haifar da haɓakar coronavirus (CoVs) da masu karɓar su, ciki har da mutane, tsawon dubban shekaru.
Kafin 2003, an san mutane biyu CoVs (HCoVs) suna haifar da rashin lafiya, kamar sanyi na yau da kullun.
Barkewar cututtukan cutar numfashi mai tsanani (SARS) da cutar numfashi ta Gabas ta Tsakiya (MERS) sun sauya tsabar kudin don bayyana yadda mummunan cutar HCoV zai iya zama kuma yana barazanar rai.
Halin SARS-CoV-2 a tsakiyar China a karshen 2019 ya sake jawo CoVs cikin haske kuma ya yi mamakinmu tare da babban watsa shiri amma ya rage kwayoyin cuta idan aka kwatanta da 'yar'uwarta SARS-CoV.
Cutar HCoV ita ce zoonosis kuma fahimtar asalin zoonotic na HCoVs zai taimaka mana da kyau.
Yawancin HCoVs sun samo asali ne daga bats inda ba su da patogenic.
Har ila yau, an san masu karɓar tallace-tallace na tsakiya na wasu HCoVs.
Gano masu karɓar dabbobi yana da tasiri kai tsaye a kan rigakafin cututtuka na ɗan adam.
Binciken hulɗar CoV-host a cikin dabbobi na iya samar da muhimmiyar fahimta game da cutar CoV a cikin mutane.
A cikin wannan bita, muna gabatar da cikakken bayani game da ilimin HCoVs bakwai, tare da mai da hankali kan tarihin gano su da asalin zoonotic da watsa nau'i-nau'i.
Muhimmanci, mun kwatanta da kuma bambanta daban-daban HCoVs daga hangen nesa na juyin halitta da kuma sake haɗuwa da kwayoyin halitta.
A halin yanzu cutar CoV 2019 (COVID-19) ta tattauna a cikin wannan mahallin.
Bugu da ƙari, an kuma nuna bukatun don sauye-sauye masu karɓa na nasara da kuma tasirin juyin halitta na ƙwayoyin cuta akan tsananin cuta.
Coronaviruses (CoVs) na cikin dangin Coronaviridae, wanda ya ƙunshi rukuni na kwayoyin RNA masu rufi, masu kyau, masu rufewa.
Wadannan ƙwayoyin cuta suna dauke da manyan kwayoyin cuta na 26 zuwa 32 na kilobases daga cikin kwayoyin RNA an kira su "CoVs" saboda sunayensu na kambi a karkashin microscope na lantarki.
Tsarin tsari, CoVs suna da genomes marasa rarrabuwa waɗanda ke raba irin wannan ƙungiyar.
Kusan kashi biyu bisa uku na kwayoyin halitta suna dauke da manyan nau'ikan karatun bude (ORF1a da ORF1b), waɗanda aka fassara a cikin pp1a da pp1ab replicase polyproteins.
Ana ci gaba da aiwatar da polyproteins don samar da furotin 16 marasa tsari, wanda aka tsara nsp1 <0x7E> 16.
Sauran ɓangaren kwayoyin halitta sun ƙunshi ORFs don furotin tsarin, ciki har da spike (S), envelope (E), membrane (M) da nucleoprotein (N).
Har ila yau, an yi la'akari da wasu nau'i-nau'ikan nau'i-nau'i daban-daban na CoVs.
Dangane da bambanci a cikin jerin sunadarai, CoVs an rarraba su cikin tsara hudu (alpha-CoV, beta-CoV, gamma-CoV da delta-CoV), daga cikinsu beta-CoV halittar ya ƙunshi mafi yawan HCoVs kuma an raba shi zuwa jerin hudu (A, B, C da D).
Shaidun Phylogenetic sun nuna cewa bats da magunguna suna aiki a matsayin tushen kwayoyin halitta na mafi yawan alpha-CoVs da beta-CoVs, yayin da tsuntsaye sune babban tafki na gamma-CoVs da delta-CoVs.
Shekaru dubban shekaru, CoVs suna ci gaba da wucewa da shinge na jinsuna kuma wasu sun fito a matsayin muhimman cututtuka na ɗan adam.
Har ila yau, an san CoVs guda bakwai na mutum (HCoVs).
Daga cikinsu HCoV-229E da HCoV-NL63 sune alpha-CoVs.
Sauran beta-CoVs guda biyar sun hada da HCoV-OC43, HCoV-HKU1, mummunan cututtukan numfashi (SARS-CoV), cututtukan numfashi na Gabas ta Tsakiya (MERS-CoV) da SARS-CoV-2.
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 yawanci suna haifar da alamu masu sauƙi, kamar sanyi na yau da kullun da / ko ciwo.
Akasin haka, SARS-CoV, MERS-CoV da sabon SARS-CoV-2 da aka gano suna da matukar kwayar cuta, suna haifar da kamuwa da kamuwa da cututtukan numfashi a cikin ƙananan marasa lafiya tare da mafi girma damar haɓaka cutar numfashi mai tsanani (ARDS) da bayyanar wutar pulmonary.
Nau'in HCoV-229E na farko, B814, an ware shi daga fitar da marasa lafiya tare da sanyi na yau da kullun a tsakiyar 1960s.
Tun daga wannan lokacin, an tara ƙarin ilimin ta hanyar bincike mai zurfi game da HCoV-229E da HCoV-OC43, duka biyun suna haifar da alamun iyakance kai.
Hakika, an yarda da ra'ayin cewa kamuwa da cutar HCoVs ba ta da lahani ba har sai fashewar SARS.
Barkewar SARS ta faru a shekarar 2003 tana daya daga cikin mummunan hatsari a tarihin yanzu, wanda ke kamuwa da mutane sama da 8,000 tare da raunin kimanin kashi 10%.
Shekaru goma bayan haka, bala'in numfashi na Gabas ta Tsakiya (MERS) ya haifar da ci gaba da annoba a cikin tsibirin Larabawa tare da yaduwar lokaci zuwa sauran duniya.
Labarin 2019 HCoV (2019-nCoV), wanda daga baya aka sake masa suna SARS-CoV-2, shine wakilin da ke haifar da annobar cutar coronavirus 2019 (COVID-19), wanda ya yi ikirarin rayukan sama da 3,120 kuma ya kamuwa da mutane sama da 91,000 tun daga ranar 3 ga Maris, 2020.
Yanzu haka, duniya za ta shirya annobar SARS-CoV-2 da ta gabata.
Dukkan HCoVs guda bakwai suna da asalin zoonotic daga bukukuwa, yara ko dabbobi na gida.
Lissafi da yawa na shaida suna tallafawa asalin juyin halitta na dukkan HCoVs daga bututun, inda ƙwayoyin cuta sun dace da marasa lafiya amma suna nuna bambancin kwayoyin halitta.
Annobar ta COVID-19 ta gabatar da kalubale masu yawa na likita, kimiyya, zamantakewa da ɗabi'a ga China da duniya.
Binciken asalin zoonotic na HCoVs yana ba da tsari don fahimtar tarihin halitta, motsa jiki da kuma haɓaka abubuwan da ke hana nau'ikan tsalle-tsalle.
Wannan kuma zai iya jagoranci ko sauƙaƙe neman tafki, matsakaici da kuma haɓaka mai karɓar dabbobi na SARS-CoV-2, tare da muhimmiyar tasiri a rigakafin makomar nan gaba.
A cikin wannan bita mun gabatar da cikakken bayani game da asalin zoonotic, watsa nau'i-nau'i da kuma kwayar cuta na HCoVs.
Musamman, muna tattaunawa da tattaunawa game da batun yau da kullum cewa ƙwayoyin cuta na iyaye na HCoVs yawanci ba su da kwayoyin cuta a cikin masu karɓar ruwa na halitta amma suna zama marasa lafiya bayan yada nau'o'i zuwa sabon mai karɓa.
Har ila yau, muna bincika yanayin juyin halitta na HCoV wanda yawanci karuwar watsawa ya zo tare da raguwar kwayoyin cuta.
Ana kuma tattauna sakamakon barkewar SARS-CoV-2 da ke gudana a wannan yanayin.
An san CoVs na dabbobi tun daga ƙarshen shekarun 1930.
Kafin warewar farko na HCoV-229E nau'ikan B814 daga fitar da marasa lafiya waɗanda suka yi sanyi na kowa, an ware daban-daban CoVs a cikin dabbobi daban-daban da suka kamuwa da cutar, ciki har da Turkey, Mouse, Shair, alade, cat da kare.
A cikin shekarun da suka gabata, an gano HCoVs bakwai.
Taƙaitaccen taƙaitaccen tarihin binciken HCoV a cikin tsari na lokaci (Table 1) zai kasance mai bayanai da koyarwa.
An ware jinsin farko na HCoV-229E daga tsarin numfashi na marasa lafiya tare da kamuwa da kamuwa da cutar numfashi na sama a cikin shekarar 1966, kuma daga baya an daidaita shi don girma a cikin layuka na huhu na WI-38.
marasa lafiya da ke kamuwa da cutar HCoV-229E sun gabatar da alamun sanyi na yau da kullun, ciki har da ciwon kai, ƙishirwa, rashin lafiya da ciwon rai, tare da zazzabi da nauyi da aka gani a lokuta 10 <0x7E> 20%.
Daga baya a shekarar 1967, an ware HCoV-OC43 daga al'adun gargajiya da kuma matsayi na gaba a cikin kwakwalwa na jariri.
Siffofin asibiti na kamuwa da cutar HCoV-OC43 sun kasance kama da wadanda suka haifar da HCoV-229E, waɗanda ba za a iya rarraba su ba daga kamuwa da cutar tare da sauran kamuwa da cututtuka na numfashi irin su ƙwayoyin cuta na Influenza A da rhinoviruses.
Dukansu HCoV-229E da HCoV-OC43 ana rarraba su a duk duniya, kuma galibi ana watsa su a lokacin lokacin hunturu a yanayi mai zafi.
Gabaɗaya, lokacin shigarwa na waɗannan ƙwayoyin cuta biyu ya kasa da mako guda, sannan kusan makonni biyu ya biyo baya.
Bisa ga binciken mutum mai sa kai, mutane masu lafiya da ke kamuwa da HCoV-229E sun ci gaba da sanyi na yau da kullun.
Kawai 'yan marasa lafiya marasa lafiya marasa lafiya sun nuna kamuwa da cutar ta hanyar numfashi.
SARS, wanda kuma aka fi sani da "mai cutar ƙwayar cuta", shine annoba na farko da aka rubuta sosai na HCoV a tarihin ɗan adam kuma wakilin ƙwayar cuta shine SARS-CoV, na uku na HCoV da aka gano.
Ana iya gano lamarin farko na SARS zuwa ƙarshen 2002 a lardin Guangdong na kasar Sin.
Annobar SARS ta haifar da rahoton mutane 8,096 tare da mutuwar mutane 774, wanda ya yadu a fadin ƙasashe da nahiyoyi da yawa.
Baya ga masu watsawa, an kiyasta cewa kowane shari'ar na iya haifar da kimanin lokuta biyu na sakandare, tare da lokacin daukar ciki na kwanaki 4 zuwa 7 da kuma babban kaya na kwayar cutar da ke bayyana a ranar 10th na rashin lafiya.
marasa lafiya da ke kamuwa da cutar SARS-CoV sun kasance da farko tare da myalgia, ciwon kai, zazzabi, rashin lafiya da sanyi, sannan dyspnea, ciwon sukari da kuma wahalar numfashi a matsayin alamomi na ƙarshe.
Lymphopenia, gwaje-gwaje na aikin hanta, da kuma haɓaka creatine kinase sune mummunan cututtukan laboratory na SARS.
Ana kuma lura da lalacewar alveolar mai zurfi, yaduwar ƙwayoyin cuta da ƙarin macrophages a cikin marasa lafiyar SARS.
Kimanin 20-30% na marasa lafiya daga baya suna buƙatar kulawa mai tsanani da iska na inji.
Baya ga ƙananan hanyoyin numfashi, ƙungiyoyi da yawa ciki har da hanyoyin gastrointestinal, hanta da koda kuma za a iya kamuwa da cutar a cikin waɗannan lokuta masu tsanani, yawanci tare da guguwa na cytokine, wanda zai iya zama mai kisa musamman a marasa lafiya marasa lafiya.
An fara ware kwayar cutar daga asibitin huhu na wani dangin mai haƙuri da ya yi tafiya zuwa Hong Kong daga Guangzhou.
Tun daga wannan lokacin, an sadaukar da kokarin da yawa ga binciken HCoV.
An ware HCoV-NL63 daga wani yaro mai shekaru 7 daga Netherlands a ƙarshen 2004.
Da farko an gano cewa yana da yawa a cikin yara, tsofaffi da marasa lafiya marasa lafiya da ke da cututtukan numfashi.
Gabatarwa na coryza, conjunctivitis, zazzabi, da bronchiolitis na kowa ne a cikin cutar da HCoV-NL63 ke haifarwa.
Wani bincike mai zaman kanta ya bayyana warewar wannan kwayar cutar daga samfurin hanci daga wani yaro mai shekaru 8 da ke fama da ciwon huhu a Netherlands.
Kodayake an gano shi a Netherlands, a zahiri an rarraba shi a duniya.
An kiyasta cewa HCoV-NL63 yana da kimanin 4.7% na cututtukan numfashi na yau da kullun, kuma yawan lamarin ya faru a farkon bazara, bazara da hunturu.
HCoV-NL63 yana da alaƙa da laryngitis, wanda aka fi sani da croup.
A wannan shekarar, an ware HCoV-HKU1 daga wani mutum mai shekaru 71 wanda aka kwashe a asibiti da ciwon huhu da bronchiolitis a Hong Kong.
Baya ga huhu da aka samu a cikin al'umma da bronchiolitis, an ba da rahoton cewa HCoV-HKU1 yana da alaƙa da mummunan tashin hankali.
Kamar HCoV-NL63, HCoV-229E da HCoV-OC43, an sami HCoV-HKU1 a duk duniya, yana haifar da cututtukan numfashi masu sauƙi.
Duk waɗannan HCoVs guda hudu da aka samu sun dace da mutane kuma gabaɗaya ba su da matukar yiwuwar canzawa don haifar da cututtukan cututtuka masu yawa, kodayake haɗari ya faru saboda dalilai da ba a sani ba kamar yadda a cikin yanayin ƙarancin nau'ikan HCoV-NL63 ba, wanda aka ruwaito kwanan nan ya haifar da cutar da numfa a cikin numfashi a kasar Sin.
Gabaɗaya, lokacin da wadannan HCoVs suna samun ikon watsawa da inganci da kuma kula da kansu a cikin mutane, sun kuma zama ƙasa da cututtuka ko cututtuka.
An fara ware MERS-CoV a shekarar 2012 daga huhu mai shekaru 60 wanda ya haifar da ciwon huhu da rashin lafiya a Saudi Arabia.
Duk da yake mafi yawan lokuta da aka tabbatar da gwaje-gwaje sun fito ne daga Gabas ta Tsakiya, an ba da rahoton lokuta da aka shigo da su tare da yaduwar sakandare a cikin ƙasashe daban-daban na Turai da Tunisia.
Wani bala'i na biyu ya faru a Koriya ta Kudu a shekarar 2015 tare da an tabbatar da 186 cututtuka.
Abubuwan da ke nunawa na MERS suna kama da na SARS, wanda ke da alaƙa da ci gaban ciwon huhu.
Ba kamar SARS ba, marasa lafiya da ke da MERS sun kuma ci gaba da gazawar ƙwayoyin cuta, wanda har yanzu ya kasance na musamman ga MERS a tsakanin cututtukan HCoV.
Fiye da 30% na marasa lafiya da ke da alamun gastrointestinal, irin su diarrea da rikice-rikice.
Tun daga ranar 14 ga watan Fabrairu, 2020, an ba da rahoton shari'o'in gwaje-gwaje sama da 2500 tare da babban mutuwar mutum 34.4%, wanda ya sanya MERS-CoV ɗaya daga cikin ƙwayoyin cuta mafi girma da aka sani da mutane.
A tsakiyar watan Disamba zuwa ƙarshen Disamba 2019, an gano rukunin marasa lafiya na huhu da aka sani da alaƙa da kamuwa da cutar SARS-CoV-2 a Wuhan, lardin Hubei, China.
Hukumar Lafiya ta Duniya ta ayyana barkewar kamuwa da cutar ta kasa da ke haifar da SARS-CoV-2 a gaggawa ga lafiyar jama'a na damuwa ta duniya kuma ta kira cutar COVID-19.
Tun daga ranar 3 ga Maris, 2020, an tabbatar da mutane 90,053 a duk duniya, tare da mutuwar cutar ta kashi 3.4%.
Musamman, mutuwar lamarin a Hubei, kasar Sin ita ce kashi 4.2%, yayin da daya daga cikin waje shine kashi 1.2%.
SARS-CoV-2 yana haifar da kamuwa da cutar numfashi mai tsanani kamar SARS-CoV da MERS-CoV, wanda aka gabatar a matsayin zazzabi, nauyi da dyspnea.
Ana kuma ganin diarrea a wasu marasa lafiya.
Pneumonia yana daya daga cikin cututtuka mafi tsanani kuma yana iya ci gaba da sauri zuwa cutar numfashi mai tsanani.
Kodayake SARS-CoV da SARS-CoV-2 suna kama da su saboda babban jerin nucleotide na 82%, suna tattara zuwa rassan daban-daban a cikin itacen phylogenetic.
SARS-CoV-2 yana da ƙarancin kwayoyin cuta amma mafi sauki idan aka kwatanta da SARS-CoV da MERS-CoV.
An bayar da rahoton batutuwa marasa alama waɗanda suka kamu da SARS-CoV-2 kuma suna iya taimakawa wajen yaduwar sauri a duk faɗin duniya.
Kwatanta da bambance-bambancen SARS-CoV-2 tare da sauran HCoVs shida suna nuna kamanni da bambance-bambancen sha'awa mai girma.
Na farko, lokacin daukar ciki da kuma tsawon lokacin cutar HCoV suna kama da haka.
A wannan yanayin, SARS-CoV-2 yana bin yanayin gabaɗaya na sauran HCoVs shida.
Na biyu, tsananin alamun COVID-19 yana tsakanin SARS-CoV da HCoVs hudu da aka samu na al'umma (watau HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63).
A gefe guda, kamuwa da cutar SARS-CoV-2 yana nuna siffofin da aka fi gani a lokacin kamuwa da cuta tare da HCoVs da aka samu na al'umma, ciki har da gabatar da ba na musamman ba, mai sauƙi ko har ma babu alamun alamun.
A gefe guda, ana iya ganin ƙananan ƙananan lokuta masu tsanani na COVID-19 kamar yadda yake a cikin cutar SARS-CoV, kodayake rabo yana da ƙananan ƙananan.
Na uku, watsawar SARS-CoV-2 kuma yana nuna alamun ban sha'awa na HCoVs da SARS-CoV waɗanda aka samu.
A gefe guda, yaduwar SARS-CoV-2 ya fi girma kamar na HCoVs da aka samu a cikin al'umma.
A gefe guda kuma, ya ci gaba da tabbatar da ko sauyawa na SARS-CoV-2 ya ragu bayan sauyawa a cikin mutane kamar yadda yake a cikin yanayin SARS-CoV da MERS-CoV.
A ƙarshe, kamar sauran HCoVs, za a iya gano SARS-CoV-2 a cikin samfurori na fecal.
Ko yaduwar magani na SARS-CoV-2 yana taka muhimmiyar rawa kamar yadda yake a cikin yanayin SARS-CoV a kalla a karkashin wasu yanayi ya kamata a bayyana ta hanyar binciken nan gaba.
Har ila yau, yana da mahimmanci a ga ko SARS-CoV-2 na iya nuna yanayin lokaci kamar yadda yake a cikin lokuta na HCoVs na al'umma.
Duk da haka, siffofin SARS-CoV-2 ciki har da watsawa, kwayoyin cuta da kuma yaduwar da ake samu bayan abubuwan da aka wuce a cikin mutane zasu tasiri a kan ƙarshen ƙarshen barkewar COVID-19 da ke ci gaba.
Dukkanin HCoVs guda hudu da aka samu a cikin al'umma waɗanda ke haifar da alamu masu sauƙi sun dace da mutane.
Daga wani ra'ayi, zai iya zama gaskiya cewa mutane sun dace da waɗannan HCoVs hudu.
A wasu kalmomi, duka biyu na iya zama tsira daga cututtukan HCoV na tsohuwar.
An kawar da HCoVs waɗanda ke haifar da cututtuka masu tsanani a cikin mutane da mutane waɗanda suka haifar da cututtuka masu tsanani na HCoV.
Don wannan ya faru, HCoVs dole ne su sake maimaitawa a cikin mutane har zuwa isa don ba da damar tara maye gurbin da suka dace da abubuwan yanke shawara.
A cikin wannan ma'anar, tsawon lokacin da barkewar SARS-CoV-2 ke ci gaba da kasancewa da mutane da yawa da ke kamuwa da su, mafi girman yiwuwar da zai daidaita da mutane.
Idan ya daidaita da kyau, yaduwarsa a cikin mutane zai zama da wuya a dakatar da ta hanyar keɓewa ko wasu matakan kulawa da kamuwa da cuta.
Shekaru da yawa, CoVs hudu da aka samu na al'umma sun yadu a cikin jama'ar ɗan adam, suna haifar da sanyi na yau da kullun a cikin batutuwa marasa lafiya.
Wadannan cututtuka ba su buƙatar ajiyar dabbobi ba.
Akasin haka, SARS-CoV da MERS-CoV ba su dace da mutane sosai kuma ba za a iya ci gaba da watsawar su a cikin mutane ba.
Suna buƙatar kiyayewa da yada a cikin tafkunan zoonotic kuma suna neman damar zubar da hankali ga manufofin ɗan adam, mai yiwuwa ta hanyar daya ko fiye da matsakaici da kuma haɓaka masu karɓa.
SARS-CoV-2 yana da siffofin da ke kama da duka SARS-CoV / MERS-CoV da hudu HCoVs da al'umma suka samu.
Yana da matukar watsawa kamar HCoVs na al'umma, akalla a halin yanzu.
Duk da haka, yana da kwayar cuta fiye da HCoVs da aka samu a cikin al'umma da kuma kasa kwayar cuta fiye da SARS-CoV ko MERS-CoV.
Har ila yau, ya kamata a ga ko zai daidaita cikakken ga mutane kuma ya yada cikin mutane ba tare da tafki ba ko mai karɓar dabbobi na tsaka-tsaki.
Kafin tattauna asalin dabbobi na HCoVs, zai yi amfani da mu sosai don tattauna ma'anoni da halaye na juyin halitta, na halitta, tafki, matsakaici da haɓaka masu karɓa na HCoVs.
Dabbobi suna aiki a matsayin mai karɓar juyin halitta na HCoV idan ya haifar da kakanni masu dangantaka sosai da raba babban homology a matakin jerin nucleotide.
Kwayar cutar kakannin ta yawanci tana dacewa sosai kuma ba mai cutarwa ba a cikin wannan masaukin.
Hakazalika, mai watsa shiri na tashar jiragen ruwa na HCoV yana ci gaba da kuma na dogon lokaci.
A cikin duka lokuta, masu karɓar baƙi suna kamuwa da cutar kuma sune masu karɓar baƙi na HCoV ko ƙwayar cutar iyaye.
Sabanin haka, idan an gabatar da HCoV zuwa wani mai watsa shiri na tsakiya kafin ko kusa da gabatar da shi ga mutane, ba a dace da sabon mai watsa shiri ba kuma sau da yawa yana da cuta.
Wannan mai watsa shiri na tsakiya na iya zama tushen zoonotic na kamuwa da cutar ɗan adam kuma yana taka rawa a matsayin mai karɓar baƙi ta hanyar ba da damar kwayar cutar ta yi maimaitawa ta hanyar wucewa sannan ya watsa shi ga mutane don kara girman adadin kamuwa da cuta na ɗan adam.
HCoV na iya fuskantar kamuwa da kamuwa da cuta idan ba zai iya ci gaba da watsawa a cikin mai watsa shiri ba.
A maimakon haka, HCoVs na iya daidaitawa da mai watsa shiri na tsaka-tsaki har ma ya kafa cututtuka na dogon lokaci.
A wannan yanayin, mai watsa shiri na tsakiya ya zama mai karɓar baƙi na yanayi.
Bayanan annobar sun bayyana a baya cewa lamarin SARS yana da tarihin tuntuɓar dabbobin wasan.
Binciken na gaba na seroprevalence ya nuna cewa 'yan kasuwar dabbobi suna da mafi yawan anti-SARS-CoV IgG idan aka kwatanta da na yawan jama'a.
An fara gano civets dabino (Paguma larvata) da kare racoon a kasuwannin dabbobi masu rai don ɗaukar kwayoyin cuta kamar SARS-CoV waɗanda suke kusan daidai da SARS-CoV.
Wannan yana goyon bayan kai tsaye ta gaskiyar cewa ba a bayar da rahoton ƙarin SARS ba bayan kashe duk civets a kasuwanni.
Duk da haka, an bayar da rahoton cewa sivets dabino masu ɓoye daga daji ko gonaki ba tare da nunawa ga kasuwannin dabbobi masu rai ba su da kyau ga SARS-CoV, yana ba da shawarar cewa sivets dabino masu ɓoye zasu iya zama kawai a matsayin mai karɓar baƙi na SARS-CoV amma ba a cikin tafkin halitta ba.
Musamman, tunda kashi 80% na dabbobi daban-daban a kasuwanni a Guangzhou suna da anti-SARS-CoV kwayoyin halitta, ba za a iya cire yiwuwar da yawancin nau'o'in kananan mahaifa na iya aiki a matsayin matsakaicin haɓaka masu karɓar bakuncin SARS-CoV ba.
Duk waɗannan suna da alama sune masu karshen SARS-CoV.
Binciken da ke biyo baya ga mai karɓar dabba na SARS-CoV ya bayyana wani bath mai alaƙa da ke da alaƙa da SARS Rhinolophus bat CoV HKU3 (SARSr-Rh-BatCoV HKU3), wanda ke cikin bats na dawakai na kasar Sin.
Wadannan bats suna da kyau ga anti-SARS-CoV antibodies da jerin genome na SARSr-Rh-BatCoV HKU3.
Wannan da sauran CoVs na 88-92% na nucleotide jerin homology tare da SARS-CoV.
Wadannan nazarin sun kafa tushe ga sabon ra'ayi wanda bats ke karɓar ƙwayoyin cuta na ɗan adam.
Har ila yau, an gano CoVs da yawa masu kama da SARS (SL-CoVs) daga bukukuwa, amma babu wani sai dai wanda aka tsara WIV1 za a iya ware shi azaman kwayar cuta mai rai.
An san angiotensin mai canza enzyme 2 (ACE2) wanda ke karɓar SARS-CoV.
WIV1 wanda aka samo daga samfurin ƙwayar ƙwayar ƙwayar cuta an nuna shi don amfani da bat, civet da mutum ACE2 a matsayin mai karɓa don shiga tantanin halitta.
Abin ban sha'awa shine, marasa lafiya na SARS na convalescent sun iya kawar da WIV1.
Har zuwa yanzu, WIV1 yana wakiltar kakannin SARS-CoV mafi dangantaka, wanda ke raba 95% na nucleotide jerin homology.
Kodayake babban homology tsakanin waɗannan kwayoyin cuta guda biyu, an yi imanin cewa WIV1 ba shine kwayar cutar iyaye na SARS-CoV ba, kuma bats ba shine mai watsa shiri na SARS-CoV ba.
Binciken Phylogenetic ya ƙunshi MERS-CoV zuwa rukuni ɗaya kamar bat CoV-HKU4 da bat CoV-HKU5.
Bat CoV-HKU4 da MERS-CoV suna amfani da mai karɓar mai karɓa guda ɗaya, dipeptidyl peptidase 4 (DPP4), don shiga cutar.
Jerin RNA mai dogara da RNA polymerase na MERS-CoV suna kusa da takwarorinsu a cikin beta-CoVs da aka gano daga Turai da Afirka.
Har zuwa yanzu, ba za a iya samun MERS-CoV mai rai a cikin daji bats.
MERS-CoV da kuma mafi kusa da dangi na CoV-HKU25 suna raba 87% ne kawai na nucleotide jerin homology.
Saboda haka, bats ba za su zama mai ba da rikodin nan take na MERS-CoV.
A gefe guda, karatu a Gabas ta Tsakiya sun nuna cewa raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman suna da kyau ga MERS-CoV na musamman, kamar raƙuman asalin Gabas ta Tsakiya a ƙasashe da yawa na Afirka.
Live MERS-CoV kama da kwayar cutar da aka samo a cikin mutane an ware shi daga ƙananan raƙuman dromedary, wanda ya ƙara nuna cewa raƙuman suna aiki a matsayin mai gabatarwa na MERS-CoV.
Har ila yau, yana da kyau a lura cewa gabaɗaya alamun cututtuka masu sauƙi amma an lura da zubar da ƙwayoyin cuta a cikin raƙuman da ke kamuwa da cutar MERS-CoV.
Musamman, raƙuman da suka kamu da cututtuka suna zubar da kwayoyin cuta ba kawai ta hanyar numfashi ba amma kuma ta hanyar hanyoyin da zafi-kai, wanda shine ma babban hanya don kwayar cutar daga kwayar cuta.
Duk da haka, tambayoyi har yanzu suna ci gaba tun lokacin da aka tabbatar da lokuta masu yawa na MERS ba su da tarihin tuntuɓar raƙuma kafin kammala alamu, wanda aka ba da shawara ga yada mutum zuwa ɗan adam ko hanyoyin yadawa wanda ya shafi nau'ikan da ba a san su ba wanda ke da tashar jiragen ruwa na MERS-CoV.
SARS-CoV-2 yana rarraba homology na nucleotide 96.2% tare da kwayar CoV RaTG13 wanda aka ware daga kwayar Rhinolophus affinis.
Kamar yadda yake a cikin lokuta na SARS-CoV da MERS-CoV, bambanci tsakanin SARS-CoV-2 da RaTG13 ya fi girma don sanya dangantakar iyaye.
Wato, bats ba zai iya zama mai karɓar bakuncin SARS-CoV-2 ba sai dai idan an gano CoVs kusan iri ɗaya a nan gaba.
Tabbas, masu karɓar kiwon dabbobi masu tsaka-tsaki na SARS-CoV-2 ya kamata su kasance daga cikin nau'in dabbobin daji da aka sayar da su kuma aka kashe a kasuwar abincin ruwa ta Huanan, wanda yawancin lokuta na farko na COVID-19 sun haɗa da su, alal misali na yiwuwar taron watsa dabbobi zuwa ɗan adam.
Yawancin nazarin kwanan nan da suka danganci jerin metagenomic sun nuna cewa rukuni na kananan dabbobi masu haɗari da aka sani da Pangolins (Manis javanica) na iya mallakar kakanni beta-CoVs da ke da alaƙa da SARS-CoV-2.
Wadannan kwayoyin halittar pangolin CoV suna 85-92% na nucleotide jerin homology tare da SARS-CoV-2.
Duk da haka, suna da alaƙa da RaTG13 tare da kimanin 90% ainihin a matakin jerin nucleotide.
Suna tattara a cikin layi biyu na SARS-CoV-2 kamar ƙwayoyin cuta a cikin bishiyar phylogenetic, ɗayan wanda ke raba yanki mai karɓa (RBD) tare da SARS-CoV-2, tare da 97.4% ainihin jerin amino acid.
A cikin bambanci mai mahimmanci, RBDs na SARS-CoV-2 da RaTG13 sun fi bambanta, kodayake mafi girma na jerin homology na genome-wide.
Wani binciken da ya gabata game da pangolins masu cutar kuma ya ba da rahoton gano kwayar cutar daga samfurori na huhu, wanda ya nuna hakan ya danganta da SARS-CoV-2.
Wannan binciken ya ɗauki hanyoyin taro daban-daban da curation na hannu don samar da wani ɓangare na kwayoyin halitta wanda ya ƙunshi kimanin 86.3% na cikakken tsawon kwayar halitta.
Ba za mu iya cire yiwuwar cewa pangolin yana daya daga cikin masu karɓar dabbobi na SARS-CoV-2 ba.
Duk da haka, a halin yanzu babu wata shaida da ke goyon bayan asalin pangolin kai tsaye na SARS-CoV-2 saboda bambancin jerin tsakanin SARS-CoV-2 da pangolin SARS-CoV-2 da ke da alaƙa da beta-CoVs.
Bugu da ƙari, nisa tsakanin SARS-CoV-2 da RaTG13 ya fi gajeren fiye da tsakanin SARS-CoV-2 da pangolin SARS-CoV-2 da ke da alaƙa da beta-CoVs.
Hanyar juyin juya hali na SARS-CoV-2 a cikin bats, pangolins da sauran mahaifa har yanzu ba za a kafa ba.
Duk da yake an sami mafi girman jerin homology a cikin RBDs tsakanin SARS-CoV-2 da Pangolin, SARS-CoV-2 da ke da alaƙa da beta-CoVs, SARS-CoV-2 da RaTG13 suna raba mafi girman jerin homology.
Yana da mahimmanci cewa babban matakin kamanni tsakanin RBDs na Pangolin SARS-CoV-2 da ke da alaƙa da beta-CoVs da SARS-CoV-2 yana motsawa ta hanyar juyin juya halin haɗin gwiwa.
Bambanci mai ba da shawara ya fi dacewa da sake hadewa tsakanin pangolin SARS-CoV-2 da ke da alaƙa da beta-CoV da RaTG13 a cikin nau'in dabbobi na uku na daji.
A matsayin mai motsawa a cikin juyin halitta, sake haɗi yana yadu a tsakanin beta-CoVs.
Har ila yau, shari'ar ta fito ne akan asalin zoonotic na SARS-CoV-2.
Baya ga HCoVs masu kwayar cutar, an kuma nazarin asalin zoonotic na HCoV-229E, HCoV-OC43, HCoV-NL63 da HCoV-HKU1.
Shaidun Phylogenetic sun nuna cewa duka HCoV-NL63 da HCoV-229E na iya samo asali ne daga CoVs na Bat, yayin da cututtukan iyaye na HCoV-OC43 da HCoV-HKU1 an sami su a cikin rukuni.
An ba da rahoton cewa wani bath CoV mai suna ARCOV.2 (Appalachian Ridge CoV) an gano shi a cikin bath tricolored na Arewacin Amirka da aka nuna dangantaka ta kusa da HCoV-NL63.
A gefe guda, HCoV-229E yana da alaƙa da kwayoyin halitta zuwa wani bututu CoV, wanda ake kira Hipposideros / GhanaKwam/19/2008, wanda aka gano a Ghana, yayin da ake zargin camelids a matsayin mai watsa shiri na tsakani.
Don tabbatarwa, an taƙaita ilimin yanzu game da asalin dabba na HCoVs da aka sani a cikin Figura 1 da Table 2.
Binciken Phylogenetic ya ba da shaida ga abubuwan da ke faruwa a cikin HCoVs a tarihi.
Lokacin da HCoV-OC43 ya wuce nau'i-nau'i don kamuwa da mutane daga dabbobi na gida a kusa da 1890, an rubuta annoba na kamuwa da cutar numfashi.
Tarihin watsawa na nau'ikan HCoV-229E ya fi dacewa.
An gano Bat alpha-CoVs da ke da alaƙa da HCoV-229E.
A tsakaninsu akwai alpaca alpha-CoV.
Lissafi da yawa na shaida suna tallafawa watsa kwayar cutar daga kwayar cuta zuwa ga mutane kai tsaye.
Na farko, mutane amma ba alpacas ba za su iya tuntuɓar bukukuwa a cikin wani muhalli da aka raba.
Maimakon haka, mutane suna da dangantaka sosai da alpacas.
Na biyu, da alaka da HCoV-229E alpha-CoVs suna daban-daban kuma ba su da kwayoyin cuta a cikin bats, yayin da alpaca alpha-CoV ya haifar da barkewar cutar numfashi a cikin dabbobi masu kamuwa da cutar.
A ƙarshe, ba a samu alpaca alpha-CoV a cikin dabbobi masu dabba ba.
Saboda haka, ba za a iya cire yiwuwar cewa alpacas ya sami alpha-CoV-229E da ke da alaƙa da HCoV daga mutane ba.
A gaskiya ma, bats ne kai tsaye tushen cututtukan cututtuka na ɗan adam ciki har da rabies virus, Ebola virus, Nipah virus da Hendra virus.
Saboda haka ba abin mamaki ba ne cewa bats na iya watsa HCoV-229E ga mutane kai tsaye.
A madadin haka, yayin da bat alpha-CoVs ke aiki a matsayin kwandon kwayoyin halitta na HCoV-229E, alpacas da raƙuman raƙuman zasu iya zama masu karɓar bakuncin tsaka-tsaki waɗanda ke watsa kwayoyin cuta ga mutane, kamar yadda yake a cikin yanayin MERS-CoV.
MERS-CoV yana aiki a matsayin misali mai kyau na watsa nau'i-nau'i daga bats zuwa raƙuman dromedary da kuma daga raƙuman dromedary zuwa mutane.
An san asalin juyin halitta na MERS-CoV daga ganga a farkon gano shi kuma an ƙarfafa shi ta hanyar binciken da suka biyo baya.
A bayyane yake cewa bats suna samar da tuddai mai arziki na nau'ikan ƙwayoyin cuta don musayar nau'ikan nau'ikan nau'ikan kwayoyin halitta da watsa nau'ikan nau'ikan.
Tsawon lokaci, ƙauyuka masu yawa, haɗin gwiwa na zamantakewa da ƙarfin ƙarfin tashi duk yanayi ne masu kyau don bats su zama "mai watsa kwayar cutar."
A gefe guda, an gabatar da MERS-CoV ga raƙuman dromedary tsawon shekaru.
An daidaita shi da waɗannan raƙuman da suka juya daga mai karɓar baƙi zuwa mai karfin ruwa mai tsayi.
MERS-CoV yana haifar da cuta mai sauƙi kuma yana kula da ƙananan maye gurbin a cikin waɗannan dabbobi.
Yaduwarsa ga mutane wani hatsari ne kuma mutane suna ci gaba da karshen MERS-CoV saboda ba za a iya ci gaba da yaduwa ba.
Ya bambanta da rawar raƙuman raƙumi a cikin watsawar MERS-CoV, rawar pangolins, idan akwai wani, a cikin watsawar SARS-CoV-2 ya bambanta.
Musamman, Pangolin beta-CoVs suna da matukar kwayar cuta a cikin Pangolins.
Suna iya zama mai karfin mutuwa don beta-CoVs masu alaƙa da SARS-CoV-2, kama da civets a cikin yanayin SARS-CoV.
Yawancin yiwuwar watsa nau'ikan SARS-CoV-2 daga dabbobi zuwa mutane dole ne a yi mulki a ko kuma a cire su a nazarin nan gaba.
Na farko, bats na iya zama mai watsa shiri na tafki na kwayar cutar SARS-CoV-2 da ke da alaƙa da SARS-CoV-2 kusan daidai da SARS-CoV-2.
Mutane na iya raba niche na muhalli tare da button ta hanyar bushewa ko hakar ma'adinai.
Na biyu, pangolins na iya kasancewa daya daga cikin matsakaicin mai karɓa wanda aka gabatar da kwayar cutar SARS-CoV-2.
Mutane sun yi kwangilar kwayar cutar ta hanyar butcher da kuma amfani da nama na wasan.
Yana iya yiwuwa cewa dabbobi da yawa ciki har da dabbobi na gida suna fuskantar SARS-CoV-2.
Ana tabbatar da bincike na dabbobi na gida da na daji don antibodies.
Na uku, kamar yadda aka ambata a sama, sake haɗi da daidaitawa na SARS-CoV-2 na iya faruwa a cikin nau'i na uku wanda ke da alaƙa da bats da pangolins.
Binciken asalin dabbobi na SARS-CoV-2 har yanzu yana ci gaba.
Baya ga nau'ikan dabbobi daban-daban, manyan dalilai uku a gefen kwayar cutar ma suna da mahimmanci don sauƙaƙe CoVs don haɗuwa da shinge nau'ikan nau'ikan.
Da farko dai, yawan maye gurbin su a cikin RNA replication.
Idan aka kwatanta da sauran kwayoyin RNA guda ɗaya, ana iya la'akari da adadin maye gurbin CoVs a matsayin "matsakaici" zuwa "matsakaicin" tare da matsakaicin maye gurbin <0x7E> 10-4 a kowace shekara, dangane da matakin daidaitawar CoV zuwa sabbin masu karɓa.
CoVs suna da hujjar karatun exoribonuclease, wanda cirewa ya haifar da babban canji da attenuation ko har ma rashin ƙarfi.
Abin sha'awa, ana san analog na nucleotide Remdesivir don hana jurewa na CoV ta hanyar hana wannan exoribonuclease da RNA mai dogara da RNA polymerase.
Remdesivir yana daya daga cikin mafi kyawun maganin anti-SARS-CoV-2 da za a gwada a gwaje-gwaje na asibiti.
Duk da haka, yawan maye gurbi na CoVs sun fi sau miliyan fiye da na masu karɓar su.
Bugu da ƙari, yawan maye gurbin sau da yawa yana da yawa lokacin da CoVs ba su dace da mai karɓar ba.
Idan aka kwatanta da SARS-CoV tare da babban maye gurbin, adadin maye gurbin SARS-CoV-2 ya fi ƙananan, yana nuna mafi girman matakin daidaitawa ga mutane.
Tabbas, an riga an daidaita shi zuwa wani mai shirya kusa da ɗan adam.
Baya ga SARS-CoV-2, wannan kuma ya shafi MERS-CoV, wanda ya dace da raƙuman dromedary.
A zahiri, ba zai yiwu ba cewa ƙwayoyin cuta za su sa alluran rigakafi da maganin rigakafi da SARS-CoV-2 ba su da tasiri da sauri.
Na biyu, babbar RNA Genome a cikin CoVs yana motsa karin filastik a cikin canje-canje na kwayoyin halitta don maye gurbin da kuma sake haɓaka, don haka yana ƙara yiwuwar haɓaka nau'ikan haɓaka, wanda ke da amfani ga fitowar sabon CoVs lokacin da yanayin ya dace.
Wannan yana goyon bayan fasahar karatu na musamman da ayyukan sunadarai da aka tsara zuwa ƙarshen 3<0xE2><0x80><0xB2> na kwayoyin halitta.
Na uku, CoVs a bambanci da sau da yawa canza samfurori a lokacin RNA replication ta hanyar wani "mai zaɓi" na musamman.
A cikin wani rundunar da ke aiki a matsayin jirgin ruwa na haɗewa, canzawa na wucin gadi yana faruwa sau da yawa a lokacin CoV RNA transcription.
Har ila yau, cikakken tsawo da kuma subgenomic RNAs na iya samar da sabon CoVs.
An gano shaidar phylogenetic na sake haɗi a duka HCoV-HKU1 da HCoV-OC43, da kuma CoVs na dabba irin su Bat SL-CoV da BatCoV-HKU9.
Virus-Host hulɗa dangane da watsawa
Baya ga dalilai uku na kwayar cutar da aka ambata a sama, hulɗar kwayar cutar tare da mai karɓar karɓa shine wani muhimmiyar mahimmanci akan yaduwa.
A ciki, ana ɗaukar sake haɗin SARS-CoV a matsayin misali na yau da kullun, wanda kuma ya nuna shaidar zaɓi mai kyau a lokacin abubuwan watsawa na nau'o'i.
Dangane da binciken da aka kwatanta tsakanin rukuni na mutum da civet SARS-CoVs, ana tunanin SARS-CoV ya wuce saurin daidaitawa a cikin daban-daban, musamman tare da maye gurbi a RBD na S protein.
Gabaɗaya, RBD a cikin furotin S na CoV yana hulɗa da mai karɓar wayar salula kuma an zaɓi shi sosai ta hanyar mai karɓar amsawa.
A cikin SARS-CoV, RBD yana cikin 318 zuwa 510th amino acid a kan S1, wanda ke da alaƙa da ɗan adam ACE2 da kuma coreceptors don shigar da kwayar cutar.
RBD na SARS-CoV yana iya gane masu karɓar ACE2 na dabbobi daban-daban, ciki har da bat, civet, mouse da raccoon kare, yana ba da damar watsa nau'o'i nau'ikan kwayar cutar.
A gaskiya ma, an lura da ragowar amino acid guda 6 ne kawai daban-daban daga ɗan adam da civet viruses a cikin RBD kuma 4 daga cikinsu suna located a cikin mai karɓar mai karɓa don hulɗa tare da mai karɓar ACE2.
Civet SARS-CoV yana da maye gurbin K479N da S487T a cikin RBD, wanda zai iya ƙara haɗin haɗin gwiwa na furotin spike tare da mai karɓar ACE2 na ɗan adam.
A wasu kalmomi, waɗannan maye gurbin amino acid guda biyu na iya zama muhimmanci don daidaitawa na kwayar halitta ga mutane.
Yana da kyau a lura cewa SARS-CoV-2 yana raba mai karɓar wayar salula tare da SARS-CoV.
Bambanci 30% tsakanin SARS-CoV-2 da SARS-CoV a cikin S1 nau'in furotin S yana nufin cewa haɗin haɗin furotin S tare da ɗan adam ACE2 na iya canzawa.
Hakika, nazarin cryo-EM yana nuna dangantaka mai sau 10 zuwa 20 na wannan haɗin fiye da tsakanin mutum ACE2 da SARS-CoV S furotin.
Har ila yau, yana da sha'awar sanin ko wani mai karɓar SARS-CoV-2 zai iya buƙata.
Har ila yau, HCoV-NL63 yana da alaƙa da ACE2 amma tare da wani ɓangare na S.
Akwai wasu masu karɓar HCoV da yawa, irin su aminopeptidase N don HCoV-229E, da 9-O-acetylated sialic acid don HCoV-OC43.
Hakanan zasu iya la'akari da nasarar daidaita waɗannan CoVs a cikin mutane bayan yada nau'ikan nau'ikan daga masu karɓar dabbobi.
Baya ga masu karɓar wayar salula, sakamakon watsawar nau'o'i na HCoVs ma ana sarrafa shi ta wasu abubuwan dogara da ƙuntatawa.
Bambanci na wadannan furotin masu karɓa tsakanin mutane da masu karɓar ruwa na HCoVs na halitta kamar bukukuwan, raƙuman raƙuman raƙuman ruwa da kuma magudanar ruwa na iya zama matsala ga watsawar nau'o'i-nau'i.
HCoVs dole ne su rinjayi abubuwan dogara ga mai karɓar baƙi da kuma ƙayyadaddun ƙuntatawa masu karɓa don yada nau'ikan yanayi mai nasara.
A wannan batun, ƙayyadaddun kwayoyin a cikin wannan muhimmin yanki na haɗin gwiwa na ƙwayoyin cuta suna ci gaba da ganewa da siffantawa.
Binciken kwayoyin halitta mai ban sha'awa na dogara da abubuwan iyaka na SARS-CoV-2 ta amfani da fasahar fasahar CRISPR na iya zama mai amfani.
<0xC6><0x98>addamarwa na labari na HCoVs: Komawa zuwa ƙasa zero
Bambanci na Bat CoVs yana ba da dama mai yawa don fitowar sabon HCoVs.
A cikin wannan ma'anar, Bat CoVs suna aiki a matsayin kwantar da hankali na HCoVs.
Bugu da ƙari, maye gurbin sauri da sake haɓaka kwayoyin halitta kuma suna haifar da juyin halitta na HCoV kuma suna aiki a matsayin matakai biyu masu muhimmanci a wannan tsari.
Alal misali, sayen ko asarar kwayoyin halitta na sabon sunadarai yana da damar canza ƙwayoyin cuta sosai.
Daga cikin furotin haɗin SARS-CoV, an yi tunanin ORF8 yana da muhimmanci a daidaitawa ga mutane, kamar yadda aka ware ƙwayoyin ƙwayoyin cuta masu alaƙa da SARS-CoV amma an gano su don yin amfani da furotin ORF8 daban.
An sami halayen cirewar 29-nucleotide na SARS-CoVs a cikin nau'ikan da aka ware a farkon annobar mutum.
Wannan sharewa ya raba ORF8 zuwa ORF8a da ORF8b kuma ana zaton shine maye gurbin adanawa wanda ke inganta sauyawa na masu karɓa.
Bugu da ƙari, SARS-CoV yana da yiwuwar tarihin sake hadewa tare da zuriyar alpha- da gamma-CoVs, inda aka gano yawancin ƙananan yankuna masu sake hadewa a cikin RNA mai dogara da RNA polymerase.
An kuma gano wuraren sake haɗuwa a cikin nsp9, mafi yawan nsp10, da sassa na nsp14.
Hakanan, an nuna cewa annobar MERS-CoV ta fuskanci abubuwan da suka faru tsakanin zuriya daban-daban, wanda ya faru a cikin raƙuman raƙuman da ke cikin Saudi Arabia.
Baya ga SARS-CoV da MERS-CoV, an kuma lura da abubuwan da suka faru a wasu HCoVs, inda HCoVs ke recombine tare da sauran CoVs na dabba a cikin kwayoyin halittar su.
Ya kamata a kuma gargadi cewa zaɓin wucin gadi na iya ba da gudummawa ga canje-canje marasa nufi a cikin genomes na kwayar cuta, wanda zai iya haifar da sauƙaƙe kwayoyin cuta daga matsin lamba na zaɓi, kamar yadda tsarin rigakafi.
Misalin wadannan tasirin shine asarar cikakken tsawon ORF4 a cikin irin nau'in HCoV-229E, saboda cire nucleotide biyu.
Duk da yake ana iya lura da ORF4 mara kyau a cikin ƙwayoyin cuta da raƙumi da ke da alaƙa da HCoV-229E, alpaca alpha-CoV yana nuna shigarwar nucleotide guda ɗaya, wanda ke haifar da frameshift.
A karshe amma ba a kalla ba, juyin halitta na sabon HCoVs kuma yana jawo hankalin matsa lamba na zaɓi a cikin masu karɓar tafkinsu.
An gano alamun cututtuka marasa alama ko kawai masu sauƙi lokacin da aka kamuwa da kwayoyin cuta tare da CoVs, yana nuna daidaitawar juna tsakanin CoVs da kwayoyin cuta.
Ya bayyana cewa bats suna dacewa da CoVs a kwayoyin halitta da jiki.
Alal misali, launin fata a kunna amsawa na pro-inflammatory a cikin bats ya rage yadda ya dace da cututtukan da CoVs ke haifarwa.
Bugu da ƙari, an hana aikin kwayoyin kisa na halitta a cikin kwayoyi saboda upregulation na mai hana kisa na halitta mai karɓar kwayar halitta NKG2/CD94 da ƙananan matakin bayyanar manyan kwayoyin hadewa mai rikitarwa na kwayoyin I.
Bugu da ƙari, babban matakin nau'in oxygen nau'ikan (ROS) wanda aka haifar daga aikin metabolic na buttons zai iya hana kwarewa na CoV kuma yana shafar karatu ta hanyar exoribonuclease, don haka samar da matsi na zaɓi don haifar da ƙwayoyin cuta sosai lokacin da aka gabatar a cikin sabon masauki.
<0xC6><0x98>arin cututtuka na CoV na iya haɓaka ta hanyar sake haɗuwa, wanda ke haifar da sabon sunadarai ko siffofin sunadarai don daidaitawa.
Saboda haka, ba ta da damar cewa labari uku na HCoVs sun fito a cikin shekaru biyu da suka gabata.
CoVs ba su da cututtuka ko kuma suna haifar da alamun cututtuka masu sauƙi a cikin mahallinsu kamar bats da raƙuma.
Suna mayar da martani sosai ba tare da samun amsar rigakafi mai karfi ba.
A ciki akwai asirin dalilin da ya sa ake ganin masu ɗaukar hoto marasa alama da kuma abin da ke haifar da mummunan cututtuka a cikin kamuwa da cuta na mutum.
Cututtuka masu tsanani sune galibi saboda hyperactivity na amsa rigakafi da guguwa na cytokine inda mafi ƙarfin amsa rigakafi, mafi tsanani lalacewar huhu.
Sabanin haka, a cikin masu ɗaukar magunguna marasa alama, amsar rigakafi an rabu da shi daga CoV replication.
Irin wannan dabarun na cutar da maganin rigakafi na iya samun tasiri mai amfani a cikin maganin anti-SARS-CoV-2.
Amsar interferon yana da ƙarfi musamman a cikin bats.
Saboda haka, gudanar da irin I interferon aƙalla a farkon mataki na kamuwa da cutar SARS-CoV-2 a cikin mutane ya kamata ya zama amfani.
Bugu da ƙari, NLRP3 inflammasome kunnawa a cikin bats ne mara kyau.
Ta wannan dalili, hana wutar lantarki na NLRP3 tare da MCC950 na iya zama da amfani a maganin COVID-19.
Saurin SARS-CoV-2 ya biyo bayan babban batun da SARS-CoV da MERS-CoV suka tashi.
Duk da yake an samu wani bat beta-CoV raba 95% nucleotide homology tare da SARS-CoV, akwai kuma bat-CoV raba 96% nucleotide homology tare da SARS-CoV-2.
Duk da yake an gano civets da sauran dabbobi a kasuwanni don kwayar cututtuka masu tashar jiragen ruwa daidai da SARS-CoV, ba a gano masu watsa shirye-shiryen tsaka-tsaki na SARS-CoV-2 ba.
An gano Pangolin beta-CoVs masu kama da SARS-CoV-2, wanda ke nuna cewa pangolins na iya zama ɗaya daga cikin masu karɓar bakuncin matsakaici ko pangolin beta-CoVs na iya ba da gudummawa ga ɓangaren kwayoyin halitta na ƙarshe na SARS-CoV-2.
Kodayake tambayoyi sun ci gaba, babu wata hujja cewa SARS-CoV-2 an yi mutum ko dai da gangan ko bala'i.
CoVs sun koma hasken rana saboda barkewar SARS-CoV-2 na kwanan nan.
Nazarin CoVs a cikin bukukuwan da sauran dabbobi ya canza sosai fahimtar mu game da muhimmancin asalin zoonotic da kuma tafkunan dabbobi na HCoVs a cikin watsawar ɗan adam.
Tabbatarwa mai mahimmanci ta nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 suna da asalin bat kuma ana watsa su ga mutane ta hanyar masu karɓar baƙi.
Tun da yake kamuwa da cutar SARS-CoV ya samo asali ne daga tuntuɓar tsakanin mutane da civets a kasuwanni, rufe kasuwanni da kisan civets a ciki zai iya kawo ƙarshen annobar SARS.
Ta hanyar wannan tunani, ya kamata a cire pangolins daga kasuwannin daji don hana yaduwar zoonotic, a la'akari da gano zuriyar pangolin beta-CoVs da ke da alaƙa da SARS-CoV-2.
Duk da haka, ko da kuma yadda SARS-CoV-2 ke watsawa ga mutane ta hanyar pangolins da sauran mahaifa har yanzu za a bayyana a cikin binciken nan gaba.
A gefe guda, MERS-CoV ya kasance a cikin raƙuman dromedary na dogon lokaci.
Wadannan raƙuman suna zama muhimmin kayan aiki don sufuri da kuma babban tushen nama, madara, fata da kayayyakin fata ga mutanen gida.
An rarraba su a duk faɗin Gabas ta Tsakiya da Afirka.
Saboda haka ba zai yiwu a miƙa dukkan raƙuman don sarrafa MERS ba, kamar yadda aka yi a kasuwannin dabbobin daji a kasar Sin don hana yaduwar SARS-CoV da SARS-CoV-2.
Don dakatar da barkewar cutar MERS, ya kamata a dauki cikakken tsari don haɓaka ingantaccen alluran rigakafi da MERS-CoV ga raƙuman, tare da wasu matakan sarrafa kamuwa da cuta.
Kamar yadda ba za mu iya kawar da waɗannan kwayoyin cuta ba, sababbin kwayoyin halitta na iya fitowa don haifar da barkewar cutar.
Akwai nau'i-nau'i daban-daban na zoonotic CoVs suna yaduwa a cikin daji.
Musamman, coVs tare da yiwuwar zoonotic suna daban-daban.
Akwai da dama da yawa da wadannan zoonotic CoVs ke haɓaka da kuma recombine, wanda ya haifar da fitowar sababbin CoVs waɗanda suka fi watsawa da / ko kisa a cikin mutane a nan gaba.
Ya kamata a bar al'adun cin dabbobin daji a wasu wurare na kasar Sin don rage hulɗa da ba dole ba tsakanin mutane da dabbobi.
Tare da matsalolin SARS, MERS da COVID-19, ya kamata a kasance mafi shirye-shirye da shirye-shiryen amsawa.
A gaskiya ma, yawancin kwayoyin cuta sun wanzu a duniya na dogon lokaci.
Suna zaune a cikin tashoshin nasu har sai an sami damar zubar da ciki.
Kodayake ƙwayar cuta tana da fasali da yawa waɗanda ke son yaduwar kwayar cuta, ana iya rage damar da mutane su kasance tare da ƙwayar ƙwayar ƙwayar cuta da sauran nau'ikan namun daji idan mutane suna koyar da su bar su.
Ci gaba da kulawa a cikin mahaifa yana buƙatar fahimtar ilimin muhalli na CoVs da masu karɓar su na halitta, wanda zai kasance da amfani wajen hana watsawa daga dabba zuwa mutum da barkewar nan gaba.
A ƙarshe, hanya mafi inganci don hana zoonosis na kwayar cutar ita ce ga mutane su guje wa wuraren muhalli na tafki na ƙwayoyin zoonotic.
Yawancin sassa a cikin guntu na asalin zoonotic na SARS-CoV-2 har yanzu basu ɓace ba.
Na farko, idan bats ya watsa kwayar cutar kakanni na SARS-CoV-2 zuwa pangolins, zai zama mai sha'awar ganin a karkashin abin da yanayin bats da pangolins zasu iya raba wannan tsarin muhalli.
Na biyu, idan bats suna taka rawar kai tsaye a cikin watsawar ɗan adam, ya kamata a ƙayyade yadda mutane suka shiga tare da bats.
Na uku, idan mahaifa na uku yayi aiki a matsayin mai watsa shiri na gaskiya, yadda yake hulɗa da nau'ikan daban-daban ciki har da mutane, bats da pangolins dole ne a bayyana.
A ƙarshe, tun da yawancin mahaifa ciki har da dabbobi na gida na iya zama mai yiwuwa ga SARS-CoV-2, ya kamata a gudanar da sa ido da kamuwa da cutar gwaji.
Idan ya kasance bat, pangolin ko wani mahaifa, ana sa ran cewa SARS-CoV-2 ko ƙwayoyin cuta na iyaye waɗanda suke kusan daidai ne za a gano su a cikin mahaifa na halitta a nan gaba.
Ci gaba da bincike a wannan yanki zai bayyana hanyar juyin juya hali na SARS-CoV-2 a cikin dabbobi, tare da muhimman tasiri a rigakafin da sarrafa COVID-19 a cikin mutane.
Ana buƙatar sabunta ka'idojin bincike na COVID-19 "matsakaicin da ake tsammani" da "matsakaicin da aka tabbatar"
A ranar 6 ga watan Fabrairun 2020, ƙungiyarmu ta wallafa jagorancin shawara mai sauri don ganowa da maganin cutar sabon coronavirus na 2019 (2019-nCoV), kuma wannan jagora ya ba mu kwarewarmu kuma yayi nazari sosai don yaki da wannan annoba a duk duniya.
Koyaya, cutar coronavirus ta 2019 (COVID-19) sabon cuta ne, iliminmu da iliminmu suna ƙaruwa a hankali bisa ga binciken bincike da kwarewar aikin asibiti; saboda haka, dabarun ganewa da magani kuma ana sabuntawa.
A cikin wannan wasiƙar, mun amsa wani sharhi game da jagorancinmu kuma muka bayar da sabbin ƙa'idodin bincike na "matsalar da ake tsammani" da "wanda aka tabbatar da shi" bisa ga sababbin hanyoyin bincike da magani na COVID-19 (sashe na bakwai) wanda kwamitin kiwon lafiya ta kasa na Jamhuriyar Jama'ar kasar Sin ya bayar.
A watan Disamba 2019, sabon coronavirus na 2019 (2019-nCoV) ya haifar da barkewar cutar, wanda yanzu an kira shi a hukumance a matsayin cutar coronavirus na 2019 (COVID-19) kuma an kira kwayar cutar coronavirus 2 (SARS-CoV-2).
A ranar 11 ga Maris 2020, WHO ta bayyana COVID-19 a matsayin annoba.
Don yaki da kamuwa da kamuwa da cutar SARS-CoV-2, ƙungiyarmu ta samar da jagorancin shawara mai sauri kuma an buga shi akan layi a cikin Binciken Likitoci na Soja a ranar 06 ga Fabrairu 2020.
Wannan ya jawo hankalin da yawa tun lokacin da aka buga shi.
Ka lura duk da haka cewa COVID-19 sabon cuta ne, iliminmu da iliminmu suna ƙaruwa a hankali dangane da binciken bincike da kwarewar aikin asibiti; saboda haka, dabarun bincike da magani suna ci gaba da sabuntawa.
Alal misali, jagoran bincike da magani na COVID-19 da kwamitin kiwon lafiya ta kasa na Jamhuriyar Jama'a ta kasar Sin (http://www.nhc.gov.cn/), tsakanin 16 ga Janairu 2020 zuwa 3 ga Maris 2020, ya ba da jimillar bugu bakwai tare da wasu mahaloli ana canza su sosai.
Yanzu jagorancinmu ya karɓi sharhi ta Zhou et al., sun gabatar da shawara mai sauƙi ta kwarewa bisa kwarewar asibiti.
Ayyukan su sun kara sababbin shaida don jagorancinmu kuma sun yi nazari mai muhimmanci ga wannan annobar a duk duniya.
Muna godiya ga aikinsu mai muhimmanci kuma muna nuna godiya.
Duk da haka, aikinsu yana buƙatar sabuntawa bisa ga sababbin hanyoyin bincike da magani na COVID-19 (Trial na bakwai) da kuma nazarin kwanan nan.
Bisa ga bugu na bakwai (3 Maris 2020), don tabbatar da shari'ar da ake zargi ya buƙaci haɗa kowane abu ɗaya na tarihin annobar tare da abubuwa biyu na nuna asibiti don yin cikakken bincike, ko buƙatar saduwa da abubuwa uku na bayyanar asibiti idan ba tare da tarihin annoba ba:
Tarihin annoba: (1) tarihin tafiya ko zama a birnin Wuhan da ke kewaye da su, ko kuma wasu al'ummomi inda aka ruwaito cutar COVID-19 a cikin kwanaki 14 da suka gabata kafin kamuwa da cutar; (2) tarihin tuntuɓar cutar SARS-CoV-2 (tare da gwaji mai kyau na nucleic acid); (3) tarihin tuntuwa da marasa lafiya da zazzabi ko alamun numfa daga birnin Wuhan da ke kewa <0xE2><0x89><0xA5> da kuma a cikin kwana, ko kuma a cikin kwana a cikin kwana biyu.
Nuna asibiti: (1) zazzabi da / ko alamun numfashi; (2) tare da siffofin hoto na kamuwa da cutar COVID-19; (3) jimlar ƙidayar kwayoyin jini da ke nuna al'ada, raguwa, ko raguwar ƙidayar limfocyte a farkon farawa.
Binciken da aka tabbatar da shari'ar ya kamata ya dogara ne akan shari'ar da ake zargi tare da kowane abu na kwayar cuta ko shaidar serology kamar haka: (1) Gwajin PCR na ainihin lokaci mai kyau don SARS-CoV-2; (2) jerin kwayoyin halitta na kwayar cutar coronavirus da aka sani da sabon coronavirus.
Zamu iya ganin cewa gwajin PCR na hakikanin lokaci don nucleic acid a cikin hanyoyin numfashi ko samfurori na jini ya kara zuwa bugu na biyu (18 Janairu 2020) da na uku (22 Janairu 2020).
An ƙara gano samfurin jini a cikin bugu na hudu (27 Janairu 2020) da na biyar (8 Fabrairu 2020); sannan an ƙara shaidar serological zuwa bugu na bakwai.
Wadannan gyare-gyare bisa binciken sun ci gaba da aiki don neman mafi kyawun kayan ganewa na nucleic acid don gano sauri, da samfurori daga hanyoyin numfashi ciki har da samfurin jini, wanda ya kara samun samfurori daban-daban, kuma ya tallafawa kawo takamaiman sakamako mai kyau a cikin ƙa'idodin da aka tabbatar.
Bugu da ƙari, akwai ƙarin shaidar da ke tunatar da mu da gargadi tare da marasa lafiya marasa alama da marasa alama.
Saboda haka, zane-zane na Zhou et al. ya kamata a sabunta, kamar yadda suka rarraba mutumin ba tare da alamun asibiti ba a matsayin "ƙananan haɗari".
Har ila yau, dole ne a tabbatar da tsarin ƙididdiga a cikin ƙarin aikin asibiti da nazarin.
Don kammala, muna fatan ƙarin bayani kai tsaye ya zo kuma muna kira ga masu karatu su ba da sharhinsu.
Don gano "matsakaicin shari'a" da "matsakaicin da aka tabbatar," muna bayar da shawarar gano da kuma bin sabbin jagororin ƙasashensu.
Har ila yau, ƙungiyarmu za ta sabunta jagorancinmu don bayar da taimako.
Bangladesh ta ruwaito sababbin mutuwar mutane biyar saboda COVID-19, mafi girma a kowace rana
A yau, Bangladesh ta tabbatar da sababbin mutuwar mutane biyar saboda COVID-19.
Wannan shine mafi yawan adadin mutuwar mutane a rana ɗaya saboda kwayar cutar.
Tun daga jiya, Cibiyar Kula da Cututtuka da Binciken Cututtuka ta Bangladesh (IEDCR) ta ba da rahoton adadin cututtukan da aka samu sun hada da shari'o'in 114 masu aiki da kuma shari'o'in 33 da aka dawo da su wadanda ke zaune a gida.
An samu rahoton mutuwar mutum 17.
A wani sakon labarai na kan layi, darektan IEDCR, Dr Meerjady Sabrina Flora, ya ce mutuwar ta hada da maza hudu da mace daya.
A cewar Dr Meerjady, shari'o'i biyu sun kai shekaru 60, biyu tsakanin 51 da 60, da kuma shekaru 41-50.
Ta kuma ce mutane biyu daga cikin wadanda ake zargin sun fito ne daga Habasha.
Hukumar Lafiya ta Duniya (WHO) ta bayyana cutar COVID-19 a ranar 11 ga Maris.
Wani jami'in asibiti ya sanar da hukumar Anadolu, wata manema labarai na gida, cewa daya daga cikin wadanda suka mutu shi ne Jalal Saifur Rahman, darektan hukumar yaki da cin hanci da rashawa ta Bengali, wanda aka kula da shi a asibitin Kuwait Maitree.
A ranar Asabar, a cikin sanarwar bidiyo ta yanar gizo, Ministan Sufuri ta Bangladesh da Bridges Obaidul Quader ya ce za a rufe sufuri na jama'a tsawon tsawon lokacin da aka shirya, har zuwa ranar Asabar mai zuwa.
An fara rufe sufuri na jama'a a farkon ranar 26 ga watan Maris kuma an shirya don ƙare a ranar Asabar, 4 ga Afrilu.
Har ila yau an ba da izinin sufuri na kayayyaki masu mahimmanci - likitanci, man fetur da abinci.
A ranar 8 ga watan Maris, a cikin mutane biyu da suka dawo daga Italiya da kuma matar daya daga cikinsu.
Tun daga ranar 19 ga watan Maris, waɗannan uku sun riga sun dawo.
SARS-CoV-2 ya wuce miliyan 1 a duniya
A ranar Alhamis, yawan adadin cututtukan cutar coronavirus na SARS-CoV-2 ya wuce miliyan ɗaya a duniya, bayanai na Jami'ar Johns Hopkins.
Akalla mutane dubu 52 ne suka mutu da COVID-19, cutar da ta haifar da coronavirus.
Matsayin ya zo ne a ranar da Malawi ta tabbatar da kamuwa da cututtukan coronavirus na farko kuma Zambia na da mutuwar farko da ke da alaƙa da coronavirus.
Koriya ta Arewa ta yi ikirarin cewa, a ranar Alhamis, ita ce ɗaya daga cikin kasashe kaɗan da ba su da kamuwa da cutar coronavirus.
A jiya, Hukumar Lafiya ta Duniya ta ba da rahoton shari'o'i 1,051,635 da aka tabbatar, ciki har da shari'o'i 79,332 a cikin awanni ashirin da huɗu da suka gabata 10:00 na safe na tsakiyar Turai (800 UTC) a ranar 4 ga Afrilu.
A Amurka, an yi rajista fiye da mutane dubu 244 na coronavirus, wanda ya haɗa da akalla mutuwar mutane 5,900.
Jami'ar Johns Hopkins ta bayar da rahoton cewa, a ranar Laraba, an samu mutuwar mutane sama da 1,000 daga Jami'ar Johns Hopkins, wanda ya haifar da kamuwa da cutar coronavirus.
A duk faɗin duniya, kasashe sun sanar da ƙarin matakan hana cutar daga yaduwar.
A ranar Alhamis, Sergei Sobyanin, babban birnin Moscow, ya tsawaita kullewa zuwa 1 ga Mayu.
Shugaban kasa, Vladimir Putin ya bayyana cewa za a ci gaba da biyan kuɗin Rasha ba tare da zuwa aiki ba har zuwa 30 ga Afrilu.
Majalisar dokokin Portugal ta kada kuri'a don tsawaita jihar ta gaggawa ta kwanaki 15; kuri'un sun wuce tare da kuri'u 215 da suka amince da kuri'u goma da kuri'u daya.
Saudi Arabia ta tsawaita haraji a biranen Makka da Madina har zuwa tsawon rana; a baya, an yi haramcin tsaka-tsakin ne kawai tsakanin karfe 3 na yamma zuwa 6 na yamma.
Thailand ta yi shirin aiwatar da tsaro tsakanin karfe 10 na safe da karfe 4 na safe.
Gwamnan jihar Ohio, Mike DeWine, ya sanar da cewa jihar ta tsawaita umarnin zama a gida har zuwa 1 ga Mayu.
Stores a Australia low toilet takarda iyakance da ma'amala
A ranar Lahadi da Asabar da yamma, sarƙoƙin kantin sayar da kaya na Australia Woolworths da Coles sun rage takunkumin sayen su a kan takardar wanka zuwa kunshin biyu da ɗaya a kowane ma'amala a duk kantin sayar da kaya a matakin ƙasa, bi da bi.
Har ila yau, ALDI ya gabatar da iyaka guda ɗaya, a ranar Litinin.
Wadannan iyakancewa an buga su a matsayin saƙonni a kan biyan kuɗi, da kuma a kan jerin shafukan Facebook.
An ba da rahoton cewa masu sayarwa suna stock up saboda tsoron COVID-19 idan mutane suna buƙatar rufe kansu.
A ranar Laraba, Woolworths kuma iyakance sayayya da takarda na wanka don isar da gida zuwa fakiti ɗaya a kowace oda.
Wadannan canje-canje sun biyo baya da fakitin hudu na kowane iyakacin ma'amala da Woolworths da Coles suka gabatar a ranar 4 ga Maris da 5 bi da bi.
"Coles, a cikin watan Maris 8 kafofin watsa labarai saki, rahotanni cewa tare da hudu-faki iyaka a wuri, ""Yawancin shagunan suna har yanzu sayar a cikin awa daya na bayarwa"", kuma ya kira bukatar ""ba a taɓa gani ba"" yayin da ALDI, a wani Facebook post a ranar Talata, da ake kira shi "ba tsammani" ". "
"Tallace-tallace ya tashi a cikin "ƙaruwa mai tsanani" makon da ya gabata, a cewar mai magana da yawon shakatawa. "
Kasuwancin Costco a Canberra ya kuma iyakance adadin da aka ba da izini ga fakitoci biyu makon da ya gabata.
Don ƙara rage rashin lafiya, Coles ya ba da umarnin manyan kunshin daga masu samar da ƙarin mita, Woolworths ya ba da umarnin ƙarin kadarorin, yayin da ALDI ya sanya hannun jari don ranar Laraba ta musamman da aka shirya da wuri.
Russell Zimmerman, babban daraktan kungiyar 'yan kasuwar Australia, ya ce 'yan kasuwa suna kokarin tada hannun jari, amma takunkumin majalisar dokoki akan lokaci na kayayyaki.
Yana sa ran haɓaka farashin samarwa, yayin da masu samar da kaya suna kokarin biyan bukatun, da ƙananan ƙwarewa.
A ranar Talata, ALDI ya sanar da cewa bayan saki na farko, wasu shagunan ba za su iya gudanar da taron na musamman na Laraba ba.
A wani rahoto na News.com.au, Dr. Gary Mortimer, masanin tallace-tallace daga Jami'ar Fasaha ta Queensland, ya ce shagunan sun cika hannun jari a kowace dare.
Ya lura da takardar wanka abu ne mai girma, wanda ke haifar da ƙananan adadin hannun jari a lambobi, kuma, lokacin da aka sayar da shi, ya bar sararin sararin samaniya ba su da komai, yana ƙarfafa jin karancin.
" ""Coles da Woolworths suna da ra'ayi [idan akwai abubuwa da yawa a kan tebur, idan samfurin kamar rolls da sanitizer zai iya zama [saye] kuma akwai a yawa, watakila za ku rage tsoro," in ji Russell Zimmerman a ABC News. "
A ranar Litinin da ya gabata, mai sana'ar da aka sake yin amfani da ita ya ce ba za su dauki nauyin su ba.
Kimberly-Clark, wanda ke sa Kleenex Toilet Tissue, da kuma Solaris Paper wanda ke yin Sorbent, sun jaddada cewa suna aiki 24/7 don kiyaye samar da su, a cewar News.com.au report.
Domain.com, wani shafin gida, ya ba da rahoton wasu masu siyar da dukiyar da ke ba da takarda kyauta kyauta ga mai gabatarwa na farko akan tallace-tallace a Melbourne, lokacin da aka gudanar da auctions kaɗan saboda masu sayarwa suna da lokaci don dogon karshen mako na ranar Labour.
Bugawar Alhamis na NT News, wanda aka buga kowace rana a Darwin, ya haɗa da sakin shafi takwas wanda aka yi amfani da shi a matsayin takardar wanka.
A cewar wata rahoto daga ABC Australia a ranar 3 ga watan Maris, wanda suka ce ba su da shirin gabatar da takunkumin a kan sayen.
Russell Zimmerman ya kara da cewa wasu kayayyakin kuma suna cikin babban buƙatar, ciki har da masks, sanitiser, bushewa kayayyakin, handwash da lu'u-lu'u.
Hakazalika, a waje da Australia, a ranar Lahadi da yamma a kan layi na kan layi na Birtaniya Ocado an lura da iyakance sayan takardar wanka na Andres zuwa fakitoci 12.
Hukumar Lafiya ta Duniya ta bayyana cutar COVID-19
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta bayyana barkewar COVID-19 - cutar da ta haifar da coronavirus SARS-CoV-2 - ta zama annoba.
"Kodayake kalmar ""annobar"" kawai tana nufin yadda cutar ta yadu, ba yadda wasu lokuta masu haɗari suke ba, WHO ta lura da bukatar fitar da gwamnatoci zuwa aiki: "
"Duk kasashe na iya canza hanyar wannan annobar."
"Idan kasashe sun gano, gwaji, kulawa, warewa, ganowa da kuma tattara mutanensu a cikin amsar," in ji Tedros Adhanom Ghebreyesus, Daraktan Janar na WHO.
"Muna damu sosai game da matakan yaduwar da tsanani da kuma matakan rashin aiki."
"A cewar Dr. Tom Fried, tsohon darektan Cibiyoyin Kula da Cututtuka na Amurka, ba a taɓa ganin annobar ba."
"Ya ce, a cikin jawabin da CNN ta wallafa a watan Fabrairun, "ba tare da fashewa ba, babu wani kwayar cutar numfashi da aka bi daga fitowa zuwa ci gaba da yaduwar duniya."
Ghebreyesus ya bayyana irin wannan ra'ayi, yana cewa, "Ba mu taɓa ganin annobar cutar coronavirus ba."
Ya ci gaba da cewa, "Kuma ba mu taɓa ganin annobar da za a iya sarrafa ta a lokaci guda ba."
Sabuwar matsayi a matsayin annobar ya biyo bayan yanke shawarar WHO a watan Janairu na sanar da cutar ta zama gaggawa na kiwon lafiyar jama'a na damuwa a duniya.
"Daraktan Cibiyar National ta Amurka na Allergy da Cututtukan Cututtuka, Dr. Anthony Fauci, ya ce game da barkewar, "Line na gaba, zai zama mafi muni."
A ranar Alhamis, Associated Press ta ruwaito cewa akwai akalla mutane 126,000 na COVID-19 a duk duniya, wanda ya haifar da mutuwar mutane sama da 4,600.
Cutar coronavirus ta 2019-20 annoba ce ta ci gaba da cutar coronavirus ta 2019 (COVID-19), wadda ta haifar da mummunar cutar coronavirus 2 (SARS-CoV-2).
An gano barkewar a Wuhan, China, a watan Disamba 2019, an bayyana shi a matsayin gaggawa ga lafiyar jama'a na damuwa ta duniya a ranar 30 ga Janairun 2020, kuma an gane shi a matsayin annobar a ranar 11 ga Maris 2020.
Tun daga ranar 10 ga Afrilu 2020, an ba da rahoto game da cutar COVID-19 miliyan 1.61 a ƙasashe 210 da yankuna, wanda ya haifar da kimanin 97,000.
Kimanin mutane 364,000 ne suka warke.
An kiyasta adadin mutuwar mutum ya kai kashi 4% a kasar Sin, yayin da yake tsakanin kashi 13.04% a Algeria zuwa kashi .08% a New Zealand.
Alamun cututtuka na yau da kullum sun haɗa da zazzabi, ciwo da kuma gajeren numfashi.
Cututtuka na iya haɗawa da pneumonia da cutar numfashi mai tsanani.
Lokaci daga bayyanar cututtuka zuwa farkon alamu yawanci yana kusa da kwanaki biyar, amma yana iya kasancewa daga kwanaki biyu zuwa goma sha huɗu.
Babu wata rigakafin da aka sani ko magani na musamman na antivirus.
Babban magani shine alama da kuma goyon bayan magani.Manufofin karewa da aka ba da shawara sun hada da wanke hannu, rufe bakin mutum yayin da yake yin makoki, kiyaye nisa daga wasu mutane, da sa ido da rufi da kai ga mutanen da ke zargin cewa sun kamuwa da cutar.
Hukumomi a duk duniya sun amsa ta hanyar aiwatar da takunkumi na tafiya, keɓewa, ƙaurace-tallace, iko da haɗarin aiki, da rufe wuraren.
Annobar ta haifar da mummunan rushewar zamantakewa ta tattalin arzikin duniya, jinkirta ko soke abubuwan wasanni, addini, siyasa da al'adu, da kuma rashin kayayyaki da yawa da aka kara ta hanyar sayen tsoro.
Makarantu da jami'o'i sun rufe ko dai a fadin kasa ko na gida a kasashe 193, suna shafar kimanin kashi 99.4 na yawan ɗaliban duniya.
Rashin bayanai game da kwayar cutar ya yadu a kan layi, kuma akwai abubuwan da suka faru na xenophobia da nuna bambanci a kan mutanen kasar Sin, wasu mutanen Gabas da Kudu maso Gabas ta Asiya da bayyanarsu, da sauransu daga yankuna masu dauke da cutar.
Saboda rage tafiye-tafiye da rufe masana'antu masu nauyi, an rage gurɓataccen iska da hayaki na carbon.
Hukumomin kiwon lafiya a Wuhan, China ( babban birnin lardin Hubei) sun ba da rahoton rahoton rahotanni da ba a san su ba a ranar 31 ga Disamba 2019, kuma an kaddamar da bincike a farkon Janairu 2020.
Yawancin lokuta suna da alaƙa da kasuwar abincin teku ta Huanan, don haka ana tunanin kwayar cutar tana da asalin zoonotic.
An san kwayar cutar da ta haifar da barkewar SARS-CoV-2, sabon kwayar cutar da aka gano a kusa da kwayar cutar coronavirus, pangolin coronavirus, da kuma SARS-CoV. Daga baya an gano mutumin da aka fi sani da alamun da ya fada a ranar 1 ga Disamba 2019, kuma wannan mutumin ba shi da alaƙa mai ban mamaki tare da rukunan kasuwa daga baya.
Daga cikin farkon tarin lokuta da aka ruwaito a watan Disamba na 2019, an gano kashi biyu bisa uku suna da alaƙa da kasuwa.
A ranar 13 ga watan Maris, 2020, rahoto da ba a tabbatar ba daga The South China Morning Post ya ba da shawarar cewa wani shari'ar da aka sake sake dubawa zuwa 17 ga Nuwamba 2019, a wani dan shekara 55 daga lardin Hubei, na iya zama na farko. A ranar 26 ga watan Fabrairun 2020, WHO ta ruwaito cewa, yayin da aka ruwai sabbin shari ya raguwa ya raguwa a kashi a kashi a kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar nan dai dai dai dai dai dai dai dai dai dai dai dai dai dai dai dai dai dai dai dai dai dai dai dai dai dai ta ta ta ta ta kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa ne ne ne nedadadadadadadadadadadadadadadadadadadadadadadadadadadadadada dai dai dai ta ta ta ta ta ta ta kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa da kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa da kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa da kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa kasa mu mu mu mu mu mu mu mu mu mu mu mu mu mu mu mu mu mu mu mu mu mu mu mu mu mu mu mu mu mudadadadadadadadadadadadadadadadadadadadadadadadadadadadadadadadadadadadadadadadadadadadadadadadadadadadadadadadadadadadada
Akwai yiwuwar rashin rahotanni masu yawa, musamman ma waɗanda ke da alamun cututtuka masu sauƙi.
A ranar 26 ga watan Fabrairun, an ba da rahoto a tsakanin matasa, tare da wadanda 19 kuma a karkashin kashi 2.4% na lokuta a duniya. Babban mai ba da shawarar kimiyya na Birtaniya, Patrick Vallance, ya kiyasta cewa 60% na yawan jama'ar Burtaniya za su buƙaci su kamuwa da cutar kafin a samu nasarar rigaka.
Cases yana nufin adadin mutanen da aka gwada su don COVID-19, kuma wanda aka tabbatar da gwajin su bisa ga ƙa'idodin hukuma.
Tun daga ranar 23 ga watan Maris, babu wata ƙasa da ta gwada fiye da kashi 3% na yawan jama'arta, kuma ƙasashe da yawa suna da manufofin hukuma don gwada waɗanda ke da alamun cututtuka kawai, kamar Italiya, Netherlands, Spain, da Switzerland.
Binciken da aka buga a ranar 16 ga Maris ya gano cewa a kasar Sin, har zuwa 23 ga Janairu, kimanin kashi 86% na kamuwa da cutar COVID-19 ba a gano su ba, kuma wadannan kamuwa da cututtukan da ba a rubuta su ne tushen kamuwa da cuta na kashi 79% na kamuwa da cuta.
Binciken kididdiga da aka buga a ranar 30 ga Maris ya kiyasta cewa adadin kamuwa da cututtuka a Italiya sun fi yawa fiye da wadanda aka ruwaito.
Kimanin farko na lambar asali (R0) na COVID-19 shine 1.4 zuwa 2.4.
Binciken da Cibiyar Kula da Cututtuka ta Amurka ta wallafa ya kammala cewa yana iya zama 5.7.
Yawancin mutanen da ke da cutar COVID-19 sun dawo.
Ga waɗanda ba su yi ba, lokaci daga ci gaban alamun zuwa mutuwa ya kasance tsakanin kwanaki 6 zuwa 41, tare da mafi yawan kwanaki 14.
Tun daga ranar 10 ga Afrilu, 2020, an danganta kimanin 97,000 ne ga COVID-19.
A kasar Sin, tun daga ranar 5 ga Fabrairu, kusan kashi 80% na mutuwar sun kasance a cikin wadanda sama da 60, kuma kashi 75% suna da yanayin lafiyar da suka gabata ciki har da cututtukan zuciya da ciwon sukari.
Adadin mutuwar gaske daga COVID-19 na iya zama mafi girma, saboda ba zai iya hada da mutanen da suka mutu ba tare da gwaji ba - misali a gida, a gidajen kulawa, da dai sauransu.
Bayanan da aka samu daga Italiya sun gano cewa yawan mutuwar da aka yi a lokacin annobar ya wuce mutuwar COVID ta hukuma ta hanyar factor na 4-5x.
"Wata mai magana da yawun Cibiyoyin Kula da Cututtuka na Amurka (CDC) ta amince da ""Mun san cewa [wanda aka bayyana mutuwar mutuwar] wani rahoto ne"," wata sanarwa da rahotanni da aka tabbatar da tabbacin rahotanni na rashin kididdigar a Amurka. Irin wannan rahoton sau da yawa yana faruwa a cikin annoba, kamar annoba na H1N1 2009.
Mutuwa ta farko a waje da kasar Sin ta faru a ranar 1 ga Fabrairu a Philippines, kuma mutuwar farko a waje da Asiya ta kasance a Faransa a ranar 14 ga Fabrairu.
A ranar 28 ga watan Fabrairu, a waje da kasar Sin, kowannensu ya mutu fiye da goma sha biyu a Iran, Koriya ta Kudu, da Italiya.
A ranar 13 ga Maris, fiye da kasashe arba'in da yankuna sun ba da rahoton mutuwar, a kowane nahiyar ban da Antarctica.
Wadannan lambobi sun bambanta da yankin da kuma tsawon lokaci, kuma suna tasiri da girman gwaji, ingancin tsarin kiwon lafiya, zaɓin magani, lokaci tun farkon barkewar cutar, da halaye na jama'a kamar shekaru, jima'i, da kuma lafiyar gaba ɗaya.
Bisa ga ƙididdiga na Jami'ar Johns Hopkins, rabo na mutuwa zuwa hali shine 6.0% (97,039 / 1,617,204) tun daga 10 ga Afrilu 2020.
Adadin ya bambanta da yankin.
A kasar Sin, kimantattun rabo na mutuwa zuwa mutuwa ya ragu daga 17.3% (ga wadanda ke da alamu a farkon 1-10 Janairu 2020) zuwa 0.7% (ga wadanda ke da alamun farawa bayan 1 Fabrairu 2020).Wasu matakai sun haɗa da yawan mutuwar mutum (CFR), wanda ke nuna kashi na mutanen da aka gano wadanda suka mutu daga cutar, da kuma cutar da cutar (IFR) wanda ya nuna kashi.
Wadannan ƙididdiga ba su da lokaci kuma suna bin takamaiman yawan jama'a daga kamuwa da cuta ta hanyar warware shari'a.
Yawancin masana kimiyya sun yi ƙoƙarin lissafin waɗannan lambobin ga wasu al'ummomi.
Cibiyar Magunguna ta Jami'ar Oxford ta kiyasta cewa adadin mutuwar kamuwa da cutar a gaba ɗaya yana tsakanin 0.1% zuwa 0.39%.
Babban kimantawa na wannan jerin ya dace da sakamakon gwajin farko na COVID-19 a Jamus, da kuma binciken kididdigar da ke bincika tasirin gwajin akan kimanin CFR.
WHO ta ce za a iya sarrafa cutar.
Tsawon lokaci da kuma ƙarshen barkewar basu tabbata ba kuma suna iya bambanta ta wurin wuri.
"Maciej Boni na Jami'ar Jihar Penn ya ce, "Ba a bincika ba, barkewar kamuwa da cutar sau da yawa ba, sa'an nan kuma ya fara raguwa lokacin da cutar ta fita daga masu karɓar baƙi. "
"Amma kusan ba zai yiwu a yi kowane hasashe mai mahimmanci a yanzu game da lokacin da hakan zai kasance."
"Babban mai ba da shawarar kiwon lafiya na gwamnatin kasar Sin Zhong Nanshan ya yi jayayya cewa za a iya wucewa a watan Yuni" idan za a iya tattara dukkan ƙasashe don bin shawarar WHO game da matakan da za a dakatar da yaduwar cutar.
"A ranar 17 ga Maris, Adam Kucharski na Makarantar Tsaro ta London &amp; Tropical Medicine ya bayyana cewa SARS-CoV-2 "zai zama yaduwa, watakila shekara guda ko biyu"."
"A cewar Nazarin Kwalejin Imperial wanda Neil Ferguson ya jagoranci, za a buƙaci nesa da wasu matakai" har sai da allurar rigakafi ta zama samuwa (matsakaicin watanni 18 ko fiye) ".
"William Schaffner na Jami'ar Vanderbilt ya ce, "Ina tsammanin ba zai yiwu ba cewa wannan coronavirus - saboda yana da sauƙin watsawa - zai ɓace gaba ɗaya" kuma "zai iya zama cutar yanayi, yana mai dawowa kowace shekara" "."
Sakamakon sake dawowa zai dogara ne akan rigakafin garuruwa da kuma yawan maye gurbin.
Alamun COVID-19 na iya zama marasa takamaiman kuma mutane masu kamuwa da cutar na iya zama marasa alama.
Mafi yawan cututtuka biyu sune zazzabi (88%) da bushewa na ciki (68%).
<0xC6><0x98>ananan cututtuka na kowa sun haɗa da gajiya, samar da ƙwayar numfashi (phlegm), asarar ma'anar numfashi, gajeren numfashi, tsoka da ciwon haɗin kai, ciwon kai, jijiyoyi, ciwo, hemoptysis, ciwo, ko cyanosis.The WHO ya ce kusan mutum daya daga cikin shida ya zama rashin lafiya sosai kuma yana da wahala.
Cibiyoyin kula da cututtuka da kuma hana cututtuka (CDC) na Amurka sun lissafa alamun gaggawa kamar wahalar numfashi, ciwon kirji ko matsin lamba, ba zato ba tsammani, wahalar farkawa, da kuma fuskar blue ko lebe; ana ba da shawarar kula da likita nan da nan idan waɗannan alamun suna nan.
Wasu daga cikin wadanda suka kamuwa da cutar na iya zama marasa alama, ba tare da alamun asibiti ba amma tare da sakamakon gwajin da ke tabbatar da kamuwa da cutar, don haka masu bincike sun ba da shawarar cewa waɗanda ke da alaƙa da tabbacin mutanen da ke da cutar ya kamata a kula da su da kuma bincika su hana kamuwa da cutar.
Kimanin kasar Sin na rabo na asintomatic ya kasance daga ƙananan zuwa 44%.
Lokacin da aka saba da shigarwar (lokacin tsakanin kamuwa da cuta da alamun farawa) ya kasance daga kwanaki ɗaya zuwa 14; mafi yawanci kwanaki biyar.A matsayin misali na rashin tabbas, kimanin kashi na mutanen da ke da COVID-19 waɗanda suka rasa ma'anar zafi ya kasance 30% kuma daga baya ya fadi zuwa 15%.
Har ila yau, wasu bayanan game da yadda ake yaduwar cutar.
An yi imanin cewa cutar ta yadu da farko yayin tuntuɓar kusanci da ƙananan ƙananan ƙananan da aka samar a lokacin ciwo, ƙishirwa, ko magana; tare da tuntuɓar kusa da kasancewa a cikin 1 zuwa 2 mita (3 zuwa 6 feet).
Nazarin ya gano cewa ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwa na iya haifar da ƙwaƙwalwar ƙwaƙwalwa zuwa mita 4.5 (15 feet) zuwa mita 8.2 (27 feet).
Wasu sun ba da shawarar cewa za a iya watsa kwayar cutar ta hanyar ƙananan ƙananan ƙananan da ke zaune na tsawon lokaci a cikin iska, wanda za a iya samar da shi yayin magana. Hakanan ana iya samar da ƙananan ƙananan ƙananan ƙananan lokacin numfashi, ciki har da lokacin magana, kodayake cutar ba gabaɗaya ba ta da iska.
Kwayoyi na iya sauka a cikin bakuna ko hanci na mutanen da ke kusa ko kuma wataƙila ana numfashi cikin huhu.
Wasu hanyoyin likita irin su intubetion da kardiopulmonary resuscitation (CPR) na iya haifar da numfashi aerosolized kuma hakan ya haifar da yaduwar iska.
Hakanan yana iya yaɗa lokacin da mutum ya taɓa wani abu mai laushi, ciki har da fata, sa’an nan kuma ya taɓa idanunsa, hanci, ko bakinsa.
Duk da yake akwai damuwa da za a iya yada ta hanyar fashewa, ana tsammanin wannan haɗarin yana da ƙananan.
Gwamnatin kasar Sin ta ƙaryata yiwuwar yaduwar SARS-CoV-2 na gajiya. Kwayar cutar ta fi kwayar cuta a cikin kwanaki uku na farko bayan farawar alamun cutar, kodayake yana iya yaduwa kafin a bayyana alamun kuma a matakai na baya na cutar.
Mutane sun gwada lafiyar cutar har zuwa kwana uku kafin bayyanar alamun da ke nuna yiwuwar watsawa kafin ta haifar da manyan alamun.
Kawai rahotanni kaɗan na shari'o'in da aka tabbatar da asintomatic sun wanzu, amma wasu ƙasashe sun gano asintomatic watsa a lokacin binciken da aka samo.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta bayyana cewa yayin da ba a bayyana yadda cutar ta yadu ba, mutum ɗaya gabaɗaya yana kamuwa da wasu biyu zuwa uku.
Musamman, an gano kwayar cutar har zuwa kwanaki uku a kan roba (polypropylene) da 304 bakin karfe, don rana ɗaya a kan kartani, kuma har zuwa awanni hudu a kan jan ƙarfe.
Wannan, duk da haka, ya bambanta dangane da zafi da zafin jiki.Pets da sauran dabbobi sun gwada kyau ga COVID-19.
Babu wata shaida dabbobi za su iya ba da kwayar cutar ga mutane, kodayake hukumomin Birtaniya sun ba da shawarar wanke hannun mutum bayan tuntuɓar dabbobi, kamar bayan tuntuɓar wasu saman da mutane suka kamuwa da cutar.
Kwayar cutar coronavirus 2 (SARS-CoV-2) mai tsanani ne na sabon kwayar cutar, na farko an ware shi daga mutane uku da ke da ciwon huhu da alaƙa da cututtukan cututtukan cututtukan numfashi a Wuhan.
Duk siffofin kwayar cutar SARS-CoV-2 suna faruwa a cikin coronaviruses masu alaƙa a cikin yanayi.A waje da jikin mutum, ana kashe kwayar ta hanyar sabulun gida, wanda ya rushe ta kariya.SARS-CoV-2 yana da alaƙa da asalin SARS-CoV.
An yi imanin cewa yana da asalin zoonotic.
Binciken kwayoyin halitta ya nuna cewa cutar coronavirus ta kwayar cutar tare da jinsin Betacoronavirus, a cikin Sarbecovirus (line B) tare da nau'i biyu da aka samo asali.
Yana da kashi 96% daidai a dukan matakin genome zuwa wasu samfurori na bat coronavirus (BatCov RaTG13).
A watan Fabrairun 2020, masu bincike na kasar Sin sun gano cewa akwai bambanci guda ɗaya na amino acid a wasu sassa na jerin kwayoyin halitta tsakanin kwayoyin cuta daga pangolins da wadanda daga mutane.
Kwatanta dukkanin kwayoyin halitta har zuwa yau ya gano mafi yawan kashi 92% na kayan kwayoyin halitta da aka raba tsakanin pangolin coronavirus da SARS-CoV-2, wanda bai isa ba don tabbatar da pangolins su zama mai karɓar baki.
Cutar ta kwayar cutar za a iya gano ta wucin gadi dangane da alamun cututtuka, kodayake tabbatarwa a ƙarshe ta hanyar mayar da layin polymerase (rRT-PCR) na kamuwa da cutar ko hotuna na CT.
Wani binciken da ya kwatanta PCR da CT a Wuhan ya nuna cewa CT ya fi dacewa fiye da PCR, kodayake ba a takaice ba, tare da yawancin siffofin zane-zane da sauran ƙwayoyin cuta da tsarin cuta.
Tun daga watan Maris 2020, Kwalejin Kula da Radiology ta Amurka ta ba da shawarar cewa “Ba za a yi amfani da CT don dubawa ko a matsayin gwajin farko don gano COVID-19” ba.
WHO ta wallafa ka'idojin gwajin RNA da dama don SARS-CoV-2, tare da farkon da aka bayar a ranar 17 ga Janairu.
Gwajin yana amfani da real-time reverse transcription polymerase sarkar reaction (rRT-PCR).
Ana iya yin gwajin a kan samfurori na numfashi ko jini.
Gabaɗaya ana samun sakamako a cikin 'yan sa'o'i zuwa kwanaki.
Gabaɗaya ana gudanar da wannan gwajin a kan nasopharyngeal swab kodayake ana iya amfani da magungunan magungunan.Mafi yawan laboratori da kamfanoni suna haɓaka gwaje-gwaje na serological, wanda ke gano kwayoyin halitta.
Tun daga ranar 6 ga Afrilu, 2020, babu ɗaya daga cikin waɗannan da aka tabbatar da isasshen daidai don amincewa don amfani da yawa.
A Amurka, an amince da gwajin serological wanda Cellex ya kirkiro don amfani da gaggawa ta laboratories kawai.
Siffofin zane-zane na siffofi akan rediyographs da kuma lissafi na tomography (CT) na mutanen da ke da alamu sun haɗa da opacities na gilashin ƙasa na asimmetric da kuma babu efffusions na pleural.
<0xC6><0x98>ungiyar Radiological ta Italiya tana tattara bayanan yanar gizo na duniya na binciken hotuna don tabbatar da shari'o'i.
Saboda rikice-rikice tare da sauran kamuwa da cututtuka irin su adenovirus, zane-zane ba tare da tabbacin PCR ba yana da takamaiman takamaiman gano COVID-19.
Wani babban bincike a kasar Sin ya kwatanta sakamakon CT na kirji zuwa PCR kuma ya nuna cewa kodayake hoto ya fi takamaiman kamuwa da cutar, yana da sauri kuma mafi m, yana ba da shawarar la'akari da shi a matsayin kayan aikin bincike a yankunan annoba.
An kirkiro hanyoyin sadarwa na ƙwayoyin cuta don gano siffofin hoto na kwayar cutar tare da radiographs da CT.
Dabarun hana watsawa na cutar sun haɗa da kiyaye tsabta mai kyau, wanke hannayen hannu, guje wa taɓa idanu, hanci, ko bakinka tare da hannuwan da ba a wanke su ba, da kuma yin jijiyoyi ko hanci a cikin nama da kuma sanya nama kai tsaye a cikin akwatin sharar gida.
Wadanda suka riga sun sami kamuwa da cutar, an ba da shawarar sanya mask a cikin jama'a.
Hakanan ana ba da shawarar matakan nesa na jiki don hana watsawa.Gwamnatoci da yawa sun ƙuntata ko sun ba da shawara kan duk tafiye-tafiye marasa mahimmanci zuwa da daga ƙasashe da yankunan da cutar ta shafi.
Duk da haka, kwayar cutar ta kai matakin yaduwar al'umma a yawancin sassan duniya.
Wannan yana nufin cewa kwayar cutar tana yadu a cikin al'ummomi, kuma wasu mambobin al'umma ba su san inda ko yadda aka kamuwa da cutar ba. Ana ba da shawarar masu kula da lafiya da ke kula da wani wanda zai iya kamuwa da cutar don amfani da tsaro na yau da kullun, matakan tuntube, da kare idanu.
Amfani da bayanan wuri daga wayoyin hannu da gwamnatocin ke yi don wannan dalili ya haifar da damuwa game da sirrin sirri, tare da Amnesty International da kuma fiye da 100 wasu kungiyoyi da ke ba da sanarwa da ake kira iyakancewar irin wannan sa ido.
An aiwatar da aikace-aikace daban-daban na wayar hannu ko kuma an gabatar da shi don amfani da sa kai, kuma daga ranar 7 ga Afrilu, 2020, sama da ƙungiyoyin ƙwararrun goma suna aiki akan hanyoyin da ke da kyau, kamar yin amfani da Bluetooth don yin rajista kusancin mai amfani da sauran wayar salula.
Sa'an nan masu amfani za su karɓi saƙo idan sun kasance a cikin dangantaka da wani wanda ya gwada lafiya don COVID-19.Misconceptions suna yada game da yadda za a hana kamuwa da cutar; misali, wanke hanci da gugling da bakin wanka ba su da tasiri.
Babu allurar rigakafin COVID-19, kodayake ƙungiyoyi da yawa suna aiki don haɓaka ɗaya.
Ana ba da shawarar wanke hannu don hana yaduwar cutar.
CDC ya ba da shawarar mutane su wanke hannayensu sau da yawa tare da sabulu da ruwa don akalla ashirin seconds, musamman bayan tafiya zuwa wanka ko lokacin da hannayensu suke da marmari; kafin cin abinci; da kuma bayan busa hanci na mutum, ciwo, ko hakori.
Wannan shi ne saboda a waje da jikin mutum, kwayar cutar ta kashe ta hanyar sabulun gida, wanda ya fashe da bubble na kariya.
CDC ya kara ba da shawarar yin amfani da mai tsabtace hannu mai tushen giya tare da akalla 60% barasa ta hanyar girma lokacin da sabulu da ruwa ba su samuwa ba.
WHO ta ba da shawarar mutane su guji taɓa idanu, hanci, ko bakin da ba a wanke hannu ba.
Ana iya cire surfaces tare da mafita da dama (a cikin minti daya na bayyanar da disinfectant ga wani bakin karfe surface), gami da 62-71% ethanol, 50-100% isopropanol, 0.1% sodium hypochlorite, 0.5% hydrogen peroxide, da 0.2-7.5% povidone-iodine.
Sauran hanyoyin, kamar benzalkonium chloride da chrohexidine gluconate, sun fi tasiri.
CDC ya ba da shawarar cewa idan an zargi ko tabbatar da shari'ar COVID a wani wuri kamar ofishin ko kulawar rana, ya kamata a tsaftace duk yankunan kamar ofisoshin, wanka, yankuna na yau da kullun, kayan lantarki da aka raba kamar allunan, allon taɓawa, keyboards, kulawa nesa, da injin ATM waɗanda marasa lafiyarsu ke amfani da su.
<0xC6><0x98>ungiyoyin kiwon lafiya sun ba da shawarar cewa mutane su rufe bakinsu da hanci da ganye ko namiji lokacin da suka yi nauyi ko ƙanshi, da kuma zubar da kowane nama nan take.
Ana ba da shawarar abin rufe fuska ga waɗanda za su iya kamuwa da cutar, kamar yadda sanya abin rufe fuska zai iya iyakance girman da kuma nisan tafiya na ƙananan ƙananan ƙananan da aka warwatse yayin magana, ƙishirwa, da kuma ciwo.
WHO ta ba da umarnin lokacin da kuma yadda za a yi amfani da masks.
"A cewar Stephen Griffin, masanin ilimin halittu a Jami'ar Leeds, "Lokacin da ke sanya abin rufe fuska na iya rage yawan mutane don taɓa fuskarsu, wanda shine babban tushen kamuwa da cutar ba tare da tsabtace hannu ba." "Masks kuma an ba da shawarar yin amfani da wadanda ke kula da mutumin da cutar. "
WHO ta ba da shawarar saka mask ɗin mutane masu lafiya kawai idan suna cikin haɗari, kamar waɗanda suke kula da mutumin da ke da COVID-19, ko da yake suna kuma yarda cewa saka mask na iya taimaka wa mutane su guji taba fuskarsu.
Yawancin ƙasashe sun fara karfafa amfani da mask ɗin fuska ta membobin jama'a.
A Amurka, CDC ya ba da shawarar saka abin rufe fuska mara magani wanda aka yi daga tufafi.China ta ba da shawarar musamman yin amfani da abin rufe fuskar likita mai laushi ta membobi masu lafiya na jama'a, musamman lokacin da suka zo kusa da dangantaka (1 m (3 ft) ko kasa) tare da wasu mutane.
Hong Kong ta ba da shawarar saka abin rufe fuska a lokacin daukar sufuri na jama'a ko zauna a wurare masu tasowa.
Jami'an kiwon lafiya na Thailand suna ƙarfafa mutane su yi abin rufe fuska a gida kuma su wanke su kowace rana.
Jamhuriyar Czech da Slovakia sun haramta fita a cikin jama'a ba tare da sanya mask ko rufe bakin mutum ba.
A ranar 16 ga Maris, Vietnam ta bukaci kowa da kowa ya sanya abin rufe fuska yayin tafiya zuwa wuraren jama'a don kare kansu da sauransu.
Gwamnatin Austria ta ba da umarnin cewa duk wanda ya shiga kantin sayar da kayan ado dole ne ya sanya mask fuska.
Isra'ila ta bukaci kowa da kowa ya sanya abin rufe fuska a lokacin da yake cikin jama'a.
Taiwan, wanda ke samar da abin rufe fuska miliyan goma a kowace rana tun tsakiyar watan Maris, ya bukaci fasinjoji a kan jiragen kasa da bas din su sanya abin rufe fuska a ranar 1 ga Afrilu.
Panama ta sanya wajibi ne a sanya abin rufe fuska a duk lokacin da yake waje, yayin da yake ba da shawarar yin abin rufe fuska na gida ga waɗanda ba za su iya saya abin rufe fuska ba.
An kuma yi amfani da abin rufe fuska a Japan, Koriya ta Kudu, Malaysia, da Singapore.
Nisa na zamantakewa (wanda aka fi sani da nisa na jiki) ya haɗa da ayyukan sarrafa kamuwa da cuta da aka yi niyya don rage yaduwar cututtuka ta hanyar rage dangantaka tsakanin mutane.
Hanyoyin sun haɗa da keɓewa; ƙuntatawa ta tafiye-tafiye; da rufe makarantu, wuraren aiki, filayen wasanni, wasan kwaikwayo, ko cibiyoyin shopping.
Mutane za su iya amfani da hanyoyin nesa na zamantakewa ta wajen zauna a gida, iyakance tafiya, guje wa yankuna masu taru, yin amfani da gaisuwa ba tare da tuntuɓar ba, da kuma nisantar kansu daga wasu.
Gwamnatoci da yawa yanzu suna ba da umarni ko kuma bayar da shawarar nisantar zamantakewa a yankunan da cutar ta shafa.
Matsakaicin girman taro da hukumomin gwamnatin Amurka da kungiyoyin kiwon lafiya suka ba da shawarar da aka rage daga mutane 250 (idan ba a san COVID-19 ba a yankin) zuwa mutane 50, sannan daga baya zuwa mutane 10.
"A ranar 22 ga Maris 2020, Jamus ta haramta taron jama'a fiye da mutane biyu.Tsohon manya da waɗanda ke da yanayin likita kamar su ciwon sukari, cutar zuciya, cutar numfashi, hypertension, da kuma tsarin rigakafi sun fuskanci karuwar hadarin ciwo mai tsanani da rikice-rikice kuma CDC ta ba da shawarar su kasancewa gida kamar yadda zai yiwuri a ya yiwu a yayin dacewa a wurare a wurarewar cutar da jama'a na al'a.
" Amfani da kalmar "" nisa ta zamantakewa " " ya haifar da tasirin cewa mutane ya kamata su shiga cikin cikakken warewar zamantakewa, maimakon ƙarfafa su su kasance tare da wasu ta hanyar madaidaiciya. Wasu hukumomi sun ba da umarnin kiwon lafiya don amfani a lokacin annobar. "
Wadannan sun haɗa da shawarwari don yin jima'i kawai tare da wani da kake zaune tare da shi, wanda ba shi da kwayar cutar ko alamun kwayar cutar.
An ba da shawarar rufe kansu a gida ga waɗanda aka gano da COVID-19 da waɗanda suka yi zargin cewa sun kamu da cutar.
Hukumomin kiwon lafiya sun bayar da cikakken umarnin rufe kai da ya dace. Gwamnatoci da yawa sun ba da umarni ko sun ba da shawarar kiwon lafiya ga dukan al'ummomin da ke zaune a yankunan da suka shafa.
An ba da umarnin da aka fi ƙarfin kai na kiwon lafiya ga waɗanda ke cikin manyan ƙungiyoyi masu haɗari.
Waɗanda suka iya fallasa ga wani da ke da COVID-19 da kuma waɗanda suka yi tafiya kwanan nan zuwa wata ƙasa ko yanki tare da yaduwar yaduwar, an ba da shawarar su yi wa kansa kiwon lafiya na kwanaki 14 daga lokacin da za a iya nunawa na ƙarshe.
Dabarun da ke kula da barkewar barkewa sune ƙuntatawa ko kawar da su, da ragewa.
Ana gudanar da rikodin a farkon matakai na barkewar kuma yana nufin ganowa da ware wadanda suka kamu da cutar da kuma gabatar da wasu matakan kula da kamuwa da cutar da allurar rigakafi don hana cutar daga yadawa ga sauran jama'a.
Lokacin da ba zai yiwu a dakatar da yaduwar cutar ba, ƙoƙarin sannan ya koma matakin ragewa: ana daukar matakai don rage yaduwar da kuma rage tasirinsa akan tsarin kiwon lafiya da al'umma.
Ana iya yin haɗin haɗin haɗin haɗin biyu da matakan ragewa a lokaci guda.
Ragewa yana buƙatar ƙarin matakan da za su mayar da annobar ta hanyar rage adadin haihuwar asali zuwa kasa da 1.Part na gudanar da barkewar kamuwa da cutar yana ƙoƙarin rage yawan annobar, wanda aka sani da ƙaddamar da cutar.
Wannan yana rage haɗarin ayyuka na kiwon lafiya da kuma samar da ƙarin lokacin da za a bunkasa allurai da magani.
<0xC6><0x98>ungiyoyin da ba su da magungunan da za su iya sarrafa barkewar sun haɗa da matakan kare kai, kamar tsabtace hannu, tufafin fuska, da kuma kiwon kai; matakan al'umma da ke nufin nesa da jiki kamar rufe makarantu da soke taron abubuwan da suka faru.
Sauran kasashe kuma sun yi amfani da matakai daban-daban da ke nufin hana yaduwar kwayar cutar.
Koriya ta Kudu ta gabatar da binciken taro da ke sanya takwarorina, kuma ta ba da gargadi game da motsi na mutanen da suka kamu da cutar.
Singapore ta ba da tallafi na kudi ga wadanda suka kamu da kansu kuma ta sanya manyan kudade ga waɗanda suka kasa yin hakan.
Taiwan ta ƙara samar da mask fuska da kuma azabtar da adana kayan aikin likita.Simulations ga Birtaniya da Amurka sun nuna cewa ragewa (kimantawa amma ba hana yaduwar annoba) da kuma mamayewa (matsalar ci gaban annoba) suna da manyan kalubale.
Manufofin ragewa mafi kyau na iya rage yawan buƙatun kiwon lafiya ta 2/3 da mutuwar rabi, amma har yanzu yana haifar da daruruwan dubban mutuwa da tsarin kiwon lafiya.
Za a iya fi so kawar da cutar amma dole ne a kiyaye shi muddin kwayar cutar tana yaduwa a cikin jama'ar ɗan adam (ko har sai allurar rigakafin ya zama available, idan wannan ya zo da farko), kamar yadda watsawa ya sake dawo da sauri lokacin da matakai ke hutawa.
Tsakanin tsawon lokaci don kawar da cutar yana haifar da farashin zamantakewa da tattalin arziki.
Babu takamaiman magungunan antivirus da aka amince da COVID-19, amma kokarin ci gaba suna gudana, ciki har da gwajin magani na yanzu.
Yin amfani da magunguna masu sanyi, shan ruwa, da hutawa na iya taimakawa wajen rage alamun.
Dangane da tsananin, magani na oxygen, ruwa na intravenous, da kuma goyon bayan numfashi na iya buƙatar.
Amfani da steroids na iya haifar da mummunan sakamako.
Yawancin mahalarta da aka amince da su a baya don maganin wasu cututtukan kwayar cutar ana bincika su don amfani da su wajen magance COVID-19.
"WHO ta kuma bayyana cewa wasu maganin gargajiya da gida" na iya samar da jinkirin alamun da SARS-CoV-19 ya haifar.
<0xC6><0x98>ara iyawa da daidaita kiwon lafiya ga bukatun marasa lafiya na COVID-19 WHO ta bayyana a matsayin ma'auni mai mahimmanci na magance barkewar cutar.
ECDC da ofishin yankin Turai na WHO sun ba da umarni ga asibitoci da sabis na kiwon lafiya na farko don sauya albarkatun a matakai daban-daban, ciki har da mayar da hankali ga ayyukan gwaje-gwaje don gwajin COVID-19, soke hanyoyin zaɓaɓɓen a duk lokacin da zai yiwu, raba marasa lafiya masu kyau na COVID-19, da kuma haɓaka yawan masu kula da masu kulawa.
Akwai ra'ayoyi daban-daban game da inda batun farko (wanda ake kira mai haƙuri zero) zai iya samo asali.
Shari'ar farko da aka sani game da sabon coronavirus na iya samo asali zuwa 1 ga Disamba 2019 a Wuhan, Hubei, China.
A cikin wata daya, yawan cutar coronavirus a Hubei ya karu a hankali.
Wadannan galibi suna da alaƙa da kasuwar abincin teku ta Huanan, wanda kuma ya sayar da dabbobi masu rai, kuma ka'idar ɗaya ita ce cewa kwayar cutar ta fito daga ɗayan waɗannan dabbobi; ko, a wasu kalmomi, tana da asalin zoonotic.A pneumonia cluster na dalilin da ba a sani ba an lura da shi a ranar 26 ga watan Disa.
"A ranar 30 ga Disamba, wata kungiyar likitoci a Asibitin Wuhan ta Tsakiya ta sanar da abokan aikinsu game da ""SARS-kamar coronavirus""."
Takwas daga cikin wadannan likitoci, ciki har da Li Wenliang, 'yan sanda sun gargadi su kan yada jita-jita na ƙarya, kuma wasu, Ai Fen, sun yi watsi da su daga sarakunanta don ƙararrawa.
Daga baya Hukumar Lafiyar Municipal ta Wuhan ta fitar da sanarwar jama'a a ranar 31 ga Disamba kuma ta sanar da WHO.
An ba da rahoto ga hukumomin kiwon lafiya a Wuhan don fara bincike a farkon Janairu.A lokacin farkon barkewar cutar, yawan lokuta sun yi kusan kusan kowane kwanaki bakwai da rabi.
A farkon Janairu da tsakiyar 2020, kwayar cutar ta yadu zuwa sauran larduna na kasar Sin, wanda ya taimaka ta hanyar ƙaurawar Sabuwar Shekara ta kasar Sin kuma Wuhan ya kasance cibiyar sufuri da manyan musayar jirgin kasa.
A ranar 20 ga watan Janairu, China ta ba da rahoton sababbin shari'o'i 140 a rana guda, ciki har da mutane biyu a Beijing da ɗaya a Shenzhen.
Daga baya bayanan hukuma ya nuna cewa mutane 6,174 sun riga sun sami alamun cututtuka a ranar 20 ga Janairu 2020.A ranar 26 ga watan Maris, Amurka ta mamaye China da Italiya tare da mafi yawan wadanda aka tabbatar da su a duniya.A ranar 9 ga Afrilu 2020, an ba da rahoton fiye da mutum miliyan 1.61 a duk duniya; fiye da mutane 97,000 sun mutu kuma fiye da 364,000 sun warke.
Kimanin ƙasashe 200 da yankuna suna da akalla shari'a daya.
Saboda annobar a Turai, kasashe da dama a yankin Schengen sun iyakance 'yanci da kuma kafa iko kan iyaka.
Amsoshin kasa sun haɗa da matakan ƙuntatawa irin su kwararru (wanda aka sani da umarnin zama a gida, umarnin mafaka, ko kulle-lokaci) da kuma guitarwa.A ranar 2 ga Afrilu, kusan mutane miliyan 300, ko kusan 90% na yawan jama'a, suna ƙarƙashin wani nau'i na kulle a Amurka, fiye da mutane miliyan 50 suna kullewa a Philippian, kusan mutane miliyan 59 ne a cikin kullewa a Afidancin Afinan Afinan Afinan Afinan Afia.
A ranar 26 ga watan Maris, mutane biliyan 1.7 a duniya suna ƙarƙashin wani nau'i na kullewa, wanda ya karu zuwa mutane biliyan 2.6 kwanaki biyu bayan haka - kusan kashi uku na yawan jama'ar duniya.
An gano shari'ar COVID-19 ta farko da aka tabbatar da ita har zuwa 1 ga Disamba 2019 a Wuhan; wani rahoto da ba a tabbatar da shi ba ya nuna cewa farkon shari'ar ya kasance a ranar 17 ga Nuwamba.
Likitan Zhang Jixian ya lura da cutar da ba a san dalili ba a ranar 26 ga Disamba, inda asibitinta ta sanar da Wuhan Jianghan CDC a ranar 27 ga Disamba.
Gwajin kwayoyin halitta na farko na samfuran marasa lafiya a ranar 27 ga Disamba 2019 ya nuna kasancewar coronavirus kamar SARS.
Hukumar Lafiya ta Hukumar Wuhan ta fitar da sanarwar jama'a a ranar 31 ga Disamba.
An sanar da WHO a wannan rana.
"A yayin da wadannan sanarwar suka faru, 'yan sanda sun gargadi likitoci a Wuhan game da ""fadawa jita-jita"" game da barkewar. "
Hukumar kiwon lafiya ta kasar Sin ta farko ta yi ikirarin cewa babu "ainihin shaida" na watsawa daga mutum zuwa mutum.
"A karshen watan Janairu, gwamnatin kasar Sin ta kaddamar da yakin neman zaɓe mai tsanani daga baya da babban sakataren Jam'iyyar Kwaminis ta kasar Sin Xi Jinping ya bayyana a matsayin "yakin mutane" don ɗaukar yaduwar cutar.
"A cikin abin da aka bayyana a matsayin ""mafi girma a cikin tarihin ɗan adam""," an sanar da wani cordon na lafiya a ranar 23 ga Janairu dakatar da tafiya a kuma daga Wuhan, wanda aka fadada zuwa jimillar birane 15 a Hubei, wanda ya shafi kimanin mutane miliyan 57. "
An dakatar da amfani da motoci masu zaman kansu a birnin.
An soke bikin Sabuwar Shekara ta China (25 Janairu) a wurare da yawa.
Hukumomi sun kuma sanar da gina asibiti na wucin gadi, asibitin Huoshenshan, wanda aka kammala a cikin kwanaki 10.
An gina wani asibiti bayan haka, asibitin Leishenshan, don kula da ƙarin marasa lafiya.
Baya ga sabon asibitoci da aka gina, kasar Sin ta mayar da wasu wurare 14 a Wuhan, kamar cibiyoyin taron da filayen wasanni, zuwa asibitoci na wucin gadi.A ranar 26 ga Janairu, gwamnati ta kafa ƙarin matakan da za su dauki barkewar COVID-19, ciki har da fitar da sanarwar kiwon lafiya ga matafiya da kuma tsawon hutuwar bazarar bazara.
An kuma rufe jami'o'i da makarantu a fadin kasar.
Yankunan Hong Kong da Macau sun kafa matakai da dama, musamman dangane da makarantu da jami'o'i.
An kafa matakan aiki na nesa a yankuna da yawa na kasar Sin.
An ƙaddamar da takunkumin tafiye-tafiye a ciki da waje na Hubei.
An canza sufuri na jama'a, kuma an rufe gidajen tarihi a ko'ina cikin kasar Sin na ɗan lokaci.
"An yi amfani da sarrafa motsi na jama'a a birane da yawa, kuma an kiyasta cewa kimanin mutane miliyan 760 (fiye da rabin yawan jama'a) sun fuskanci wani nau'i na iyakancewa a waje. Bayan barkewar ta shiga matakin duniya a watan Maris, hukumomin kasar Sin sun dauki matakai masu tsanani don hana kwayar cutar daga "mai" daga wasu ƙasashe.
Alal misali, Beijing ta sanya takunkumi na kwanaki 14 ga dukan matafiya na kasa da kasa da suka shiga birnin.A ranar 23 ga Maris, babban kasar China dai wani shari'ar da aka watsa a cikin gida a cikin kwanaki biyar da suka gabata, a wannan yanayin ta hanyar matafiya dawowa Guangzhou daga Istanbul.
A ranar 24 ga Maris, 2020, Firayim Ministan kasar Sin Li Keqiang ya ruwaito cewa yaduwar cututtukan da aka watsa a cikin gida an dakatar da shi kuma an sarrafa barkewar a kasar Sin.
A wannan rana an sauƙaƙe takunkumin tafiya a Hubei, ban da Wuhan, watanni biyu bayan an sanya kullewa.Ma'aikatar harkokin waje ta kasar Sin ta sanar a ranar 26 ga Maris 2020 cewa za a dakatar da shiga don biza ko ma'aikatan izinin zama daga ranar 28 ga Maris, ba tare da cikakken bayani game da lokacin da wannan manufofin zai ƙare ba.
Wadanda suke so su shiga kasar Sin za su nemi visa a ofisoshin jakadancin kasar Sin ko kwasultan kasar Sin.
Gwamnatin kasar Sin ta ƙarfafa kasuwanci da masana'antu su sake budewa a ranar 30 ga watan Maris, kuma ta samar da kungiyoyi masu tasowa na kudi ga kamfanoni. Majalisar Jihar ta ayyana ranar makomar da za ta fara da shiru na minti uku na kasa a ranar 10:00 4 ga watan Afrilu, tare da bikin Qingming, ko da yake cewa gwamnatin ta buka wa iyalai da iyalansu su biyantar da su biyantar da su a kan layin a kan layi don biyantar da su a kan layi a kan layi a kan layi a kan layi na nesa na nesa.
An tabbatar da cewa COVID-19 ya yadu zuwa Koriya ta Kudu a ranar 20 ga Janairun 2020 daga China.
Hukumar kiwon lafiya ta kasar ta ba da rahoton karuwar da aka tabbatar a ranar 20 ga watan Fabrairu, wanda aka danganta shi da taron da aka yi a Daegu na wani sabon rukuni na addini da aka sani da Cocin Shincheonji na Yesu.
An zargi masu bauta wa Shincheonji da ke ziyarci Daegu daga Wuhan a matsayin asalin barkewar.
Tun daga ranar 22 ga watan Fabrairun, daga cikin mabiya 9,336 na coci, 1,261 ko kusan 13% sun ba da rahoton alamun cututtuka. Koriya ta Kudu ta bayyana mafi girma a ranar 23 ga Fabrairu 2020.
A ranar 28 ga watan Fabrairu, an ba da rahoto game da shari'o'i sama da 2,000 a Koriya, inda ya kai 3,150 a ranar 29 ga Fabrairu.
Dukkanin sojojin Koriya ta Kudu an keɓe su ne bayan gwajin sun tabbatar da cewa sojoji uku suna da kyau ga kwayar cutar.
Koriya ta Kudu ta gabatar da abin da aka ɗauka shirin mafi girma kuma mafi kyau a duniya don duba yawan jama'a don cutar, da kuma ware duk mutanen da suka kamuwa da cutar, da kuma bincika da kewaye waɗanda suka tuntube su.
Hanyoyin bincike sun haɗa da wajibi ne a bayar da rahoton alamomi ta sababbin masu zuwa a duniya ta hanyar aikace-aikacen wayar hannu, gwajin gwajin kwayar cutar tare da sakamakon da ke samuwa a rana mai zuwa, da kara yawan gwajin gwaji don ba da izinin gwaji har zuwa 20,000 a kowace rana.
An yi la'akari da shirin Koriya ta Kudu a matsayin nasarar sarrafa barkewar barkewar cutar duk da ba a keɓe dukkan biranen ba.
Yawancin 'yan Korean sun sanya hannu kan roƙo ko dai suna kiran daukar Moon kan abin da suka yi ikirarin cewa gwamnati ce ke magance barkewar barkewar baki, ko kuma yaba wa amsarsa.
A ranar 23 ga watan Maris, an ruwaito cewa Koriya ta Kudu tana da mafi ƙasƙanci na kwana ɗaya a cikin makonni huɗu.
A ranar 29 ga watan Maris, an ba da rahoton cewa tun daga farkon 1 ga watan Afrilu, duk sababbin masu zuwan kasashen waje za a keɓe su na tsawon makonni biyu.
A ranar 1 ga watan Afrilu, Koriya ta Kudu ta karbi neman taimakon gwajin kwayar cutar daga kasashe 121 daban-daban.
Iran ta ba da rahoton shari'ar ta farko da aka tabbatar da cutar SARS-CoV-2 a ranar 19 ga watan Fabrairu a birnin Qom, inda, a cewar Ma'aikatar Lafiya da Ilimi na Kiwon Lafiya, mutane biyu sun mutu daga baya a wannan rana.
Ayyukan farko da gwamnati ta sanar sun hada da soke wasanni da sauran abubuwan al'adu, abubuwan wasanni, da sallar Jumma'a, da rufe jami'o'i, cibiyoyin ilimi mafi girma, da makarantu.
Iran ta ba da dala biliyan biyar don yaki da cutar.
Shugaba Hassan Rouhani ya ce a ranar 26 ga watan Fabrairun 2020 babu wani shiri da ke ketare yankunan da cutar ta shafa, kuma mutane ne kawai za a ketare.
An sanar da shirye-shiryen iyakance tafiya tsakanin birane a watan Maris, kodayake zirga-zirga mai tsanani tsakanin biranen kafin Sabuwar Shekara ta Farisa Nowruz ya ci gaba.
Iran ta zama cibiyar yaduwar cutar bayan kasar Sin a watan Fabrairu.
A tsakiyar da'awar rufe yawan barkewar cutar a Iran, fiye da kasashe goma sun koma Iran a ranar 28 ga watan Fabrairu, wanda ya nuna cewa yawan barkewar cutar na iya zama mafi tsanani fiye da 388 da gwamnatin Iran ta ruwaito a wannan rana.
An rufe Majalisar Iran, inda 23 daga cikin mambobinta 290 suka ruwaito cewa sun yi gwajin cutar a ranar 3 ga Maris.
A ranar 12 ga watan Maris, hukumomin kare hakkin dan Adam sun bukaci hukumomin fursunonin Iran su saki masu kare hakkin dan adam da aka tsare saboda rashin amincewa da zaman lafiya, kuma su saki duk fursunoni da suka cancanta na ɗan lokaci.
Ya bayyana cewa akwai haɗarin cutar da za a yada a rufe cibiyoyin kamar cibiyoyin tsarewa, waɗanda kuma ba su da isasshen kulawa da lafiya.
A ranar 15 ga watan Maris, gwamnatin Iran ta ba da rahoton mutuwar mutum 100 a rana daya, mafi yawan wadanda aka rubuta a kasar tun lokacin da barkewar cutar ta fara.
Akalla mutane 12 ko tsohon 'yan siyasar Iran da jami'an gwamnati sun mutu daga cutar har zuwa ranar 17 ga Maris.
A ranar 23 ga watan Maris, Iran tana fuskantar sababbin lokuta 50 a kowace awa da sabon mutuwar kowane minti goma saboda coronavirus.
A cewar wani jami'in WHO, za a iya samun mutane sau biyar a Iran fiye da abin da ake bayarwa.
Har ila yau, an ba da shawarar cewa takunkumi na Amurka kan Iran na iya shafi ikon kudi na kasar don magance barkewar cutar.
Babban Kwamishinan kare hakkin dan Adam na Majalisar Dinkin Duniya ya bukaci takunkumin tattalin arziki don sauƙaƙe ga ƙasashe da suka fi rinjayar cutar, ciki har da Iran.
An tabbatar da barkewar ta yadu zuwa Italiya a ranar 31 ga watan Janairu, lokacin da masu yawon bude ido biyu na kasar Sin suka gwada SARS-CoV-2 a Roma.
Batutuwan sun fara tashi sosai, wanda ya sa gwamnatin Italiya ta dakatar da duk jiragen sama zuwa kasar Sin da kuma sanar da jihar gaggawa.
A ranar 21 ga Fabrairu, a ranar 22 ga watan Fabrairun, Majalisar Ministoci ta sanar da sabon doka don ɗaukar barkewar cutar, ciki har da keɓe mutane sama da 50,000 daga gundumomi 11 daban-daban a arewacin Italiya.
Firayim Minista Giuseppe Conte ya ce, "A yankunan barkewa ba za a bayar da shigar da fita ba."
"A ranar 4 ga watan Maris, gwamnatin Italiya ta ba da umarnin rufe dukkan makarantu da jami'o'i a duk fadin kasar yayin da Italiya ta kai mutuwar 100."
Duk manyan abubuwan wasanni, ciki har da wasannin kwallon kafa na Serie A, an gudanar da su a bayan kofofin rufe har zuwa watan Afrilu, amma a ranar 9 ga watan Maris, an dakatar da dukkan wasanni gaba ɗaya akalla wata daya.
A ranar 11 ga watan Maris, Firayim Minista Conte ya umarci dakatar da kusan dukkanin ayyukan kasuwanci ban da supermarkets da magunguna.A ranar 6 ga Maris, Kwalejin Italiyanci na Anaesthesia, Analgesia, Resuscitation da Intensive Care (SIAARTI) ta wallafa shawarwari game da ka'idojin da za a yi amfani.
A ranar 19 ga Maris, Italiya ta mamaye kasar China a matsayin kasar da ta fi mutuwar cutar coronavirus a duniya bayan rahoton mutuwar mutane 3,405 daga cutar.
Ranar 22 ga watan Maris, an ruwaito cewa Rasha ta tura jiragen soja tara tare da kayan aikin likitanci zuwa Italiya.
Tun daga ranar 5 ga watan Afrilu, akwai mutane 128,948 da aka tabbatar da su, 15,887 sun mutu, da kuma 21,815 wadanda suka warke a Italiya, inda yawancin wadanda ke faruwa a yankin Lombardy.
Wani rahoto na CNN ya nuna cewa hadewar tsofaffin jama'a na Italiya da rashin iya gwada duk waɗanda ke da kwayar cutar har zuwa yau na iya taimakawa ga yawan mutuwar.
Amsar Burtaniya ga cutar ta fara fitowa a matsayin daya daga cikin mafi shakatawa na kasashe da suka shafa, kuma har zuwa 18 Maris 2020, gwamnatin Burtaniya ba ta tilasta kowane nau'i na nesa na zamantakewa ko matakan keɓewa a kan 'yan ƙasa.
A ranar 16 ga watan Maris, Firayim Ministan Boris Johnson ya ba da sanarwar shawara kan duk matafiya da hulɗar zamantakewa, yana ba da shawarar mutane suyi aiki daga gida inda zai yiwu kuma su guje wa wuraren da suke kamar gidajen shakatawa, gidajen cin abinci, da kuma wasan kwaikwayo.
A ranar 20 ga watan Maris, gwamnatin ta sanar da cewa duk wuraren shakatawa kamar wuraren shakatawa da gidajen motsa jiki sun rufe nan da nan, kuma sun yi alkawarin biyan har zuwa kashi 80% na albashin ma'aikata zuwa iyakacin <0xC2><0xA3> 2,500 a wata don hana rashin aikin yi a cikin rikicin. A ranar 23 ga Maris, Firayim Minista ya sanar da mafi wuya a kan matakan nesa, hana taron mutane fiye da mutane biyu da kuma yin tafiya da kuma aiki.
Ba kamar matakan da suka gabata ba, 'yan sanda sun aiwatar da waɗannan ƙuntatawa ta hanyar bayar da haraji da kuma watsa taron.
"Yawancin kamfanoni an umurce su rufe, sai dai ga kamfanoni da ake dauke da "muhimmanci"", ciki har da supermarkets, ma'aikatan likitoci, bankuna, kayan aiki shaguna, tashoshin man fetur, da gidajen gidaje. "
A ranar 20 ga Janairu, an tabbatar da shari'ar COVID-19 ta farko a jihar Pacific ta Arewa maso Yamma ta Washington a wani mutum da ya dawo daga Wuhan a ranar 15 ga Janairu.
An kafa rundunar kwayar cutar Coronavirus ta fadar White House a ranar 29 ga Janairu.
A ranar 31 ga watan Janairu, gwamnatin Trump ta bayyana gaggawa ga lafiyar jama'a, kuma ta sanya takunkumi kan shiga ga matafiya daga kasar Sin.
A ranar 28 ga watan Janairun 2020, Cibiyar Kula da Cututtuka - babbar cibiyar kiwon lafiyar jama'a ta gwamnatin Amurka - ta sanar da cewa sun haɓaka kayan gwaji na kansu.
Duk da yin haka, Amurka tana da jinkirin farawa a gwaji, wanda ya ɓoye ainihin yawan barkewar a lokacin.
Gwajin ya lalace da kayayyakin gwaji marasa kyau da gwamnatin tarayya ta samar a watan Fabrairun, rashin amincewar gwamnatin tarayya don kayayyakin gwajin ba na gwamnati (ta jami'a, kamfanoni da asibitoci) har zuwa ƙarshen Fabrairu, da kuma ƙayyade ƙa'idodin mutane don cancantar gwajin har zuwa farkon Maris (an liki ne ake bukata a bayan haka).
A ranar 27 ga Fabrairu, Washington Post ta ruwaito cewa an gudanar da gwaje-gwaje sama da 4,000 a Amurka.
A ranar 13 ga Maris, The Atlantic ta ruwaito cewa an gudanar da gwaje-gwaje sama da 14,000.
"A ranar 22 ga watan Maris, Associated Press ta ruwaito: 'Yawancin mutane da ke da alamun cutar da umurnin likita sun jira sa'o'i ko kwanaki don gwaji.'" Bayan an ba da rahoton mutuwar farko a jihar Washington a ranar 29 ga Fabrairu, Gwamna Jay Inslie ya bayyana a matsayin gaggawa, wani mataki da sauran jihohi suka bi. "
Makarantu a yankin Seattle sun soke aji a ranar 3 ga watan Maris, kuma a tsakiyar watan Maris, an rufe makarantu a fadin kasar.A ranar 6 ga Maris 2020, Amurka ta ba da shawarar yin tsinkaya game da tasirin sabon coronavirus a kasar ta wata ƙungiya ta masu ilimin annoba a Kwalejin Imperial London.
A wannan rana Shugaba Trump ya sanya hannu kan Dokar Shirye-shiryen Coronavirus da Amsawa, wanda ya ba da dala biliyan 8.3 na kudi na gaggawa ga hukumomin tarayya don magance barkewar.
Kamfanoni sun sanya takunkumin tafiye-tafiye na ma'aikata, sun soke taron, kuma sun ƙarfafa ma'aikata su yi aiki daga gida.
A ranar 11 ga watan Maris, Trump ya sanar da takunkumin tafiye-tafiye ga mafi yawan Turai, ban da Burtaniya, na kwanaki 30, sakamakon 13 ga Maris.
Washegari, ya fadada ƙuntatawa don hada da Burtaniya da Ireland.
A ranar 13 ga watan Maris, ya sanar da gaggawa na kasa, wanda ya samar da kudaden tarayya don amsawa ga rikicin.
Tun daga ranar 15 ga watan Maris, kamfanoni da yawa sun rufe ko rage sa'o'i a duk faɗin Amurka don ƙoƙarin rage yaduwar cutar.
A ranar 17 ga watan Maris, an tabbatar da annobar a duk jihohi hamsin da kuma gundumar Columbia. A ranar 23 ga Maris, an ba da rahoton cewa Birnin New York yana da mutane 10,700 na cutar coronavirus, fiye da jimillar cutar a Koriya ta Kudu.
A ranar 25 ga watan Maris, gwamnan ya bayyana cewa nesa na zamantakewa yana aiki, kamar yadda kimanin shari'ar da aka yi ya ragu daga kwanaki 2.0 zuwa kwanaki 4.7.
Tun daga ranar 28 ga watan Maris, akwai cututtuka 32,308 da aka tabbatar a Birnin New York, kuma mutane 672 sun mutu sakamakon cutar. A ranar 26 ga Maris, an ba da rahoton cewa Amurka tana da karin cututtukan cutar coronavirus fiye da kowace kasa a duniya, ciki har da China da Italiya.
A ranar 30 ga watan Maris, Shugaban Amurka Trump ya yanke shawarar tsawaita ka'idojin nesa na zamantakewa har zuwa 30 ga Afrilu.
A wannan rana, USNS Comfort, wani jirgin ruwa a asibiti da kimanin gado dubu, ya yi wasan kwaikwayo a New York.
A ranar 3 ga watan Afrilu, Amurka ta samu rikodin mutuwar 884 saboda coronavirus a cikin tsawon sa'o'i 24.
A jihar New York, shari'ar sun wuce mutane 100,000 a ranar 3 ga watan Afrilu, an soke fadar White House saboda rage barazanar da sarrafa saƙon ta hanyar jagorantar jami'an kiwon lafiya da masana kimiyya don daidaita bayanan jama'a da wallafe-wallafen da suka shafi cutar tare da ofishin mataimakin shugaban kasa Mike Pence.
Gabaɗaya amincewa da jagorancin Trump na rikicin an cire shi a kan layi na 'yan siyasa.
Wasu jami'an Amurka da masu sharhi sun soki dogaro da Amurka akan shigo da kayan aiki masu muhimmanci, ciki har da kayan aikin kiwon lafiya, daga kasar Sin.
An yi amfani da nazarin yanayin tafiya na iska don taswirar da hasashen yanayin yaduwar kuma an buga shi a Journal of Travel Medicine a tsakiyar Janairu 2020.
Dangane da bayanai na 2018 daga Hukumar Sufuri ta Duniya, Bangkok, Hong Kong, Tokyo, da Taipei suna da mafi girman matafiya daga Wuhan.
An kuma bayar da rahoton Dubai, Sydney, da Melbourne a matsayin shahararren wurare ga mutanen da ke tafiya daga Wuhan.
An bayar da rahoton Bali a matsayin aƙalla a cikin biranen 20 da suka fi shahara a cikin shirye-shiryen shirye-shiryen, yayin da aka ɗauki birane a Australia mafi cancanta.Australia ta fitar da shirin amsawa ga gaggawa na Novel Coronavirus (COVID-19) a ranar 7 ga Fabrairu.
Ya bayyana cewa har yanzu ba a gano abubuwa da yawa game da COVID-19 ba, kuma cewa Australia za ta jaddada sarrafa iyakokin da sadarwa a cikin martani ga annobar.
A ranar 21 ga watan Maris, an ayyana gaggawa na tsaro na ɗan adam a Australia.
Saboda tantancewar tasiri na sufuri na jama'a a Wuhan da Hubei, kasashe da dama sun shirya dakatar da 'yan ƙasa da ma'aikatan diflomasiyya daga yankin, da farko ta hanyar jiragen da aka yi wa gida, tare da hukumomin kasar Sin suna ba da izini.
Kanada, Amurka, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus, da Thailand sun kasance daga cikin farko da suka shirya fitar da 'yan ƙasa.
Pakistan ta ce ba za ta kori 'yan kasa daga kasar Sin ba.
A ranar 7 ga watan Fabrairun, Brazil ta kwashe 'yan Brazil 34 ko 'yan iyali, ban da Poles hudu, wani ɗan kasar Sin, da ɗan asalin Indiya.
'Yan Poland, China, da Indiya sun shirya a Poland, inda jirgin sama na Brazil ya tsaya kafin ya bi hanyarsa zuwa Brazil.
An keɓe 'yan Brazil wadanda suka tafi Wuhan a wani tushe da ke kusa da Brasilia.
A wannan rana, an kwantar da 215 Kanada (176 daga jirgin sama na farko, da 39 daga jirgin sama na biyu da gwamnatin Amurka ta kwantar da su daga Wuhan zuwa CFB Trenton don a keɓe su na makonni biyu.
A ranar 11 ga Fabrairu, wani jirgin sama na 185 Kanada daga Wuhan ya sauka a CFB Trenton.
Hukumomin Australia sun kwashe 'yan ƙasa 277 a ranar 3 da 4 ga watan Fabrairu zuwa Cibiyar Kula da tsibirin Kirsimeti, wanda aka sake sanya shi a matsayin cibiyar kewayawa, inda suka zauna na kwanaki 14.
Jirgin fitar da New Zealand ya isa Auckland a ranar 5 ga Fabrairu; fasinjojinta (ciki har da wasu daga Australia da Pacific) an keɓe su a wani tushe na teku a Whangaparoa, arewacin Auckland.
A ranar 15 ga Fabrairu, Amurka ta sanar da cewa za ta kwashe Amurkawa a kan jirgin ruwa na Diamond Princess.
A ranar 21 ga watan Fabrairun, jirgin sama da ke ɗauke da fasinjoji 129 na Kanada waɗanda aka kwashe daga Diamond Princess ya sauka a Trenton, Ontario.
A farkon Maris, gwamnatin Indiya ta fara fitar da 'yan ta'adda daga Iran. A ranar 14 ga Maris wani jirgin jirgin sama na Afirka ta Kudu wanda gwamnatin Afirka ta Kudu ta ba da 'yan Afirka ta Kudu zuwa 112.
An gudanar da binciken likita kafin tashi, kuma an bar 'yan Afirka ta Kudu hudu da ke nuna alamun coronavirus don rage haɗarin.
Kawai 'yan Afirka ta Kudu waɗanda suka yi gwajin da ba su da kyau sun dawo gida.
Sakamakon gwajin ya share duk 'yan Afirka ta Kudu, ciki har da ma'aikatan jiragen sama, ma'aikatan hotel,' yan sanda da sojoji da suka shiga cikin aikin agaji wanda, a matsayin ma'auni na tsaro, dukkansu sun kasance a cikin kula da kuma a cikin keɓe na tsawon kwanaki 14 a The Ranch Resort.
A ranar 20 ga Maris, Amurka ta fara janye sojojinta daga Iraki saboda annobar.
A ranar 5 ga Fabrairu, ma'aikatar harkokin waje ta kasar Sin ta bayyana cewa kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar, da Iran) sun aika taimako zuwa kasar Sin.
Wasu dalibai na kasar Sin a jami'o'i na Amurka sun shiga tare don taimakawa wajen aika taimako ga sassan da ke tattare da kwayar cutar a kasar Sin, tare da ƙungiyoyin haɗin gwiwa a yankin Chicago mafi girma da aka ruwaito cewa suna gudanar da aika abin rufe fuska 50,000 N95 zuwa asibitoci a lardin Hubei a ranar 30 ga watanduou.
"A ranar 5 ga Fabrairu, Bill da Melinda Gates sun ba da gudummawar dala miliyan 100 ga WHO don tallafawa binciken allurar rigakafi da kokarin magani tare da kare al'ummomin da ke cikin haɗari a Afirka da Kudancin Asiya" .
Interaksyon ya ruwaito cewa gwamnatin kasar Sin ta ba da gudummawar abin rufe fuska 200,000 ga Philippines a ranar 6 ga Fabrairu, bayan Sanata Richard Gordon ya shigar da abin rufe fuska miliyan 3.16 zuwa Wuhan.
A ranar 19 ga watan Fabrairun, Hukumar Red Cross ta Singapore ta sanar da cewa za ta aika da dala miliyan 2.26 na tallafi ga kasar Sin.
Japan ta ba da gudummawar mask miliyan daya ga Wuhan, Turkiyya ta aika kayan aikin kiwon lafiya, Rasha ta aika fiye da tan 13 na kayan aikin likita ga Wuhan, Malaysia ta sanar da ba da gudummawar kiwon lafiya miliyan 18 ga China, Jamus ta ba da kayan aikin likita daban-daban ciki har da kayan hatsari 10,000, kuma Amurka ta ba damar 17.8 ton na kiwon kiwon liki ga China ga kasar China kuma ta kasar Sin.
A watan Maris, China, Cuba da Rasha sun aika da kayan aikin likita da masana don taimakawa Italiya ta magance cutar coronavirus.
Jack Ma ya aika da kayan gwaji miliyan 1.1, abin rufe fuska miliyan 6, da tufafin kariya 60,000 zuwa Addis Ababa, Habasha don rarraba ta Tarayyar Afirka.
Daga baya ya aika da kayan gwaji na 5,000, abin rufe fuska na 100,000 da masu fashewa 5 zuwa Panama.
Ma kuma ya ba da gudummawar kayan aikin likita ga Kanada.The Netherlands, Spain, Turkey, Georgia, da kuma Czech Republic sun bayyana damuwa game da abin da suka shafi abin rufe fuska da kayan gwaji na kasar Sin.
Alal misali, Spain ta janye kayan gwajin coronavirus na kasar Sin 58,000 tare da adadin daidaito na kashi 30%, yayin da Netherlands ta tuna da abin rufe fuska na kasar Sin 600,000 waɗanda ba su da kyau.
Belgium ta tuna da abin rufe fuska 100,000, wanda ba za a iya amfani dashi ba, wanda aka yi tunanin shi ne daga China, amma a zahiri daga Colombia.
A watan Afrilu 2, Bankin Duniya ya kaddamar da ayyukan goyon bayan gaggawa ga kasashe masu tasowa.
WHO ta yaba da kokarin da hukumomin kasar Sin ke gudanar da dauke da cutar.
"WHO ta lura bambanci tsakanin bala'in SARS na 2002-2004, inda aka zargi hukumomin kasar Sin da asirin da ke hana rigakafin da ƙuntatawa, da kuma rikicin yanzu inda gwamnatin tsakiyar ta samar da sabuntawa na yau da kullun don kauce wa firgita kafin bukukuwan Sabuwar Shekara" .
"A ranar 23 ga Janairu, a mayar da martani ga hukumomin tsakiya ' yanke shawarar aiwatar da haramcin sufuri a Wuhan, wakilin WHO Gauden Galea ya ce yayin da "babu shawarwari da WHO ta yi", shi ne kuma "alamar muhimmancin da ke dauke da cutar a inda ya fi mayar da cutar", kuma ya kira shi "dawar da cutar da cutar da cutar da cutar da cutar da cutar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar kasar.
Daraktan Janar Tedros Adhanom na WHO ya ce PHEIC ne saboda hatsarin yaduwar duniya, musamman ga kasashen da ke da matsakaicin kudin shiga ba tare da tsarin kiwon lafiya mai ƙarfi ba.
"A mayar da martani ga aiwatar da takunkumi na tafiya, Tedros ya ce "babu wani dalili na matakan da ba su dace da tafiye-tafiye da ciniki na kasa da kasa" kuma "WHO ba ta bada shawarar iyakancewar kasuwanci da motsi." "
A ranar 5 ga watan Fabrairun, WHO ta yi kira ga al'ummar duniya don tallafawa dala miliyan 675 don tallafawa shirye-shiryen shirye-shirye a kasashen da ke da ƙananan kudaden shiga, yana mai cewa gaggawa don tallafawa ƙasashe waɗanda ""ba su da tsarin da za su gano mutanen da suka samu kwayar cutar, ko da ta fito ".
"Tedros ya ci gaba da sanar da cewa, ""Mu ne kawai karfi kamar yadda mu raunana dangantaka"" kuma ya bukaci al'ummar kasa da kasa su "saka hannun jari a yau ko biya fiye daga baya". A ranar 11 ga Fabrairu, WHO a wani taron manema labarai kafa COVID-19 a matsayin sunan cutar. "
"A wannan rana, Tedros ya bayyana cewa babban sakataren Majalisar Dinkin Duniya António Guterres ya amince da samar da ""iko ga dukkanin tsarin Majalisar Dinkin Duniya a cikin martani "."
"A sakamakon haka, an kunna ƙungiyar kula da matsalolin Majalisar Dinkin Duniya, wanda jihohin WHO za su ba su damar mayar da hankali kan amsar lafiya yayin da sauran hukumomin zasu iya kawo ƙwarewarsu don ɗaukar tasirin zamantakewa, tattalin arziki da ci gaban barkewar" .
"A ranar 14 ga Fabrairu, an kunna ƙungiyar hadin gwiwa ta WHO tare da China don samar da kwararru na duniya da WHO a kasar Sin don taimakawa wajen gudanar da gida da kuma kimanta ""matsakaicin cutar"" ta hanyar karɓar taron taron da taron tare da manyan cibiyoyin matakan kasa da kuma ziyarar filaye-tafiye na farko, cewa ba za a shirya shirin "ancewar cutar da cuta a cikin laukan laukan laukan laukan laukan laukan laukan laukan lau, ya zama," ya zama, ya zama, yayin da kuma ya kamata yaukan yayin," yayin daukan yayin daukan yayin daukan.
A ranar 28 ga watan Fabrairun, jami'an WHO sun ce za a tashi kimanta barazanar coronavirus a matakin duniya daga "high" zuwa "high high", mafi girma matakin gargajiya da hatsarin haɗari.
Mike Ryan, babban darakta na shirin gaggawa na lafiya na WHO, ya yi gargadi a cikin wata sanarwa cewa "Wannan shine bincika gaskiya ga kowane gwamnati a duniya: Tashi."
"Wannan kwayar cutar na iya kasancewa a kan hanya kuma kuna buƙatar kasancewa a shirye," in ji cewa matakan amsawa masu kyau zasu iya taimaka wa duniya kauce wa ""mafi muni daga gare shi"." "
"Ryan ya kara bayyana cewa bayanan da ke yanzu ba su da tabbacin jami'an kiwon lafiya na jama'a su bayyana annobar duniya, yana mai cewa irin wannan sanarwa za ta nufin "Muna amincewa da cewa kowane ɗan adam a duniya za a fallasa wannan cutar."
A ranar 11 ga watan Maris, WHO ta bayyana cutar coronavirus a matsayin annoba.
"Daraktan Janar ya ce WHO tana damu sosai game da matakan yaduwa da tsanani, da kuma matakan rashin aiki."WHO ta fuskanci babbar zargi saboda abin da ake gani a matsayin rashin dacewa da cutar, ciki har da sanarwar gaggawa na lafiyar jama'a da rarraba cutar a matsayin annobar. "
Matsalar ta hada da roƙon da Daraktan Janar Tedros Adhanom na WHO ya yi watsi da murabus, wanda mutane 733,000 suka rattaba hannu a ranar 6 ga Afrilu.
A ranar 26 ga Maris 2020, 'yan masana haƙƙin ɗan adam na Majalisar Dinkin Duniya sun jaddada darajar haƙƙin kowane mutum a lokacin annobar COVID-19.
Gwamnatin Tarayya ta bayyana cewa kowa yana da 'yancin shiga tsakani da rai kuma gwamnati tana da wannan alhakin.
Gwamnatin Tarayya ta ce ba za ta taba yin amfani da inshora ko inshorar lafiya a matsayin dalilai na nuna bambanci a kan wani rukuni ba.
Masana sun tabbatar da cewa kowane mutum yana da haƙƙin lafiya, ciki har da mutanen da ba su da nakasassu, nasarorin 'yan tsiraru, tsofaffi, yan gudun hijira a cikin gida, marasa gida, wadanda ke zaune a cikin matsanancin yanayi, mutanen da aka tsare, da kuma 'yan gudun hijira da sauran kungiyoyin da ba a bayyana bukatar goyon bayan gwamnati.
Hukumomin gwamnati na duniya suna magance tasirin tattalin arziki da zamantakewa na rikicin COVID-19.
Kungiyar hadin gwiwa da ci gaban tattalin arziki ta kaddamar da dandamali don samar da cikakken bayani game da manufofin manufofi a ƙasashe a fadin duniya, da ra'ayoyi da shawara.
Daga manufofin don ƙarfafa tsarin kiwon lafiya da tattalin arzikin duniya don magance tasirin kullewa da ƙuntatawa akan tafiya, cibiyar dijital ta hada da Tracker na Kasa, kuma yana nufin taimakawa ƙasashe su koyi daga juna kuma don sauƙaƙe mayar da martani a duniya don kalubalen coronavirus.
Amurka, Ministan Birtaniya Michael Gove, da kuma shugaban kasar Brazil Jair Bolsonaro, Eduardo Bolsonaro, saboda magance cutar, wanda ya fara a lardin Hubei na kasar Sin.
An kori wasu jami'an jam'iyyar Kwaminis ta kasar Sin (CPC) da dama a lardin kasar Sin saboda gudanar da kokarin kwararru a tsakiyar kasar Sin, alama ce ta rashin jin dadi da kungiyar siyasa ta amsa ga barkewar a wadannan yankuna.
Wasu masu sharhi sun yi imanin cewa wannan mataki an yi nufin kare babban sakataren jam'iyyar kwaminisanci ta kasar Sin Xi Jinping daga fushin jama'a kan barkewar coronavirus.
Wasu jami'an kasar Sin, misali Zhao Lijian sun ki amincewa da a baya game da barkewar coronavirus da aka fara a Wuhan, don goyon bayan ra'ayin makirci game da COVID-19 da aka samo asali daga Amurka ko Italiya.
"U.S. Management of Donald Trump ya kira coronavirus a matsayin ""Chinese virus""" ko ""Wuhan virus"" yana cewa ""China centership" ya karu da kwayar cutar da yanzu ya juya zuwa annoba ta duniya"", wanda wasu masu sukar sukanki a matsayin wariyar launin fata da kuma "tsar da gwamnatinsa daga rashin lafiyar da cuta" ". ". "
"Daily Beast ya sami nau'i na gwamnatin Amurka wanda ya bayyana alamar sadarwa tare da asalin asali a Majalisar Tsaro ta Kasa, tare da dabarun da aka ambata a matsayin "Komai game da China."
"An gaya mana kokarin fitar da wannan saƙon ta kowace hanya, ciki har da taron manema labarai da wasan kwaikwayo na talabijin kamar Politico, Manufofin Harkokin Waje, da Bloomberg sun yi iƙirarin cewa kokarin China don aika taimako ga kasashen da ke fama da cutar kwayar cuta wani ɓangare ne na farfaganda don tasiri a duniya."
"Shugaban manufofin kasashen waje na Tarayyar Turai Josep Borrell ya yi gargadi cewa akwai wani ɓangare na geo-politics ciki har da gwagwarmaya don tasiri ta hanyar juyawa da kuma ' siyasa na karimci'" ".
Borrell ya kuma ce, "China tana tura saƙon cewa, ba kamar Amurka ba, ita ce abokin tarayya da ke da alhakin abin dogara."
China ta kuma yi kira ga Amurka da ta dakatar da takunkumin ta'addanci daga Syria, Venezuela da Iran, yayin da aka ruwaito cewa ta aika taimako ga kasashen biyu.
Jack Ma ya ba da gudummawa na masks 100,000 zuwa Cuba ta hanyar takunkumin Amurka a ranar 3 ga Afrilu.
Har ila yau, hukumomin Amurka sun yi zargin cewa sun kawar da taimakon da ake nufi ga sauran ƙasashe zuwa ƙasarsu.
Kuma akwai rikice-rikice da ke da alaƙa da abin rufe fuska tsakanin sauran ƙasashe, kamar Jamus, Austria da Switzerland; da Jamhuriyar Czech da Italiya.
Bugu da ƙari, Turkiyya ta dauki daruruwan masu fasahar wutar lantarki zuwa Spain.
A farkon watan Maris, gwamnatin Italiya ta yi la'akari da rashin haɗin gwiwa na Tarayyar Turai da Italiya ta shafi coronavirus.
Maurizio Massari, jakadan Italiya a Tarayyar Turai, ya ce, "Kawai kasar Sin ta amsa da juna."
Babu shakka, wannan ba alama ce mai kyau na haɗin gwiwa na Turai. "
A ranar 22 ga watan Maris, bayan wani kira tare da Firayim Ministan Italiya Giuseppe Conte, Shugaban Rasha Vladimir Putin ya shirya sojojin Rasha don aika da likitoci na soja, motoci na musamman, da sauran kayan aikin kiwon lafiya zuwa Italiya.
"Janar La Stampa ta Italiya ta ambaci wani ba a sani ba ""babban tushen siyasa""" cewa kashi 80 na taimakon Rasha ba shi da amfani ko kuma ba shi da amfani ga Italiya. "
"Magabar ta zargi Rasha da ta fara farawa a kan wani abu mai ban sha'awa da diflomasiyya."
Shugaban kasar Lombardy, Attilio Fontana, da Ministan harkokin wajen Italiya Luigi Di Maio sun yi watsi da rahotannin kafofin watsa labarun kuma sun nuna godiyarsu.
Rasha kuma ta aika jirgin saman jiragen ruwa tare da taimakon kiwon lafiya zuwa Amurka.
Kakakin Kremlin Dmitry Peskov ya ce, "Lokacin da yake ba da taimako ga abokan aiki na Amurka, [Putin] ya yi tsammani cewa lokacin da masana'antun Amurka na kayan aikin likitanci da kayan aiki suka sami ci gaba, za su kuma iya sake maimaitawa idan ya cancanta."
Za a gudanar da aikin soja na NATO da aka tsara a Jamus, Poland, da kuma jihohin Baltic, mafi girman aikin yakin NATO tun bayan karshen yakin sanyi.
Kyakkyawan sakataren kare hakkin nukiliya, Kate Hudson, ya soki aikin mai tsaron gida na 2020: "A cikin rikicin lafiyar jama'a na yanzu, yana haɗari da rayukan sojojin Amurka da kasashen Turai da yawa da ke halartar amma mazauna kasashen da suke aiki."
Shugaban Iran Hassan Rouhani ya rubuta wasiƙar jama'a ga shugabannin duniya da ke neman taimako a ranar 14 ga Maris 2020, yana mai cewa ƙasarsa tana kokarin yaki da cutar saboda rashin samun dama ga kasuwanni na kasa da kasa sakamakon takunkumin Amurka kan Iran.
Masu binciken siyasa sun yi tsammanin zai iya shafar da zaben Donald Trump a zaben shugaban kasa na 2020. dangantakar diplomatic tsakanin Japan da Koriya ta Kudu ta kara tsananta saboda annobar.
"Korea ta Kudu ta soki 'tattaunawar kiwon lafiyar Japan' bayan Japan ta sanar da duk wanda ya zo daga Korea ta Kudu za a sanya shi a cikin makonni biyu 'yan kiwon lafiya a wuraren da gwamnati ta tsara. "
Kamfanin Koriya ta Kudu na farko ya yi matukar damuwa game da amsar Shugaba Moon Jae-in game da rikicin.
Yawancin 'yan Korean sun sanya hannu kan buƙatun ko dai suna kiran daukar kan Moon kan abin da suka yi ikirarin cewa gwamnati ce rashin kula da barkewar barkewar baki, ko kuma yaba masa amsa.
Wasu masu sharhi sun nuna damuwa cewa zai iya ba gwamnatoci damar ƙarfafa ikonsu.
A Hungary, majalisar ta zabe ta ta ba da izinin Firayim Minista, Viktor Orbán, dakatar da majalisar dokoki har abada da zaben da kuma azabtar da wadanda ake ganin sun yada bayanan ƙarya game da kwayar cutar da kuma kula da gwamnatin ta rikici.
An zargi barkewar coronavirus a wasu lokuta da dama na rashin bayarwa, wanda ya samo asali ne daga karuwar amfani da kayan aiki a duniya don yaki da barkewar cutar, sayen damuwa, da kuma matsalolin masana'antu da ayyukan sadarwa.
Hukumar Abinci da Magunguna ta Amurka ta bayar da gargadi game da rashin kwayoyi da kayan aikin kiwon lafiya saboda karuwar buƙatun masu amfani da masu samar da kayayyaki.
Yawancin wurare kuma sun ga sayen firgita wanda ya haifar da shafuka da aka tsare su daga abubuwan da ke da muhimmanci kamar abinci, takardar wanka, da ruwa mai kwalba, wanda ke haifar da rashin samar da su.
Musamman masana'antar fasaha ta yi gargadi game da jinkirin zuwa kayayyakin lantarki.
A cewar babban darektan WHO Tedros Adhanom, buƙatar kayan kariya na sirri ya karu sau 100.
Wannan buƙatar ya haifar da karuwar farashin har zuwa sau ashirin da farashin al'ada kuma ya haifar da jinkirin samar da kayan likita na tsawon watanni hudu zuwa shida.
Hakanan ya haifar da rashin kayan kariya na sirri a duk duniya, tare da gargadin WHO cewa wannan zai haɗu da ma'aikatan kiwon lafiya.
A cikin Australia, annobar ta ba da sabon dama ga masu sayarwa da daigou don sayar da kayayyakin Australia zuwa China.
Ayyukan ya haifar da karancin tsarin jariri a wasu manyan kantuna kuma daga baya gwamnatin Australia ta haramta. Duk da yawan lokuta na COVID-19 a Arewacin Italiya da yankin Wuhan, da kuma babban buƙatar samfuran abinci, an ceto yankuna biyu daga rashin abinci mai tsanani.
Matakan da kasar Sin da Italiya suka yi a kan ciniki da cinikayya da haramtacciyar kayayyaki sun yi nasara, suna guje wa rashin abinci mai tsanani da ake tsammani a Turai da Arewacin Amirka.
Arewacin Italiya tare da babban samar da noma ba ta ga babban raguwa ba, amma farashin zai iya karu bisa ga wakilan masana'antu.
Rukunin abinci mai tsabta sun haɗu ne kawai na ɗan lokaci, har ma a birnin Wuhan, yayin da jami'an gwamnatin kasar Sin suka saki ajiyar dabbobi don tabbatar da isasshen abincin jama'a.
Wadannan dokoki a Italiya suna buƙatar masu samar da abinci su kiyaye ajiyar irin wannan gaggawa.
An ji lalacewar tattalin arzikin duniya a kasar Sin: bisa ga rahoton kafofin watsa labarai a ranar 16 ga watan Maris, tattalin arzikin kasar Sin ya sha wahala sosai a cikin watanni biyu na farko na shekarar 2020 saboda matakan da gwamnati ta yi don rage yaduwar kwayar cutar, kuma tallace-tallace na tallace-tallace ya raguwa 20.5%.
Kamar yadda babban kasar China babban tattalin arziki ne da kuma masana'antu cibiyar, ana ganin barkewar cutar ta haifar da babbar barazana ga tattalin arzikin duniya.
Agathe Demarais na <0xC6><0x98>ungiyar Intelligence ta Economist ta yi hasashen cewa kasuwanni za su kasance masu tasowa har sai da hoto mai haske ya fito akan sakamakon da za a iya samu.
A watan Janairun 2020, wasu masu bincike sun kiyasta cewa faduwar tattalin arzikin annobar akan ci gaban duniya na iya wucewa daga barkewar SARS ta 2002-2004.
Wani kimantawa daga wani masani a Jami'ar Washington a St. Louis ya ba da $ 300 + biliyan tasiri a kan sarkar samar da duniya wanda zai iya wucewa har zuwa shekaru biyu.
Hukumar Kasashen Kasuwancin Man Fetur (OPEC) ta ruwaito cewa "kashe" bayan raguwar farashin mai saboda raguwar buƙatar kasar Sin.
Kasuwannin jari na duniya sun fadi a ranar 24 ga Fabrairu saboda yawan adadin cututtukan COVID-19 a waje da kasar Sin.
A ranar 27 ga Fabrairu, saboda damuwa game da cutar coronavirus, ƙididdiga na hannun jari daban-daban na Amurka ciki har da NASDAQ-100, S&amp;P 500 Index, da Dow Jones Industrial Average sun buga mafi girman faduwar tun 2008, tare da Dow faduwar maki 1,191, mafi girman rana tun lokacin da rikicin 2007-2008.
Dukkan magunguna uku sun ƙare a mako fiye da 10%.
A ranar 28 ga Fabrairu, Scope Ratings GmbH ya tabbatar da rating bashi na kasar Sin, amma ya ci gaba da Negative Outlook.
Kasuwanci sun sake raguwa bisa tsoron coronavirus, mafi girman faduwar shine ranar 16 ga Maris.
Mutane da yawa suna ɗaukan tattalin arziki mai yiwuwa.
Masanin tattalin arzikin Mohamed El-Erian ya yaba wa bankuna na tsakiya da kuma matakan gaggawa na jihohi a kan lokaci.
Bankuna na tsakiya suna amsawa da sauri fiye da yadda suka yi game da hadarin kudi na 2008.
yawon bude ido yana daya daga cikin mafi yawan bangarorin da suka shafi saboda hana tafiya, rufe wuraren jama'a ciki har da jan hankalin tafiye-tafiye, da shawarar gwamnatoci game da kowane tafiya a duk faɗin duniya.
Sakamakon haka, kamfanonin jiragen sama da yawa sun soke jiragen sama saboda ƙananan buƙatu, ciki har da British Airways, China Eastern Airlines, da Quantas, yayin da kamfanin jirgin sama na Burtaniya Flybe ya rushe.
Tasirin akan masana'antar jirgin ruwa ya kasance a matakin da ba a taɓa gani ba.
Hakanan an rufe tashar jiragen ruwa da tashar jiragen ruwa da yawa.
Annobar ta yi daidai da Chunyun, babban lokacin tafiya da ke hade da bikin Sabuwar Shekara ta kasar Sin.
Gwamnatocin kasa da yanki sun soke wasu abubuwan da suka shafi taro, ciki har da bukukuwan Sabuwar Shekara na shekara-shekara, tare da kamfanoni masu zaman kansu kuma sun rufe shagunansu da abubuwan jan hankalin yawon bude ido irin su Hong Kong Disneyland da Shanghai Disneyland.
An rufe yawancin abubuwan da ke faruwa a Sabuwar Shekara da abubuwan jan hankalin yawon bude ido don hana taron jama'a, ciki har da Birnin da aka haramta a Beijing da bikin haikali na gargajiya.
A cikin 24 na larduna 31 na kasar Sin, kananan hukumomi da yankuna, hukumomi sun tsawaita bikin Sabuwar Shekara zuwa 10 ga Fabrairu, suna umurci mafi yawan wuraren aiki kada su sake buɗewa har zuwa wannan ranar.
Wadannan yankuna sun wakilci kashi 80% na GDP na kasar da kashi 90% na fitarwa.
Hong Kong ta hau matakin amsawa na cututtukan cututtuka zuwa mafi girma kuma ta bayyana gaggawa, rufe makarantu har zuwa Maris da soke bikin Sabuwar Shekara. Sashen sayar da kayayyaki ya shafi duniya, tare da raguwa a cikin sa'o'i ko rufewa na wucin gadi.
Ziyarci masu sayarwa a Turai da Latin Amurka sun ragu da kashi 40%.
Kasuwancin Arewacin Amirka da Gabas ta Tsakiya sun ga raguwar 50-60%.
Wannan kuma ya haifar da raguwa da kashi 33-43% na zirga-zirga zuwa cibiyoyin sayarwa a watan Maris idan aka kwatanta da Fabrairu.
A cewar hukumar tattalin arzikin Majalisar Dinkin Duniya ta Majalisar Dinkin Duniya ta yi kimanta ƙarin matakan, irin wannan karuwar tsaftacewa, shigar da na'urorin thermal scanners don duba yawan zafin jiki na masu sayarwa, da kuma soke abubuwan da suka faru.
A watan Janairu da Fabrairun 2020, a lokacin da aka yi annobar a Wuhan, kimanin mutane miliyan 5 a kasar Sin sun rasa ayyukansu.
Yawancin ma'aikatan ƙauyuka miliyan 300 na kasar Sin sun rasa gidaje a lardunansu ko kuma aka kama su a lardin Hubei. A watan Maris na shekarar 2020, fiye da mutane miliyan 10 na Amurka sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
Barkewar coronavirus na iya fara aiki miliyan 47 a Amurka kuma yawan rashin aikin yi na iya kaiwa 32%, bisa ga ƙididdigar Bankin Tarayya na St. Louis.The kulle a Indiya ya bar daruruwan miliyoyin ma'aikatan 'yan gudun hijira (wanda aka biya ta hanyar albashin yau da kullun).
A cikin rabi na biyu na Maris, ma'aikata 4 na Faransa sun nemi amfanin rashin aikin yi na wucin gadi kuma ma'aikata miliyan 1 na Birtaniya sun nemi tsarin bashi na duniya. Kusan rabin kamfanonin a Jamus sun aika ma'aikatansu a kan tsarin aiki na gajeren lokaci da gwamnati ta tallafa.
Faransa da Birtaniya sun amince da tsarin biyan kuɗi na ɗan gajeren lokaci na Jamus.
Ayyukan wasan kwaikwayo da al'adu na al'adu sun shafi annoba sosai, suna shafar ayyukan kungiyoyi da mutane - duka masu aiki da masu zaman kansu - duniya.
<0xC6><0x98>ungiyoyin fasahar fasaha da al'adu sun yi ƙoƙarin kiyaye aikinsu (sau da yawa a fannin jama'a) don samar da damar gado na al'adu ga al'umma, kula da amincin ma'aikatansu da jama'a, da tallafawa masu zane-zane idan ya yiwu.
A watan Maris 2020, a fadin duniya da kuma digiri daban-daban, gidajen tarihi, dakunan karatu, wuraren wasan kwaikwayo, da sauran cibiyoyin al'adu an rufe su har abada tare da nune-nunen su, abubuwan da suka faru da wasanni sun soke ko jinkirta.
A mayar da martani akwai ƙoƙari mai tsanani don samar da madadin ayyuka ta hanyar dandamali na dijital. Sauran kwanan nan da sauri mai saurin saurin fashewa na cutar shine soke ayyukan addini, manyan abubuwan da suka faru a wasanni, da sauran abubuwan zamantakewa, kamar bukukuwan kiɗa da kide-kide, taron fasaha, da kuma nuna fashi.
The fina-finai masana'antar ta kuma fuskantar rushewa.The Vatican ya sanar da cewa an soke bikin mako mai tsarki a Rome, wanda ke faruwa a cikin makon karshe na Kirista na Lent, an soke shi.
Yawancin masallatai sun ba da shawarar tsofaffi Kiristoci su zauna a gida maimakon halartar Mass a ranar Lahadi; wasu majami'u sun ba da sabis na coci ta hanyar rediyo, yanar gizo ko talabijin yayin da wasu ke ba da ibada.
Tare da Roman Katolika Diocese na Rome ya rufe coci da masallatai da kuma St. Peter's Square da aka cire daga mahajjata Kirista, wasu ƙungiyoyin addini kuma sun soke ayyuka da iyakance taron jama'a a majami'u, masallatai, majami'u, haikali da gurdwaras.
Ma'aikatar kiwon lafiya ta Iran ta sanar da soke addu'o'in Jumma'a a yankunan da barkewar cutar ta shafa daga baya an rufe su, yayin da Saudi Arabia ta haramta shiga mahajjata kasashen waje da mazaunata zuwa wurare masu tsarki a Makka da Madina.
Annobar ta haifar da matsala mafi muhimmanci ga kalandar wasanni na duniya tun lokacin yakin duniya na biyu.
Yawancin manyan abubuwan wasanni an soke su ko kuma an dakatar da su, ciki har da gasar zakarun Turai ta UEFA 2019-2020, 2019-2020 Premier League, UEFA Euro 2020, 2019-2020 NBA kakar, da kuma 2019-2020 NHL kakar.
"Barkewar cutar ta rushe shirye-shiryen gasar Olympics ta bazara ta 2020, wanda aka shirya a farkon Yuli; Kwamitin Olympics ta Duniya ya sanar a ranar 24 ga watan Maris cewa za a sake shirin taron zuwa wani kwanan wata bayan 2020 amma ba ƙarshen bazara na 2021."
Wannan ya jagoranci 'yan wasan da yawa su motsa kan layi, tare da shafukan caca na kan layi da yawa suna ba da rahoton ƙaruwa mai muhimmanci a cikin kudaden sabon rajista.The nishaɗi masana'antu kuma an shafa, tare da ƙungiyoyin kiɗa daban-daban dakatar da ko soke yawon shakatawa.
Yawancin wasan kwaikwayo kamar su a Broadway sun dakatar da duk wasanni.
"Wasu masu zane-zane sun bincika hanyoyin ci gaba da samar da raba aikin akan intanet a matsayin madadin gargajiya na rayuwar wasan kwaikwayo, irin su streaming kide-kide ko ƙirƙirar ""festivals"" don masu fasaha don yin, rarraba, da tallace-tallace na aikinsu. "
Online, da yawa coronavirus internet memes ya yadu kamar yadda mutane da yawa juya zuwa dariya da sha'awa a cikin rashin tabbas.
Tun daga fashewar COVID-19, an lura da ƙaruwar nuna bambanci, kalubale, da wariyar launin fata ga mutanen kasar Sin da Gabashin Asiya, da kuma mutane daga wuraren da ke cikin Turai, Amurka da sauran ƙasashe.
An lura da abubuwan tsoro, shakka, da kuma adawa a ƙasashe da yawa, musamman a Turai, Gabashin Asiya, Arewacin Amirka, da yankin Asiya-Pacific.
Rahotanni daga watan Fabrairun (a lokacin da yawancin shari'o'in har yanzu an rufe su zuwa kasar Sin) sun rubuta ra'ayin wariyar launin fata da aka bayyana a kungiyoyi daban-daban na mutanen kasar Sin da suka cancanci kwayar ko karɓar abin da aka yi ikirarin azabtarwa.
Wasu kasashe a Afirka sun kuma ga karuwar ra'ayi na yaki da kasar Sin.
Yawancin mazauna Wuhan da Hubei sun ba da rahoton nuna bambanci dangane da asalinsu na yanki.
Akwai goyon baya ga 'yan kasar Sin, a kan layi da kuma waje, da kuma ga waɗanda ke cikin yankunan da aka fama da cutar.
Bayan ci gaba da barkewar barkewar zuwa sababbin ƙasashe masu zafi, mutane daga Italiya, kasa ta farko a Turai da ke fuskantar mummunan barkewar COVID-19, za a iya fuskantar shakka da kuma xophobia. 'Yan ƙasa a kasashen da suka haɗa da Malaysia, New Zealand, Singapore, da Koriya ta Kudu sun sanya hannu a farkon takaita umarni don hana mutanen kasar kasar kasar kasar kasar kasar Sin.
A cikin Japan, hashtag #ChineseDontComeToJapan ya kasance a kan Twitter.
Mutanen kasar Sin da sauran 'yan Asiya a Burtaniya da Amurka sun ba da rahoton karuwar cin zarafin lalata, da kuma harin.
"Shugaban Amurka Donald Trump ya fuskanci zargin da yake magana game da coronavirus a matsayin "Chinese Virus", kalma da masu sukar suka yi la'akari da wariyar launin fata da kuma anti-Chinese. "
Masu zanga-zanga a Ukraine sun kai hari kan bas dauke da 'yan gudun hijirar Ukrainian daga Wuhan zuwa Novi Sanzhary.
Dalibai da suka fito daga Arewa maso Gabashin Indiya, wanda ke raba iyaka da kasar Sin, da kuma nazarin a manyan biranen Indiya sun fuskanci harin da ya shafi barkewar coronavirus.
"Shugaban jihar Bharatiya Janata a Yammacin Bengal Dilip Ghosh ya bayyana cewa kasar Sin ta lalata yanayi kuma wannan shine dalilin da ya sa Allah ya yi fansa da su."
"A baya aka yanke hukunci da maganganun da hukumar kasar Sin ta kasar Sin a Kolkata, kiran shi ""qaryama"".A kasar Sin, xanfobia da wariyar launin fata da mazauna ba na kasar Sin sun sake ƙonewa ta hanyar annobar, tare da baƙi da aka kwatanta da ""skararru na kasashen waje"" kuma aka yi niyyacewa da ""ra""".
Yawancin jaridu tare da paywalls sun cire su don wasu ko duk bayanan coronavirus.
Mutane da yawa masu wallafa kimiyya sun yi takardun kimiyya da suka shafi barkewar barkewar da ake samuwa tare da samun damar bude.
Wasu masana kimiyya sun zaɓi su raba sakamakonsu da sauri a kan sabobin preprint kamar bioRxiv.
Cutar kamuwa da cutar ta fito - cutar mai kamuwa da cuta ta fitowa, sau da yawa sabon salo a cikin kewayon barkewarta ko yanayin watsawa
Globalization da cututtuka - Gabaɗaya na Globalization da watsa cututtuka
Jerin annoba da cututtuka - Jerin adadin mutuwar mutane saboda cututtukan cututtuka
Gudanar da namun daji da zoonoses - haɗarin lafiya da ke da alaƙa da cinikayya a cikin namun daji
Gwajin gwajin laboratory don cutar coronavirus na numfashi na 2019 (COVID-19) da kuma kwayar cutar SARS-CoV-2 da ke da alaƙa sun haɗa da hanyoyin da ke gano kasancewar kwayar cutar da wadanda ke gano kwayoyin halitta da aka samar a mayar da martani ga kamuwa da cutar.
An tabbatar da kasancewar kwayoyin cuta a cikin samfurori ta RT-PCR, wanda ke gano RNA na coronavirus.
Wannan gwajin na musamman ne kuma an tsara shi don gano RNA na SARS-CoV-2.
Ana amfani dashi don tabbatar da kamuwa da cututtuka na kwanan nan ko masu aiki.
Gano kwayoyin cuta (serology) ana iya amfani da su duka don ganowa da kuma kula da yawan jama'a.
Gwajin kwayoyin cuta ya nuna yawan mutanen da ke da cutar, ciki har da waɗanda alamun su ba su da alamu ko wadanda ba su da alama.
Ana iya ƙayyade daidaitaccen adadin mutuwar cutar da matakin rigakafi a cikin yawan jama'a daga sakamakon wannan gwajin.
Saboda gwajin da aka yi, har zuwa watan Maris 2020 babu kasashe da ke da cikakken bayani game da yawan cutar a yawan jama'arsu.
A ranar 23 ga watan Maris, babu wata ƙasa da ta gwada fiye da kashi 3% na yawan jama'arsu, kuma akwai bambance-bambancen a cikin yawan gwajin da aka yi a fadin ƙasashe.
Wannan bambance-bambancen zai iya zama mummunan tasiri wanda aka bayar da rahoton rahoton mutuwar mutuwa, wanda zai iya zama mummunan kimantawa a wasu ƙasashe.
Amfani da real-time reverse transcription polymerase sarkar reaction (rRT-PCR) gwajin za a iya yi a kan numfashi samfurori samu ta hanyoyi daban-daban, ciki har da nasopharyngeal swab ko sputum samfurin.
Gabaɗaya ana samun sakamako a cikin 'yan sa'o'i zuwa kwanaki biyu.
Gwajin RT-PCR da aka yi tare da mahaifa yana da abin dogara ne kawai a cikin mako na farko na cutar.
Daga baya a kan kwayar cutar na iya ɓacewa a cikin makogwaro yayin da yake ci gaba da yawa a cikin huhu.
Ga mutanen da aka kamuwa da cutar da aka gwada a mako na biyu, za a iya amfani da kayan samfurin samfurin daga zurfin hanyoyin iska ta hanyar shayarwa catheter ko yin nauyi (sputum).
Ɗaya daga cikin gwaje-gwaje na PCR na farko an haɓaka shi a Charité a Berlin a watan Janairun 2020 ta amfani da sashin sarkar polymerase (rRT-PCR), kuma ya kafa tushen kayayyaki 250,000 don rarrabawa ta Hukumar Lafiya ta Duniya (WHO).
Kamfanin Koriya ta Kudu Kogenebiotech ya haɓaka sakandare na asibiti, wanda ke tushen PCR SARS-CoV-2 (PowerChek Coronavirus) a ranar 28 ga Janairu 2020.
"Yana neman kwayoyin halittar ""E"" da aka raba ta dukan cututtukan coronavirus, da kuma kwayoyin RdRp na musamman ga SARS-CoV-2.A kasar Sin, BGI Group na ɗaya daga cikin kamfanonin farko da suka karbi amincewar amfani da gaggawa daga Hukumar Kula da Magunguna ta kasar Sin don gano kit na SARS-CoV-2. A Amurka, Cibiyar-2019 Cibiyar-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N-N--N-N-N-N-N-N-N-N-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Ɗaya daga cikin gwaje-gwajen kwayoyin halitta guda uku a cikin tsofaffin samfuran gwajin ya haifar da sakamakon rashin kuskure saboda reagents, da kuma gwajin gwaji a CDC a Atlanta; wannan ya haifar da matsakaicin samfuran ƙasa da 100 a kowace rana ana sarrafa su cikin nasara a duk watan Fabrairu 2020.
Ba a yanke shawarar tabbatar da gwaje-gwajen da aka yi amfani da su ba har zuwa 28 ga Fabrairu 2020, kuma ba har sai an ba da izinin gwajin jihar da na gida su fara gwajin ba.
Hukumar Abinci da Magunguna ta amince da gwajin a karkashin aiwatar da amfani na gaggawa. Labs na kasuwanci sun fara gwaji a farkon Maris 2020.
Tun daga ranar 5 ga Maris 2020 LabCorp ta sanar da samuwar gwajin COVID-19 a fadin kasar bisa RT-PCR.
Har ila yau, gwajin gwajin COVID-19 ya kasance a duk fadin kasar a ranar 9 ga Maris 2020.
Ba a sanar da ƙayyadaddun yawa ba; Dole ne a yi tarin samfurin da sarrafa su bisa ga bukatun CDC.
A Rasha, gwajin COVID-19 ya haɓaka da kuma samar da shi ta Cibiyar Nazarin Jihar na Virology da Biotechnology VECTOR.
A ranar 11 ga Fabrairu 2020, hukumar kula da lafiya ta Tarayya ta yi rajista gwajin. A ranar 12 ga Maris 2020, an ba da rahoton Mayo Clinic ta samar da gwajin don gano kamuwa da cutar COVID-19. A ranar 13 ga Maris 2020, Roche Diagnostics ya karɓi amincewar FDA don gwajin da za'a yi a cikin sa'o'o'o'i 3.5, don haka ya ba damar damar da inji daya ya yi kiman kiman kiman 4, 4, 128 a cikin 24 houruwa.
A ranar 19 ga Maris 2020, FDA ta ba da izinin amfani gaggawa (USA) ga Abbott Laboratories don gwaji akan tsarin Abbott m2000; FDA ta bayar da izinin wannan ga Hologic, LabCorp, da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, Cepheid ya karbi UAE daga FDA don gwajin da ya dauki minti 45.
FDA ta amince da gwajin da ke amfani da fasahar fasahar fasahar nucleic acid na isothermal maimakon PCR.
Tun da wannan ba ya buƙatar jerin sauye-sauye na zafin jiki, wannan hanyar zai iya ba da sakamako mai kyau a cikin minti biyar da sakamakon mara kyau a cikin minti 13.
A halin yanzu akwai kimanin 18,000 daga cikin wadannan inji a Amurka kuma Abbott yana tsammanin ya haɓaka masana'antu don isar da gwaje-gwaje 50,000 a kowace rana.A gwajin wanda ke amfani da kwayoyin halitta wanda ke haɗa musamman da furotin nucleocapside (N) na sabuwar coronavirus a Taiwan, tare da fatan cewa zai iya samar da sakamakon a cikin minti 15 zuwa 20 kamar yadda ake sauri.
"Binciken wallafe-wallafen Maris 2020 ya kammala cewa ""zane-zane na radiography ba su da ƙananan ƙimar bincike a farkon matakai, yayin da binciken CT na iya kasancewa har ma kafin kamuwa da cutar." "
Siffofin halittu a kan CT sun haɗa da opacificities na ƙasa-glass na biyu tare da rarraba na gefen, asimmetric da na baya.
Subpleural mallakar, crazy paving da karfafa ta ci gaba yayin da cutar ta ci gaba.
Wani binciken da ya kwatanta PCR da CT a Wuhan a lokacin asalin annobar ta halin yanzu ya nuna cewa CT ya fi dacewa fiye da PCR, kodayake ba a takaice ba, tare da yawancin siffofin hoto da ke tattare da sauran ƙwayoyin cuta da tsarin cuta.
"A ranar Maris 2020, Kwalejin Radiology ta Amurka ta bada shawarar cewa ba za a yi amfani da CT don dubawa ko a matsayin gwajin farko don gano COVID-19 ba."A ranar Maris 2020, CDC ya ba da shawarar PCR don binciken farko. "
Sashe na mayar da martani ga kamuwa da cuta shine samar da kwayoyin halitta ciki har da IgM da IgG.
Ana iya amfani da waɗannan don gano kamuwa da cutar a cikin mutane daga kwanaki 7 ko haka bayan farawar alamun cutar, don ƙayyade rigakafi, kuma a cikin sa ido na jama'a.Assays za a iya yi a cikin babban gwajin gwaji (CLT) ko ta gwajin kulawa (PoCT).
Tsarin sarrafa kansa a cikin gwaje-gwaje da yawa na asibiti zasu iya yin waɗannan gwaje-gwaje amma samar da su zai dogara ne akan adadin samar da kowane tsarin.
Ga CLT ana amfani da samfurin guda ɗaya na jini na gefen, kodayake ana iya amfani da samfuran serial don bi amsar rigakafi.
Don PoCT, yawanci ana samun samfurin jini ɗaya ta hanyar ƙuƙwalwa na fata.
A ranar 26 ga Maris, 2020, FDA ta ba da sunayen hukumomi 29 waɗanda suka ba da sanarwar ga hukumar kamar yadda ake buƙata kuma yanzu suna iya rarraba gwaje-gwaje na kwayoyin halitta.
Tun daga ranar 7 ga watan Afrilu, 2020, FDA ta amince da gwajin guda ɗaya kawai a ƙarƙashin izinin amfani da gaggawa. A ƙarshen Maris 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun karbi amincewar Turai don kayan gwajin su, wanda zai iya gano kwayoyin IgG da IgA akan kwayar cutar a cikin jini.
Samar da gwajin shine samfurori da yawa a cikin sa'o'i kuma saboda haka ya fi sauri fiye da gwajin PCR na kwayoyin RNA na yau da kullum.
A farkon Afrilu, Birtaniya ta gano babu ɗaya daga cikin kayan gwajin gwajin kwayoyin halitta da ta saya ya isa ya yi amfani da su.
"Hong Kong ta kafa wani tsari inda ake zargin marasa lafiya za su iya zama gida, "" sashen gaggawa zai ba da samfurin bututu ga mai haƙuri "," suna fama da shi, aika shi da kuma samun sakamakon gwaji na wani lokaci bayan.The Birtaniya NHS ya sanar da cewa yana dauke da matukar motsa jiki da ake zargi a gida, wanda ya kawar daukar dauki mai cutar da cutar da cutar da wasu idan sun kai.
Cibiyoyin tafiya ta hanyar taimakawa Koriya ta Kudu yi wasu daga cikin gwaje-gwaje mafi sauri, mafi girma na kowane ƙasa. A Jamus, Hukumar Kula da Kiwon Lafiya ta Lafiya ta Kasa ta Kasa ta ce a ranar 2 ga Maris, cewa tana da ikon gwaje-gwajen kimanin 12,000 a kowace rana a cikin wurin asibiti kuma an gwada 10,700 a cikin makon da ya gabata.
Ana ɗaukar farashi ta hanyar inshorar kiwon lafiya lokacin da likita ya ba da umarnin gwajin.
A cewar shugaban Cibiyar Robert Koch, Jamus tana da ikon gwaje-gwaje 160,000 a mako.
Tun daga ranar 19 ga watan Maris, an ba da motar motar a gwaji a birane da yawa.
Tun daga ranar 26 ga Maris 2020, ba a san yawan gwaje-gwaje da aka yi a Jamus ba, saboda an ba da rahoton sakamako mai kyau kawai.
"A farko binciken lab ya bayyana cewa tun daga kalandar mako 12/2020 an gwada aƙalla 483,295 samfurori har zuwa kuma ciki har da mako 12/2020 "EFire" ko 33,491 samfurori (6.9%) gwada kyau ga SARS-CoV-2.A Isra'ila, masu bincike a Technion da Asibitin Rambam sun haɓaka da kuma gwada hanyar gwaji don gwaji daga 64 marasa lafiya a lokaci guda daya, ta 2000, ta hanyar da aka samo shi.
Tare da gine-ginen da BGI-kafa Wang Jian ya kula da shi kuma ya dauki kwanaki 5, samfurin yana nuna lokuta a Hubei zai kasance 47% mafi girma kuma farashin da ya dace da magance kwararanta zai ninka idan wannan gwajin bai zo kan layi ba.
Huo-Yan Labs a Shenzhen, Tianjin, Beijing, da Shanghai sun bi Lab ɗin Wuhan da sauri, a cikin jimillar birane 12 a fadin kasar Sin.
A ranar 4 ga watan Maris 2020 jimillar ci gaba na yau da kullum sun kasance gwaje-gwaje 50,000 a kowace rana. An saki tushen, zane-zane masu yawa da Origami Assays ya saki wanda zai iya gwadawa kamar yadda 1122 samfurori marasa lafiya don COVID19 ta amfani da 93 kawai . Ana iya gudanar da waɗannan zane-zane a cikin kananannin gwaje-gaye ba tare da buƙan robobi.
A watan Maris, raguwa da rashin isassun adadin reagency ya zama tashin hankali don gwajin taro a EU da Birtaniya da Amurka.
Wannan ya jagoranci wasu marubuta su bincika samfuran shirye-shiryen da suka haɗa da samfuran dumama a 98 <0xC2><0xB0> C (208 <0xC2><0xB0> F) na minti 5 don saki RNA genomes don ƙarin gwaji. A ranar 31 ga Maris an sanar da shi yanzu yana gwada karin yawan jama'ar Amirka don cutar Coronavirus a kowace kasa, kuma yana kan hanya don haɓaɓɓewa matakin gwajin gwaji don isa mafi yawan jama'a.
"Wannan ya kasance ta hanyar haɗuwa da ikon tafiya, da sayen gwaje-gwaje na yawan jama'a daga Groupe 42 da BGI (idangane da "Huo-Yan" gano gaggawa gwaje-gwaje a China).
An gina shi a cikin kwanaki 14, lab yana iya gudanar da dubban gwaje-gwaje na RT-PCR kowace rana kuma shine na farko a duniya na wannan sikelin da za a yi aiki a waje da kasar Sin.
An samar da samfuran gwaji daban-daban da ke kaiwa sassa daban-daban na bayanin kwayoyin halittar coronavirus a China, Faransa, Jamus, Hong Kong, Japan, da kuma Amurka.
Hukumar Lafiya ta Duniya ta amince da girke-girke na Jamus don masana'antun kayan aiki da aka aika zuwa ƙasashe masu ƙananan kudin shiga ba tare da samun albarkatu don haɓaka kansu ba.
An buga girke-girke na Jamus a ranar 17 ga Janairu 2020; yarjejeniyar da Cibiyoyin kula da cututtuka na Amurka suka kirkiro ba ta samu ba har sai 28 ga Janairu, jinkirin gwaje-gwaje a Amurka da Amurka suna da matsala tare da amintaccen kayan gwaji a farkon barkewar, kuma wadannan ƙasashe da Australia ba su iya samar da isas da isa don samar bukata da shawar da shawar da kuma shawar da gwaji.
Sabanin haka, masana kimiyya sun ce yawan gwajin da Koriya ta Kudu ta samu ya taimaka wajen rage yaduwar cutar coronavirus.
Gwamnatin Koriya ta Kudu ta gina iyakar gwaji, galibi a cikin labs na masu zaman kansu, a cikin shekaru da yawa.
A ranar 16 ga Maris, Hukumar Kula da Lafiya ta Duniya ta yi kira da haɓaka shirye-shiryen gwaji a matsayin hanya mafi kyau don jinkirin ci gaban cutar COVID-19.High buƙatar gwaji saboda yaduwar cutar ta haifar da bambancin dubban dubban gwaje-gwaje a labs masu zaman kansu na Amurka, kuma samar da swabs da sinadancin sunadadi.
A watan Maris na 2020, China ta ba da rahoton matsaloli tare da daidaito a cikin gwajin su.
"A Amurka, da gwajin kayayyakin da CDC ta ci gaba da ""flows;"" gwamnatin sa'an nan cire da hukumomin da suka hana masu zaman kansu gwaji.Spain saya gwajin kayayyakin daga China kamfanin Shenzhen Bioeasy Biotechnology Co Ltd, amma ya gano cewa sakamakon ba daidai ba ne. "
Kamfanin ya bayyana cewa sakamakon da ba daidai ba na iya zama sakamakon rashin tattara samfurori ko amfani da kayan aiki daidai.
Ma'aikatar Mutanen Espanya ta ce za ta janye kayan da suka dawo da sakamakon da ba daidai ba, kuma za su maye gurbin su da wani kayan gwaji da Shenzhen Bioeasy.80% na kayan gwaji da Jamhuriyar Czech ta sayi daga China ba daidai ba sakamako.
Firayim Minista Matovič ya ba da shawarar a jefa wadannan a cikin Danube.Ate<0xC5><0x9F> Kara na Ma'aikatar Kiwon Lafiya ta Turkiyya ya ce kayan gwaji na Turkiyya da aka saya daga kasar Sin suna da “babban kuskuren kuskure” kuma ba su yi amfani da su ba.
Gwajin, wanda aka bi tare da keɓewa na waɗanda suka gwada kyau da kuma bincika waɗanda mutane masu kyau na SARS-CoV-2 suka tuntube su, ya haifar da sakamako mai kyau.
Masu binciken da ke aiki a garin Vò na Italiya, wurin mutuwar COVID-19 na farko a Italiya, sun gudanar da zagaye biyu na gwaji akan dukkan mutanen kusan mutane 3,400, kimanin kwanaki goma.
Kimanin rabin mutanen da ke gwada lafiya ba su da alamun cututtuka, kuma duk abubuwan da aka gano sun kasance a cikin keɓewa.
Tare da ƙayyadaddun tafiya zuwa garin, wannan ya kawar da sababbin kamuwa da cututtuka gaba ɗaya.
Tare da haɓaka haɗin gwiwa, takunkumin tafiye-tafiye masu shiga, gwaji, da keɓewa, cutar coronavirus ta 2020 a Singapore ta ci gaba da sauri fiye da sauran ƙasashe masu ci gaba, amma ba tare da takunkumi mai tsanani kamar rufe gidajen cin abinci da wuraren sayar da kayayyaki ba.
An soke abubuwan da suka faru da yawa, kuma Singapore ta fara ba da shawarar mazauna da su zauna a gida a ranar 28 ga Maris, amma makarantu sun sake buɗe lokaci bayan hutu a ranar 23 ga Maris.
Har ila yau, wasu ƙasashe da dama sun gudanar da cutar ta hanyar bin hanyar haɗin gwiwa, ƙuntatawa ta tafiye-tafiye, gwaji, da keɓewa, amma tare da ƙananan kulle-kulle, kamar Iceland da Koriya ta Kudu.
Wani binciken kididdiga ya gano cewa kasashen da suka gwada karin, dangane da adadin mutuwar, suna da ƙananan adadin mutuwar cutar, watakila saboda wadannan kasashe sun fi dacewa gano wadanda ke da matsaloli ko kuma babu alamun cututtuka.
WHO ta ba da shawarar cewa kasashen da ba su da gwajin gwaji da gwaje-gwaje na kasa da iyakancewar kwarewa akan COVID-19 sun aika da samfurori guda biyar masu kyau na farko da samfurori goma na COVID-19 na farko zuwa ɗaya daga cikin gwaje-gwaje na 16 na WHO don gwajin tabbatarwa.
Daga cikin laboratori 16, 7 ne a Asiya, 5 a Turai, 2 a Afirka, 1 a Arewacin Amirka da 1 a Australia.
A cikin ginshiƙi na gaba, shafin "Matsayi a matsayin % na gwaje-gwaje" yana rinjayar manufofin gwaje-gwaje na kasar.
Kasashen da kawai ke gwada mutanen da aka shigar da su asibiti za su sami kashi na gwaje-gwaje mafi girma fiye da kasa da ke gwada duk 'yan ƙasa, ko suna nuna alamun, wasu abubuwa suna daidaita.
Wanke hannu (ko wanke hannu), wanda aka fi sani da tsaftace hannu, shine aikin tsabtace hannayen mutum don dalilin cire ƙasa, mai, kwayoyin halitta, ko wasu abubuwa marasa so.
"Hannun wanke tare da sabulu koyaushe a wasu ""lokaci masu mahimmanci"" a lokacin rana ya hana yaduwar cututtuka da yawa, misali diarroea da cholera, wanda aka watsa ta hanyar fecal-oral hanya. "
Hakanan mutane na iya kamuwa da cututtukan numfashi kamar kamuwa da cuta ko sanyi na kowa, alal misali, idan ba su wanke hannunsu ba kafin su taɓa idanunsu, hanci, ko bakinsu (watau membranes mucou).
Lokaci biyar masu muhimmanci a yau da rana inda wanke hannayen hannu da sabulu yana da mahimmanci sun haɗa da: kafin da bayan zubar da ciki, bayan tsabtace ƙasa na yaro ko canza nappers, kafin ciyar da yaro, kafin cin abinci da kuma bayan shirya abinci ko sarrafa nama mai rawaya, kifi, ko tsuntsaye.
Idan ba a samu ruwa da sabulu ba, za a iya wanke hannayensu da ash.The World Health Organization ta bada shawarar wanke hannu:
Kafin, lokacin, da kuma bayan shirya abinci.
Kafin da kuma bayan kula da mutumin da ke da rashin lafiya.
Bayan canza diapers ko tsabtace wani yaro wanda ya yi amfani da wanka.
Bayan kunna hanci, ciwo ko ciwo.
Bayan taba dabbobi, ciyar da dabbobi, ko sharar dabbobi.
Tsaftace hannu na likitanci yana nufin ayyukan tsaftacewa da suka shafi hanyoyin likitanci.
Wanke hannunka kafin a gudanar da magani ko kulawar likita na iya hana ko rage yaduwar cututtuka.
Babban manufar likita na wanke hannayen hannu shine tsaftace hannayen kwayoyin cuta (bacteria, kwayoyin cuta, ko sauran ƙwayoyin cuta waɗanda zasu iya haifar da cuta) da sinadaran da zasu iya haifar da cuta ko cututtuka.
Wannan yana da mahimmanci musamman ga mutanen da ke kula da abinci ko aiki a filin likita, amma kuma yana da mahimmanci ga jama'a.
Wanke hannu yana da amfanin kiwon lafiya da yawa, ciki har da rage yaduwar ƙwayar cuta, coronavirus, da sauran cututtuka masu kamuwa da cuta; hana dalilai masu kamuwa da ciwon ciki; rage kamuwa da cututtukan numfashi;
Rage yawan mutuwar jarirai a lokacin haihuwa a gida.
Binciken 2013 ya nuna cewa inganta ayyukan wanke hannu na iya haifar da ƙananan ingantawa a cikin tsawon ci gaban yara a cikin 'yan kasa da shekaru biyar.
A cikin ƙasashe masu tasowa, ana iya rage yawan mutuwar yara da ke da alaƙa da cututtukan numfashi da ciwon jijiyoyi ta hanyar gabatar da sauye-sauye masu sauƙin hali, kamar wanke hannu da sabulu.
Wannan mataki mai sauƙi zai iya rage yawan mutuwa daga waɗannan cututtuka ta kusan 50%.
Gudun da ke inganta wanke hannu na iya rage abubuwan ciwo ta kimanin kashi uku, kuma wannan yana kama da samar da ruwa mai tsabta a yankunan ƙananan kuɗi.
48% na raguwa a cikin ciwon daji na iya hade da wanke hannu tare da sabulu. Wanke hannunka da sabulu shine hanya mafi inganci kuma mai tsada don hana ciwon daji da kamuwa da cututtukan numfashi (ARI), kamar yadda halin atomatik ke yi a gidaje, makarantu, da al'ummomi a duniya.
Pneumonia, babban ARI, shine adadin dalilin mutuwar yara a cikin shekaru biyar, wanda ya kai rai na kimanin yara miliyan 1.8 a kowace shekara.
Diarrhea da pneumonia tare suna kimanin mutuwar yara miliyan 3.5 a kowace shekara.
A cewar UNICEF, juya hannayen hannu da sabulu kafin cin abinci da kuma bayan amfani da wanka a cikin al'ada na iya ceton rayuka fiye da kowane allura guda ko magani na likita, rage mutuwa daga ciwon daji da kusan rabin da kuma mutuwa daga cututtukan numfashi masu tsanani da kashi daya.
Yawancin lokaci ana haɗa wanke hannu tare da sauran tsabtace tsabta a matsayin wani ɓangare na shirye-shiryen ruwa, tsaftacewa da tsaftacewa (WASH).
Har ila yau, wanke hannu yana kārewa daga impetigo wanda aka watsa ta hanyar tattaunawa ta jiki kai tsaye.
<0xC6><0x98>ananan sakamako mai lahani na wanke hannu shine cewa wanke hannu sau da yawa zai iya haifar da lalacewar fata saboda bushewar fata.
Wani binciken Danish na shekarar 2012 ya gano cewa wanke hannu mai yawa na iya haifar da ƙwayar cuta, yanayin fata wanda aka fi sani da eczema ko dermatitis na hannu, wanda ya fi kowa a tsakanin ma'aikatan kiwon lafiya.
Har ila yau, ana ganin wanke hannu sau da yawa a matsayin daya daga cikin alamun cutar ossessive-compulsive (OCD).
Akwai lokuta biyar masu muhimmanci a yayin rana inda wanke hannayen hannu tare da sabulu yana da mahimmanci don rage watsawar cututtuka: bayan yin amfani da wanka (mai shimfidawa, cirewa), bayan tsabtace ƙasa na yara (sauye-sauye), kafin ciyar da yaro, kafin / bayan shirya abinci ko sarrafa nama, kifi, ko tsun.
Sauran lokuta ya kamata a yi amfani da fasaha na wanke hannu don hana yaduwar cututtuka sun haɗa da kafin da bayan magance yanke ko rauni; bayan hatsi, hakori, ko busa hanci; bayan taɓa sharar dabbobi ko sarrafa dabbobi; da kuma bayan taɓa sharar dabbobi.
A ƙasashe da yawa, akwai ƙananan ƙananan wanke hannu tare da sabulu.
Wani bincike na wanke hannu a ƙasashe 54 a 2015 ya gano cewa a matsakaicin, 38.7% na iyalai sun yi wanka hannu tare da sabulu. A 2014 binciken ya nuna cewa Saudi Arabia tana da mafi girman kashi 97; Amurka kusa da tsakiyar kashi 77; da China tare da mafi ƙasƙanci kashi 23.
"Ma'aikatar Ilimi ta Philippines ta aiwatar da shirye-shiryen kiwon lafiya mai mahimmanci" misali ne na matakin da ya dace don inganta lafiyar yara da ilimi.
Deworming sau biyu a kowace shekara, wanda aka kara da wanke hannuwa kowace rana tare da sabulu, wanke hakora kowace rana tare da fluoride, yana cikin zuciyar wannan shirin na kasa.
Hakanan an yi nasarar aiwatar da shi a Indonesia.
Cire kwayoyin halitta daga fata ana inganta ta hanyar ƙara sabulu ko detergent zuwa ruwa.
Babban aikin sabulu da detergent shine rage matsalolin magancewa, da kuma ƙara solubility.
Ruwa kadai shine mai tsabtace fata mara inganci saboda kitse da sunadarai, waɗanda ke cikin ƙasa mai tsabta, ba a warware su cikin ruwa ba.
Koyaya, tsaftacewa yana taimakawa ta hanyar kwararar ruwa mai kyau.
Sabulu mai ƙarfi, saboda yanayin da za a iya sake amfani da shi, na iya riƙe kwayoyin da aka samu daga amfani da su.
<0xC6><0x98>ananan nazarin da suka dubi canja wurin kwayoyin cuta daga sabulu mai gurɓata ya kammala canja wuri ba zai yiwu ba kamar yadda aka wanke kwayoyin ba.
"CDC har yanzu yana cewa ""sabulu mai laushi tare da iko-free hannu don bayarwa ya fi kyau"." "
An inganta sabulu na antibacterial zuwa ga jama'a masu ilimin kiwon lafiya.
Har zuwa yau, babu wata shaidar cewa yin amfani da maganin magani ko ciwon da aka ba da shawarar ya zaɓi don kwayoyin maganin rigakafi masu tsayayya da kwayoyin cuta a yanayi.
Duk da haka, sabulu na antibacterial sun ƙunshi jami'an antibacterial na yau da kullum kamar triclosan, wanda ke da jerin jerin nau'ikan resistant na kwayoyin halitta.
Saboda haka, ko da ba a zaɓi nau'ikan rigakafi ba ta hanyar sabulu na antibacterial, ba za su iya zama tasiri kamar yadda aka sayar da su ba.
Baya ga surfactant da fata-kare wakili, da m gyare-gyare na iya ƙunshi acid (acetic acid, ascorbic acid, lactic acid) a matsayin pH mai daidaitawa, antimicrobically aiki benzoic acid da kuma ƙarin fata conditioners (aloe vera, bitamin, mentol, shukacin da cire).
Ruwa mai zafi wanda ya dace don wanke hannu ba shi da zafi don kashe kwayoyin cuta.
Bacteria yayi girma da sauri a jiki da yawan zafin jiki (37 <0xC2><0xB0> C).
Duk da haka, ruwan sabulu mai zafi ya fi tasiri fiye da sanyi, ruwan sabulu a cire man fetur na halitta wanda ke riƙe da ƙasa da kwayoyin halitta.
Ba kamar yadda aka sani ba, binciken kimiyya ya nuna cewa yin amfani da ruwa mai dumi ba shi da tasiri a rage nauyin ƙwayoyin cuta a hannunsa.
Mai tsabtace hannu ko antiseptic hannun shine wakilin tsabtace hannu wanda ba shi da tushen ruwa.
A ƙarshen shekarun 1990s da farkon karni na 21, magunguna masu tsabtace hannu waɗanda ba su da ruwa (wanda aka fi sani da magunguna na hannu, magunguna na hannaye, ko masu tsabtace hannayen hannu) sun fara samun shahararren.
Yawancin sun dogara ne akan barasa na isopropyl ko ethanol wanda aka tsara tare da wakili mai kauri kamar Carbomer (polymer na acrylic acid) a cikin gel, ko kuma humectant kamar glycerin a cikin ruwa, ko fom don sauƙin amfani da kuma rage sakamakon bushewar barasa.
<0xC6><0x98>irƙirar hydrogen-peroxide mai rauni yana ƙara ƙara aikin antimicrobial.Hand sanitizers da ke dauke da ƙarancin 60 zuwa 95% barasa sune masu kisan kwayoyin halitta masu inganci.
Magungunan giya sun kashe kwayoyin cuta, kwayoyin magani masu yawa (MRSA da VRE), ƙwayoyin cuta, da wasu ƙwayoyin cuta (ciki har da HIV, herpes, RSV, rhinovirus, allurar rigakafi, influenza, da hepatitis) da fungi.
Sanitizers da ke dauke da 70% giya sun kashe 99.97% (3.5 log rage, kama da 35 decibel rage) na kwayoyin a hannun 30 seconds bayan aikace-aikace da 99.999% zuwa 99.999% (4 zuwa 5 log rage) na kwayoyin a hannun 1 minti bayan aikace-aikacen.Hand sanitizers sun fi tasiri akan kwayoyin da kasa da wasu ƙwayoyin.
Sanitizers na hannu masu tushen giya kusan gaba daya ba su da tasiri a kan norovirus (ko Norwalk) irin kwayoyin cuta, mafi yawan dalilin ciwon gastroenteritis.Continue na hannu ko magunguna dole ne a yi amfani da su cikakke ko rufe duka hannu biyu.
A gaba da baya na duka hannayen da kuma tsakanin da kuma ƙarshen duk yatsunsu ana rufe su don kimanin 30 seconds har sai ruwa, fom ko gel ya bushe.
Dole ne a wanke shawarwari na yatsa da kyau kuma, ku zubar da su a duka dabino. Cibiyar kula da cututtuka ta Amurka ta bada shawarar wanke hannu a kan wanke hannayen tsabtace, musamman lokacin da hannayensu ke marmari.
Yawan amfani da waɗannan jami'an ya dogara ne akan saurin amfani da ayyukan kisa da sauri akan ƙwayoyin halitta; duk da haka, bai kamata su zama maye gurbin wanke hannu ba sai dai idan sabulu da ruwa ba su samuwa ba.
Sau da yawa amfani da magunguna na hannu masu tushen giya na iya haifar da bushewar fata sai dai idan an ƙara emollients da / ko moisturizers na fata zuwa tsarin.
Ana iya rage sakamakon bushewa na barasa ko kawar da shi ta hanyar ƙara glycerin da / ko wasu emollients zuwa tsarin.
A cikin gwaje-gwaje na asibiti, magunguna na hannu da ke dauke da emollients sun haifar da ƙarancin fushin fata da bushewa fiye da sabulu ko antimicrobial detergent.
Allergic contact dermatitis, contact urticaria syndrome ko hypersensitivity ga barasa ko Addittives da aka samu a hannun giya rubs rare faruwa.
<0xC6><0x98>ananan halin da ake ciki don haifar da dangantaka da ciwon daji ya zama abin jan hankali idan aka kwatanta da sabulu da wanke hannu.
Duk da tasirinsu, wakilan da ba ruwa ba su tsabtace hannayensu na kayan halitta ba, amma kawai tsabtace su.
Wannan shine dalilin da ya sa masu tsabtace hannu ba su da tasiri kamar sabulu da ruwa don hana yaduwar cututtuka da yawa, tunda cututtukan cututtuka har yanzu suna cikin hannu.
Ingancin tsabtace hannu na giya ba tare da giya ba ya dogara sosai akan abubuwan da ke ciki da tsari, kuma tarihi yana da matukar muhimmanci a ƙarƙashin giya da giya.
Kwanan nan, an nuna maganganun da ke amfani da benzalkonium chloride suna da ci gaba da aiki na antimikrobial bayan aikace-aikace, ba kamar barasa ba, wanda aka nuna ya ragu da inganci bayan amfani da yawa, watakila saboda maganganun launin fata masu launin fata.
Mutane da yawa a cikin ƙananan al'ummomi ba za su iya biyan sabulu ba kuma suna amfani da ash ko ƙasa maimakon haka.
Ash ko ƙasa na iya zama mafi tasiri fiye da ruwa kaɗai, amma na iya zama ƙasa da tasiri fiye da sabulu.
Ɗaya daga cikin damuwa shine cewa idan ƙasa ko laka ta gurbata da kwayoyin halitta, zai iya ƙara yaduwar cututtuka maimakon rage shi.
Kamar sabulu, ash ma wakili ne mai tsabta saboda tare da ruwa, yana samar da maganin alkalin.
WHO ya ba da shawarar ash ko yashi a matsayin madadin sabulu lokacin da sabulu ba a samu ba.
Daidaita hannayen hannaye dabarun da Cibiyoyin kula da cututtuka na Amurka suka ba da shawarar don rigakafin watsa cututtuka sun haɗa da matakai masu zuwa:
Ruwa hannuwa tare da ruwa mai zafi ko sanyi.
Ana ba da shawarar gudun ruwa saboda tsaye bashi na iya gurɓatawa, yayin da yawan zafin jiki na ruwa ba ya haifar da bambanci.
Hannun hannu ta hanyar zubar da su da sabulu mai yawa, ciki har da baya na hannuwansu, tsakanin yatsunsu, da ƙarƙashin ƙafafu.
Sabulu suna dauke da kwayoyin cutar daga fata, kuma binciken ya nuna cewa mutane suna wanke hannayensu sosai lokacin da ake amfani da sabulu maimakon ruwa kawai.
Saukewa don akalla 20 seconds.
Scrubbing yana haifar da bambanci, wanda ke taimakawa cire kwayoyin fata daga fata, kuma scrubbing na tsawon lokaci yana cire ƙarin kwayoyin.
Sanya shi da kyau a ƙarƙashin ruwa mai zurfi.
Yin wanka a cikin kwanon rufi na iya sake gurɓata hannayensu.
Bushewa tare da tawul mai tsabta ko bari iska ta bushe.
Ruwa da zafi hannuwan suna da sauƙin recontaminated.The mafi yawan rasa yankuna su ne yatsun kafa, yatsun, yankuna tsakanin yatsun, da kuma karkashin yatsunsu.
Kayan lantarki na Artificial da nau'in polish na iya ɗaukar ƙwayoyin ƙwayoyin cuta.
Ana ba da shawarar moisturizing lotion sau da yawa don kiyaye hannayensa daga bushewa; busassun fata na iya haifar da lalacewar fata wanda zai iya ƙara haɗarin watsa kamuwa da kamuwa da cuta.
"Za'a iya yin zaɓuɓɓuka daban-daban na low-cost don sauƙaƙe wanke hannu inda ba'a samuwa ba ruwan sanyi da / ko sabulu, misali, zubar da ruwa daga jerrycan ko gourd tare da ramukan da suka dace da / ko amfani da ash idan an buƙata a ƙasashe masu tasowa.
Tippy-tap wani fasahar ne mai sauki ta amfani da jug dakatar da igiya, da kuma motar ƙafa-kafa don zuba ƙananan ruwa a kan hannayenku da mashaya na sabulu.
Tasirin bushewa na hannayen hannu wani muhimmin ɓangare ne na tsaftace hannayen hannu, amma akwai wasu muhawara game da mafi tasiri na bushewa a cikin wanka na jama'a.
Ɗaya daga cikin binciken ya nuna tawuls na takarda sun fi tsabta fiye da na'urorin na'urar wutar lantarki da aka samu a cikin wanka da yawa.
A cikin 2008, Jami'ar Westminster, London, ta gudanar da bincike, kuma masana'antar tawul ta takarda ta Turai ta Symposium, don kwatanta matakan tsaftacewa da tawuls ta takarda, dumi-air hand na'urar bushewa da kuma mafi zamani jet-air hand na'urar bushewa.
Bayan wanke hannu da bushewa tare da na'urar busar iska mai zafi, an gano adadin kwayoyin cuta ya karu a matsakaici a kan yatsa ta 194% da kuma a kan dabino ta 254%.
Bushewa tare da jet- iska na'urar bushewa ya haifar da karuwar a matsakaicin yawan kwayoyin halitta a kan yatsa da kashi 42% da kuma a kan dabino da kashi 15%.
Bayan wanke hannu da bushewa tare da tawul na takarda, an rage yawan kwayoyin kwayoyin a matsakaici a kan yatsa da har zuwa 76% da kuma a kan dabino har zuwa 77%.An kuma gudanar da gwaje-gwaje don tabbatar da ko akwai yiwuwar gurɓata wasu masu amfani da wanka da kuma yanayin wanka sakamakon kowane nau'i na bushewa.
Mai na'urar busar iska ta jet, wanda ke busa iska daga na'urar a cikin gudun 180 m / s (650 km / h; 400 mph), yana iya busa kwayoyin halitta daga hannu da na'urar kuma yana iya gurɓata sauran masu amfani da wanki da yanayin wanka har zuwa mita 2.
Amfani da na'urar busar hannu mai zafi ta yada ƙwayoyin halitta har zuwa mita 0.25 daga na'urar busar.
A cikin 2005, a cikin wani binciken da T<0xC3><0x9C>V Product and Environment ya gudanar, an kimanta hannayen bushewa daban-daban.
An lura da canje-canje masu zuwa a cikin ƙididdigar kwayoyin cuta bayan bushe hannayensu:
Yawancin masana'antun na'urar busar hannu daban-daban suna wanzu, kuma an kwatanta na'urorin na'urorin hannu da bushewa tare da tawuls na takarda.
Yin wanke hannun hannu ta amfani da wanke hannayen wanka shine madadin lokacin tafiya ba tare da sabulu da ruwa ba.
Sanitizer na hannu mai tushen giya ya kamata ya ƙunshi akalla kashi 60% giya.
Likitocin likitanci sun zama dole bayan da likitan Hungary Ignaz Semmelweis ya gano tasirinsa (a 1846) a hana cutar a cikin yanayin asibiti.
Akwai na'urorin lantarki waɗanda ke ba da martani don tunawa da ma'aikatan asibiti su wanke hannayensu lokacin da suka manta.
Ɗaya daga cikin binciken ya gano rage yawan kamuwa da cutar tare da amfani da su.
Magungunan hannu na likita ne don ƙaramin minti 15, ta amfani da yawancin sabulu da ruwa ko gel zuwa later da kuma rufe kowane ɓangare na hannu.
Ya kamata a rufe hannayensu tare da digitals tare da haɗin gwiwa.
Idan akwai rushewa a ƙarƙashin ƙananan yatsa, ana iya amfani da brush mai laushi don cire shi.
Tun da kwayoyin cuta zasu iya kasancewa a cikin ruwa a hannunsu, yana da muhimmanci a wanke su da kyau da kuma wanke bushewa da tawul mai tsabta.
Bayan bushewa, ya kamata a yi amfani da tawul na takarda don kashe ruwa (kuma bude kowane ƙofar fita idan ya cancanta).
Wannan yana hana sake ƙazantar da hannayensu daga waɗannan wurare.
"Manufar wanke hannu a cikin saitin kula da lafiya shine cire kwayoyin cuta ("magunguna") kuma kauce wa watsa su."
New England Journal of Medicine ya ruwaito cewa rashin wanke hannu ya kasance a matakan da ba a yarda ba a mafi yawan muhallin likita, tare da yawancin likitoci da ma'aikata masu kulawa suna mantawa da wanke hannayensu kafin su taɓa marasa lafiya, don haka su watsa kwayoyin halitta.
Ɗaya daga cikin binciken ya nuna cewa yadda ya dace da wanke hannu da sauran hanyoyi masu sauƙi na iya rage yawan kamuwa da cututtukan jini da ke da alaƙa da catheter da kashi 66.The World Health Organization ta wallafa takardar nuna nauyin wanke hannu da wanke hannu a sassan kiwon lafiya.
Hakanan ana iya samun jagorancin tsabtace hannu ta ƙungiyar a shafin yanar gizonta don sharhi na jama'a.
Whitby et al. ya gudanar da bita mai dacewa.
Na'urorin kasuwanci na iya aunawa da tabbatar da tsaftace hannu, idan ana buƙatar nuna bin doka.
<0xC6><0x98>ungiyar Lafiya ta Duniya tana da 'Moments biyar' don wanke hannayensu
Bayan bayyanar da jini / jikin ruwa
Kafin aiwatar da wani abu mai ban sha'awa, kuma
"Bayan kula da marasa lafiya. <0xC6><0x98>arin sunadarai masu tsabtacewa zuwa sabulu ("magunguna" ko "antimicrobial" sabulu) yana ba da aikin kisa ga wakilin wanke hannu. "
Irin wannan aikin kisa na iya zama ana so kafin yin tiyata ko a cikin saitunan da kwayoyin magani masu tsabta suna da yawa. Don 'scrub' hannayen mutum don aikin kiwon lafiya, yana da muhimmanci a sami santsi wanda za a iya kunnawa kuma kashe shi ba tare da taɓa shi ba tare da hannu ba, wasu chlorhexidine ko iodine wanka.
Ya kamata a cire duk kayan ado.
Wannan hanya yana buƙatar wanke hannayen hannu da makamai har zuwa ɗamara, yawanci minti 2-6.
Ba a buƙatar tsawon tsawon lokaci (minti 10) ba.
Lokacin wankewa, dole ne a hana ruwa a kan hannayen hannu don gudu zuwa hannun.
Bayan an kammala wanke hannu, hannuwan suna bushe da tufafi mai tsabta kuma an ba da tufafi na kiwon lafiya.
Don rage yaduwar ƙwayoyin cuta, ya fi kyau a wanke hannu ko amfani da hannayen magani kafin da kuma bayan daukar marar lafiya.
Don sarrafa kamuwa da cututtukan staphylococcal a asibitoci, an gano cewa mafi girman amfana daga tsabtace hannu ya fito ne daga kashi 20 na farko na wankewa, kuma an sami ƙarin amfani sosai lokacin da aka karu da yawan tsabtace hannaye fiye da kashi 35%.
Yin wanka tare da sabulu mai sauƙi ya haifar da fiye da sau uku yawan cututtukan kwayoyin cuta da aka watsa zuwa abinci idan aka kwatanta da wanka tare da sabulu na antibacterial.Daidai da wanke hannu tare da wanke hannu tare da sabulu na tsaka-tsaki na tsaka-tsaki 30 kowane ya nuna cewa barasa na hannunsa ya rage gurɓataccen kwayoyin kwayoyin 26% fiye da sabuwar kwayoyin kwayoyin.
Amma sabulu da ruwa sun fi tasiri fiye da rubs na hannunsa na giya don rage H1N1 virus da Clostridium difficile spores daga hannaye.Haɓaka don inganta tsaftace hannu a cikin saitunan kiwon lafiya na iya haɗa da ilimi ga ma'aikata akan wanke hannu, ƙara samun rubs na hannun, da kuma rubuce-rubutu da magana ga ma'a.
Ana buƙatar ƙarin bincike a kan waɗanne daga cikin waɗannan maganganu sun fi tasiri a cikin saitunan kiwon lafiya daban-daban.
A cikin ƙasashe masu tasowa, ana san wanke hannu da sabulu a matsayin kayan aiki mai inganci, mai mahimmanci don samun lafiya mai kyau, har ma da abinci mai kyau.
Duk da haka, rashin samar da ruwa mai dogara, sabulu ko wuraren wanke hannu a gidajen mutane, a makarantu da kuma wurin aiki yana sa ya zama kalubale don cimma halaye na wanke hannu.
Alal misali, a mafi yawan karkara na Afirka wanke hannayen hannu kusa da kowane gidan wanka mai zaman kansa ko na jama'a ba su da yawa, kodayake akwai zaɓuɓɓuka masu rahusa don gina wuraren wanka.
Duk da haka, ƙananan kuɗin wanke hannu maimakon haka na iya zama sakamakon al'adun da aka tsara maimakon saboda rashin sabulu ko ruwa.
Ingantawa da tallafi na wanke hannu tare da sabulu na iya rinjayar yanke shawarar manufofin, ƙara wayar da kan fa'idodin wanke hannu da kuma haifar da canjin hali na dogon lokaci na yawan jama'a.
Don yin wannan aiki mai kyau, ana buƙatar saka idanu da kimantawa.
"Binciken tsari na nazarin 70 ya gano cewa hanyoyin al'umma suna da tasiri wajen ƙara wanke hannu a cikin LMICs, yayin da kamfen ɗin tallace-tallace na zamantakewa ba su da tasiri. Misali ɗaya don inganta hannayen hannu a makarantu shine "" Hanyar Taurari Uku"" ta UNICEF wanda ke ƙarfafa makarantu su ɗauki da matakan sauki, marasa tsadadi don tabbatarwa don tabbatar da haka.
Lokacin da aka sami ƙananan ƙa'idodin, makarantu za su iya motsa daga taurari guda uku zuwa ƙarshe.
Gina tashoshin wanke hannu na iya zama wani ɓangare na kamfen ɗin haɓaka wanke hannu waɗanda aka gudanar don rage cututtuka da mutuwar yara.
Ranar wanke hannu ta duniya wani misali ne na kamfen din da ke kokarin cimma canjin hali.A sakamakon cutar coronavirus ta 2019-20, UNICEF ta inganta daukar alamun wanke hannu.
Nazarin kaɗan ne suka yi la'akari da yawan kudin wanke hannu a kasashe masu tasowa dangane da DALYs da aka hana.
Duk da haka, wani bita ya nuna cewa inganta wanke hannu tare da sabulu ya fi dacewa fiye da sauran ruwa da tsaftacewa.
"Muhimmancin wanke hannu don lafiyar ɗan adam - musamman ga mutanen da ke cikin yanayi mai rauni kamar uwa waɗanda suka haifi haifi ko rauni sojoji a asibitoci - an fara gane su a tsakiyar karni na 19 ta hanyar majagaba biyu na tsaftace hannu: likitan Hungary Ignaz Semmelweis wanda ke aiki a Vienna, Austria da Florence Nightingale, wanda ya kafaran English.
A wannan lokacin, yawancin mutane sun yi imanin cewa cututtukan cututtuka suna haifar da mummunan zafi da ake kira miasmas.
A cikin shekarun 1980, cututtuka da cututtukan da ke da alaka da lafiya sun haifar da cibiyoyin kula da cututtuka da kuma hana cututtuka na Amurka don inganta tsaftace hannu a matsayin muhimmin hanya don hana yaduwar cututtuka.
Barkewar ƙwayar cuta a shekarar 2009 da cutar COVID-19 a shekarar 2020 ya haifar da ƙara fahimtar muhimmancin wanke hannayen hannu da sabulu don kare kanka daga irin waɗannan cututtuka masu kamuwa da cututtuka.
" Alal misali, posters tare da ""daidaitaccen hannayen wanke hannu"" an rataye kusa da wanke hannayen hannu a cikin gidan wanka na jama'a da kuma a cikin wanka na gine-ginen ofishin da filayen jiragen saman a Jamus. "
"Ma'anar "" wanke hannuwan mutum"" wani abu, yana nufin sanar da rashin son mutum ya ɗauki alhakin abu ko raba haɗin gwiwa a ciki. "
An samo asali ne daga Littafi Mai Tsarki a Matiyu inda Pontus Bilatus ya wanke hannunsa na yanke shawarar gicciye Yesu Kristi, amma ya zama furci tare da amfani da yawa a wasu al'ummomin Ingilishi.
A cikin Shakespeare's Macbeth, Lady Macbeth ta fara wanke hannayenta a cikin kokarin tsabtace launin fata, yana wakiltar launin fata game da laifuka da ta yi kuma ta sa mijinta ya yi.
An kuma gano cewa mutane, bayan sun tuna ko sun yi la'akari da ayyukan da ba daidai ba, suna wanke hannuwa fiye da wasu, kuma suna da daraja kayan wanke hannu.
Bugu da ƙari, waɗanda aka ba su damar wanke hannayensu bayan irin wannan tunani ba za su iya shiga cikin wasu ayyukan "tsabtawa" ba, kamar yin sadaka.
Addinan addinai sun ba da umarnin wanke hannu don dalilai masu tsabta da alama. Alamar wanke hannu, ta yin amfani da ruwa amma ba tare da sabulu don wanke hannu ba, wani ɓangare ne na wanke hannu da aka nuna a cikin addinai da yawa, ciki har da Baha'í bangaskiya, Hindu, tevilah da netilat yadayim a cikin Yahudanci, Lavabo a Kiristanci, da Wudhu a Islam.
Hindu, Yahudanci da Musulunci sun ba da umarnin wanke hannu bayan amfani da wanka.
Kuma, Hindu, Buddha, Sikhism, Yahudanci da Musulunci sun ba da umarnin wanke hannuwa kafin da bayan kowane abinci.
Hanyoyin haɗari na wurin aiki don COVID-19
<0xC6><0x98>ungiyoyin haɗari na wurin aiki don COVID-19 sune aikace-aikacen tsaro na aiki da hanyoyin kiwon lafiya don kula da haɗari don rigakafin cutar coronavirus 2019 (COVID-19).
Gudun haɗari da ya dace a wurin aiki ya dogara ne akan aikin aiki da aikin aiki, dangane da kimanta haɗari na tushen bayyanar, tsananin cututtuka a cikin al'umma, da kuma abubuwan haɗari na ma'aikata guda ɗaya waɗanda zasu iya zama m ga kwangilar COVID-19.
A cewar Hukumar Tsaro da Kiwon Lafiya ta Amurka (OSHA), ƙananan ayyukan haɗari suna da ƙarancin haɗin aiki tare da jama'a da sauran abokan aiki, wanda ake ba da shawarar matakan rigakafin kamuwa da cuta, ciki har da wanke hannu, ƙarfafa ma'aikata su zauna gida idan suna da rashin lafiya, da kuma kiyaye tsaftacewa na yau da kullum da kuma tsabtacewar yanayin aiki.
Ayyukan haɗari na matsakaicin haɗari sun haɗa da waɗanda ke buƙatar haɗin kai ko kusa da mutanen da ba a san su ba ko kuma ana zargin su da COVID-19, amma ana iya kamuwa da cutar saboda watsawar al'umma ko tafiya ta duniya.
Wannan ya haɗa da ma'aikata waɗanda ke hulɗa da jama'a kamar su a makarantu, yanayin aikin yawan jama'a, da wasu saitunan sayar da kayayyaki masu yawa.
Gudun haɗari ga wannan rukuni, ban da matakan rigakafin kamuwa da cuta, sun haɗa da iska ta amfani da tace-tace na iska mai inganci, masu tsawa, da kuma samun kayan kariya na sirri da ke samuwa idan mutum da COVID-19 ya haɗu.
OSHA tana la'akari da ma'aikatan kiwon lafiya da wuraren shakatawa da aka fallasa ga mutumin da aka sani ko wanda ake zargi da COVID-19 a cikin haɗarin haɗari, wanda ke kara zuwa haɗarin haɗari mai girma idan ma'aikata suna yin hanyoyin samar da aerosol akan, ko tattara ko sarrafa samfurin daga, wanda aka sani ko wanda ake zarta da COVID-19.
Tsarin haɗari da ya dace da waɗannan ma'aikata sun haɗa da sarrafawa na injiniya kamar ɗakunan iska mara matsa lamba, da kayan aiki na sirri wanda ya dace da aikin aikin.
Barkewar COVID-19 na iya haifar da tasiri daban-daban a wurin aiki.
Ma'aikata za su iya barin aiki saboda rashin lafiya, suna buƙatar kula da wasu, ko kuma saboda tsoron yiwuwar bayyanar.
Hanyoyin kasuwanci na iya canzawa, duka biyu dangane da abin da ake buƙatar kayayyakin, da kuma hanyoyin sayen waɗannan kayayyakin (kamar sayarwa a waje-lokaci ko ta hanyar bayarwa ko ayyuka).
A karshe, za a iya dakatar da jigilar kayayyaki daga yankunan yanki da COVID-19 ya shafi mummunan rauni. Ana iya amfani da shirye-shiryen cututtuka masu kamuwa da kuma shirin amsawa don jagorancin ayyukan kariya.
Shirye-shiryen magance matakan haɗarin da ke da alaƙa da wuraren aiki da ayyukan aiki daban-daban, ciki har da tushen bayyanar, abubuwan haɗari da ke tasowa daga gida da al'umma, da kuma abubuwan haɗari na ma'aikata na mutum kamar tsufa ko yanayin likita na yau da kullum.
Suna kuma nuna iko da ake bukata don magance waɗannan hadarin, da kuma shirye-shiryen gaggawa don yanayi da za su iya tasowa sakamakon barkewar cutar.
Shirye-shiryen cututtukan cututtuka da shirye-shiryen magance cututtuka na iya zama dole ga shawarwari na kasa ko na kasa.
Manufofi don amsawa ga barkewa sun haɗa da rage watsawa tsakanin ma'aikata, kare mutanen da ke cikin haɗari mafi girma don rikice-rikice na lafiya, kiyaye ayyukan kasuwanci, da rage mummunan tasiri a kan sauran ƙungiyoyi a cikin sarƙoƙin samar da su.
Matsalar cututtuka a cikin al'umma inda kasuwancin ya shafi amsoshin da aka karɓa.
Tsarin kula da haɗari shine tsarin da aka yi amfani da shi sosai a cikin amincin aiki da kiwon lafiya don kula da haɗari ta hanyar tasiri.
Lokacin da ba za a iya kawar da haɗarin COVID-19 ba, mafi kyawun iko shine sarrafawa na injiniya, bi da iko na gudanarwa, da kuma kayan aiki na sirri.
Gudanar da injiniya sun haɗa da ware ma'aikata daga haɗarin da ke da alaƙa da aiki ba tare da dogara da halayyar ma'aikata ba, kuma zai iya zama mafi kyawun bayani don aiwatarwa.
<0xC6><0x98>ungiyoyin gudanarwa canje-canje ne a cikin manufofin aiki ko hanyoyin da ke buƙatar mataki daga ma'aikaci ko ma'aikata.
Ana ɗaukar kayan kariya na sirri (PPE) ƙasa da tasiri fiye da kulawar injiniya da sarrafa gudanarwa, amma zai iya taimakawa wajen hana wasu abubuwan da suka faru.
Dole ne a zabi duk nau'ikan PPE dangane da haɗari ga ma'aikaci, an daidaita shi kamar yadda ya dace (misali, numfashi), ya dace da daidaito, ana dubawa, kulawa, da maye gurbin, idan ya cancanta, da kuma cirewa yadda ya kamata, tsaftacewa, da adanawa ko sharewa don kaucewa gurɓa.
A cewar Hukumar Kula da Lafiya da Tsaro ta Amurka (OSHA), ƙananan ayyukan haɗarin haɗari suna da ƙananan haɗari tare da jama'a da sauran abokan aiki.
Hanyoyin rigakafin kamuwa da cuta da aka ba da shawarar ga duk wuraren aiki sun haɗa da wanke hannu mai kyau, ƙarfafa ma'aikata su zauna a gida idan sun kasance marasa lafiya, yanayin numfashi ciki har da rufe nau'i da nau'ikan ƙira, samar da nau'ikan nau'ikan nau'ikan jigilar kayayyakin aiki da kayan aiki, da kuma kiyaye tsabtacewa na yaukan yanayin yanayin aiki.
Ganowa da kuma warewa da mutane masu yiwuwar kamuwa da cutar mataki ne mai muhimmanci wajen kare ma'aikata, abokan ciniki, baƙi, da sauransu a wani aiki.
Cibiyoyin kula da cututtuka da kuma hana cututtuka (CDC) na Amurka sun ba da shawarar cewa ma'aikatan da ke da alamun cututtukan numfashi za su zauna a gida har sai sun kasance ba tare da zazzabi ba, alamun zazzabi, da kuma duk wasu alamomi na aƙalla sa'o'i 24 ba tare da amfani da zazzabi mai ragewa ba, kuma cewa ma'aikatan su zama gida don kula da wasu ma'aikatan.
A cewar OSHA, ayyuka na matsakaicin haɗari sun haɗa da waɗanda ke buƙatar haɗin kai ko kusa a cikin ƙafa shida (1.8 m) na mutanen da ba a san su ba ko kuma ake zargin marasa lafiyar COVID-19, amma ana iya kamuwa da su da SARS-CoV-2 saboda watsa shirye-shiryen al'umma a kusa da wurin kasuwanci, ko saboda mutum yana da tafiyar ƙasa da kwanan nan gaba zuwa wani wuri tare da yadu na COVID-19.
Wannan shafin yanar gizon yana amfani da kukis don samun damar yin amfani da yanar gizo / sayarwa. Ta ci gaba da amfani da shafin yanar gizon, kun yarda da wannan amfani. Ta ci gaba da amfani da shafin yanar gizon, kun yarda da wannan amfani. Bayani game da kukis da yiwuwar ka ki
Ma'aikata a cikin wannan rukunin haɗari ba sa buƙatar amfani da numfashi.
Idan mutum ya yi rashin lafiya a cikin jirgin sama, iko da ya dace don kare ma'aikata da sauran fasinjoji sun haɗa da rabu da mara lafiya daga wasu da nisa na ƙafa 6, sanya ma'aikatan daya don su bauta wa marar lafiya, da kuma ba da mafarki ga marar lafiya ko kuma tambayar marar lafiya don rufe bakinsu da hanci da nau'i.
Dole ne ma'aikatan jirgin ruwa su saka takalma na likitanci lokacin da suke daukar matafiya mai ciwo ko taba ruwa ko kuma surface masu gurɓatawa, da kuma wataƙila ƙarin kayan kariya na sirri idan mai tafiya yana da zazzabi, ci gaba da shan takalma, ko wahalar numfashi.
Dole ne a zubar da takalma da sauran abubuwa masu amfani a cikin jakar biohazard, kuma ya kamata a tsabtace surface gurɓatawa da tsabtace sufuri na kasuwanci bayan haka, gami da jiragen ruwa da sauran jiragen ruwa na fasinjoji, haɗarin haɗari sun haɗa da tafiya bayan dawowa lokacin da rashin lafiya, da kuma rufe kansa da sanar da cibiyar likinin likici nan da nan da nan take haɓaɓɓewa ko wasu alamomi.
Ga makarantu da wuraren kula da yara, CDC ya bada shawarar rufewa ga ɗan gajeren lokaci don tsabtacewa ko tsabtace idan mutum mai kamuwa da cutar ya kasance a cikin ginin makaranta ba tare da la'akari da yaduwar al'umma ba.
Lokacin da akwai ƙaramin watsa shirye-shiryen al'umma zuwa matsakaici, ana iya aiwatar da dabarun nesa na zamantakewa kamar soke tafiye-tafiye na filin, taro, da sauran manyan taro kamar ilimin jiki ko aji ko abinci a cikin cafe, ƙara sararin samaniya tsakanin tebur, isowa da watsi da lokutan da baƙi, da kuma amfani da wuri na kiwon kiwon lafiyar yara.
Lokacin da akwai babbar watsawa a cikin al'ummar gida, ban da dabarun nesa na zamantakewa, ana iya la'akari da cirewar makaranta. Domin ma'aikatan aiwatar da doka da ke yin ayyukan yau da kullun, haɗarin kiwon lafiya na nan da nan ana la'akari da ƙananan CDC.
Jami'an aiwatar da doka waɗanda dole ne su yi hulɗa da mutanen da aka tabbatar ko ana zargin cewa suna da COVID-19 ana bada shawarar su bi umarnin kamar yadda masu kiwon lafiya na gaggawa suka haɗa da kayan kariya na sirri.
Idan dangantaka ta kusa ta faru a lokacin damuwa, ma'aikata ya kamata su tsabtace kuma su tsabtace bel da kayan aiki kafin su sake amfani da gidan tsabtacewa ko sha, kuma su bi tsarin aiki na misali don ƙuntatawa da zubar da PPE amfani da kuma dauke da kuma wanke tufafi.
OSHA ta yi la'akari da wasu ma'aikatan kiwon lafiya da wuraren shakatawa a cikin babban ko babban nau'ikan haɗari.
Ayyukan haɗari masu haɗari sun haɗa da isar da kiwon lafiya, tallafi, dakin gwaje-gwaje, da ma'aikatan sufuri na likita waɗanda aka fallasa ga marasa lafiyar COVID-19 da aka sani ko ana zargin su.
Waɗannan sun zama babban haɗari idan ma'aikata suna yin hanyoyin samar da aerosol a kan, ko tattara ko sarrafa samfurori daga, wanda aka sani ko ake zargin marasa lafiya na COVID-19.
Hanyoyin samar da aerosol sun haɗa da intubetion, hanyoyin samar da ƙwaƙwalwar ƙwaƙwalwa, bronkoscopies, wasu hanyoyin hakori da jarrabawa, ko tarin samfurori masu zafi.
Ayyukan haɗari masu haɗari sun haɗa da ma'aikatan da ke shirye-shiryen jikin mutanen da suka sani ko wadanda ake zargin su game da COVID-19 a lokacin mutuwarsu; waɗannan sun zama babban haɗari idan suka yi autopsy. <0xC6><0x98>arin kula da injiniya ga waɗannan ƙungiyoyin haɗarin sun haɗa da ɗakunan ɗakunan ɗakunan marasa lafiya da aka sani ko kuma ake zarta COVID-19, ciki har da lokacin da ake yin ayyukan ayyukan sama.
Ana iya samun matsala mai laushi mai laushi a wasu wuraren kiwon lafiya da wurin zama.
Ya kamata a kula da samfurori tare da matakan biosafety Level 3.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar a raba marasa lafiya masu zuwa zuwa zuwa yankunan jira daban-daban dangane da ko su ne ake zargi da cutar COVID-19. Bugu da kari ga sauran PPE, OSHA ya ba da shawarar masu numfashi ga waɗanda ke aiki a cikin ƙafa 6 na marasa lafiya da aka sani da su, ko kuma ana zargin su, da cutar da SARS-CoV-2, da kuma waɗanda ke gudanar da ayyu.
A Amurka, NIOSH-wanda ya amince da N95 tace magunguna ko mafi kyau dole ne a yi amfani da su a cikin mahallin cikakken shirin kariya na numfashi wanda ya haɗa da gwaji, horo, da jarrabawar likita.
Sauran nau'ikan numfashi na iya samar da kariya mafi girma da inganta ta'aziyya ga ma'aikata.WHO ba ta bada shawarar coveralls ba, saboda COVID-19 cutar numfashi ce maimakon a watsa ta hanyar ruwa na jiki.
WHO ya ba da shawarar yin aikin kiwon lafiya kawai don ma'aikatan binciken ma'aikata masu shiga.
Ga waɗanda ke tattara samfurori na numfashi daga, kulawa, ko ɗaukar marasa lafiya na COVID-19 ba tare da wani tsari da ke haifar da aerosol ba, WHO ta ba da shawarar mask na kiwon lafiya, glass, ko fuska garkuwa, tufafi, da kuma fuskoki.
Idan an yi aikin samar da aerosol, ana maye gurbin abin rufe fuska tare da mai numfashi N95 ko FFP2.
Da yake cewa samar da PPE na duniya bai isa ba, WHO ta ba da shawarar rage buƙatar PPE ta hanyar sadarwa, matsalolin jiki kamar taga mai haske, suna ba da damar kawai waɗanda ke da hannu a kulawa kai tsaye su shiga cikin dakin tare da marasa lafiya na COVID-19, yin amfani da PPE kawai da ake bukata don takamaiman aiki, ci gaba da amfani da wani numfashi ba tare da cire shi yayin da kula da marasa lafiya da yawa tare da marasa lafiya tare da marasa lafiya tare da ke da su.
DAGA: Katherine Maher, Shugaban Gidauniyar Wikimedia
TO: Duk ma'aikatan Gidauniyar Wikimedia
LINE: [Covid-19] Hasken kaya da shirya don nan gaba
Aika: 14 Maris, 2020, 00:24 UTC
LICENSING: CC0: Babu haƙƙoƙin haƙƙin mallaka
Muna cikin yanayi mai ban mamaki a wannan watan.
Annobar ta COVID-19 wani abu ne da ke bayyana dangantakarmu ta duniya da hakkinmu ga juna.
Ba mu da kalubale ga kalubale, amma mun san cewa mafi kyawun amsarmu ta dogara ne akan irin tausayin duniya, hadin kai, da gina al'umma wanda ke zaune a zuciyar wannan ƙungiyar.
Abokai da kulawa da muka gani a tsakanin dukan abokan aikinmu akan imel, kira, da hira ne mai ban mamaki tabbatarwa na mutane masu ban sha'awa da muke da damar yin aiki tare.
Ba zan iya yin godiya da alfahari ba don yin la'akari da ku duka a matsayin abokan aiki.
A makon da ya gabata, wani ya yi mini godiya ga aikinmu.
Sun tunatar da ni yadda ma'anar yake ga duniya ta iya juyawa zuwa Wikipedia a yanzu, da kuma wace alama ce mai iko ita ce don wannan mahimman albarkatu don ci gaba da kasancewa a kan layi kuma yana samuwa ga kowa.
Ayyukanku suna sa wannan ya yiwu, ko kuna kiyaye shafukan yanar gizo ko abokan aikinmu sun biya ko al'ummominmu lafiya.
Duniya tana buƙatar bayanan da Wikipedia ke bayarwa, yanzu fiye da kowane lokaci.
Wannan lokaci ne wanda ba kawai abin da muke yi ba, amma yadda muke yin shi, zai haifar da tasiri mai mahimmanci a duniya.
Saboda muhimmancin wannan manufa da kuma rawar da kake da shi, za mu yi wasu muhimman gyare-gyare ga yadda muke aiki tare, fara wannan mako mai zuwa.
gyare-gyare ga aikinmu da kuma tsari
Kamar yadda Robyn ya ambata a baya, C- tawagar ta hadu da dare don tattauna yadda muke da shirinmu na kwanaki da watanni masu zuwa.
A cikin wannan tattaunawa, mun yi la'akari da abin da muke tsammani zai zama amsa mai dacewa ga abin da muke fuskantar da kuma hanya mafi kyau don ci gaba da ƙungiyar a wannan lokacin.
Muna so mu cire damuwa kuma mu tallafa wa aikinmu na dogon lokaci.
Idan kuna buƙatar sake dawowa, to, yana da kyau.
Ga dukan ma'aikata, kwangila, da ma'aikata kwangila:
Ayyukanmu na yau da kullum zai kasance kimanin sa'o'i 4 a rana, ko sa'o'i 20 a mako har zuwa sanarwar.
Ba mu sanar da hutu ba - idan kuna iya aiki fiye da sa'o'i na yau da kullun, manufa za ta iya amfani da ku.
Duk da haka, duniya ba za ta yi tsammani a yanzu ba, kuma ko kuna buƙatar kula da waɗanda suke so, samun kayan shafawa, ko zuwa likita, lafiyar ku ita ce fifikonmu.
Ba mu bincika lokacinku ba.
Idan kana da rashin lafiya, kada ka yi aiki.
Wannan ya kamata ya tafi ba tare da fada ba, amma muna faɗin haka.
Babu kwanakin rashin lafiya ko PTO da ake buƙata - kawai gaya wa manajanka da kuma taimakawa tawagarka ta sake duba kalanda da kuma jadawalin don tabbatar da manyan wurare na aikin da aka rufe.
(Idan an gano ku da kyau don COVID-19, don Allah bari Bryan a cikin T&amp;C Ops ya san don haka T&amp;C zai iya taimakawa tare da goyon baya kuma ya tabbatar da cewa yanayinku ya sami hankali mai kyau daga gudanarwa).
To, waɗannan sunã da sakamakon ninkawa sabõda abin da suka aikata.
Mun riga mun ce, kuma muna sake sadaukar da alkawarinmu ga abokan aikinmu da abokan aikinmu na sa'o'i.
Za a biya kowa bisa ga lokacin da suka saba aiki a cikin yanayi na yau da kullum.
Wannan ya haɗa da idan kun kasance marasa lafiya kuma ba za ku iya aiki ba.
Idan kana so ka yi aiki, za mu goyon bayan ka.
Yawancin mutane suna amfani da aiki a matsayin hanyar da za a magance damuwa tare da duniyar da ke kewaye da mu.
Abin da muke yi zai iya zama mai ban mamaki, musamman a lokuta irin wannan.
Sa'an nan kuma, wannan shi ne game da kula da kanka.
Tambayarmu ita ce cewa kuna sadarwa tare da manajan ku, don haka mun san abin da za mu yi tsammanin kuma za mu iya daidaita yadda ya dace.
Wasu aiki suna da muhimmanci.
Akwai wasu abubuwa da ya kamata mu ci gaba da yi.
Kungiyar SRE, HR Ops, Trust &amp; Tsaro, da ƙungiyoyin tara kuɗi (da sauransu) suna yin aiki mai mahimmanci wanda zai iya buƙatar ƙarin tallafi.
Za mu fara aiki tare da dukkan sassan don tantance manufofinmu na yanzu da kuma canza mayar da hankalinmu don tallafawa abin da ke da muhimmanci ga aikinmu.
Akwai abubuwa da yawa da za a yi wa dukanmu, kawai za mu mayar da hankali a kan mafi muhimmanci ayyuka.
Saukewa a yanzu ba zai cutar da shi ba daga baya.
Ba za mu yi shiri don "duba lokaci don kama" da zarar annobar ta wuce.
Ba za a sa ran ku yi aiki tare da ƙarin sa'o'i don biyan ƙa'idodin da ba su da gaskiya a yanzu.
Mun yarda cewa yanayi ya canza, kuma za mu yi aiki don kafa sababbin manufofi da kuma lokuta idan ya dace.
Menene ya faru da APP (Annual Shirye-shirye)?
Don daidaitawa da sabon gaskiyarmu da tsammanin sa'o'i na aiki na yau da kullun, muna shirin daidaita lokaci don isar da shirinmu na shekara-shekara 2020-2021.
Manufarmu ita ce gabatar da shirinmu na 2019-2020 wanda ke ba da damar ƙarin lokaci don tsara kasafin kudin don ba da damar ma'aikata su fifita aikin muhimmanci, kula da kai, da kulawa ga ƙaunatattu yayin da suke buƙatar ko kuma son yin aiki a cikin 'yan makonni masu zuwa.
Wannan tsawon lokaci yana rage yawan aiki na yanzu da matsin lamba a duk faɗin ƙungiyar.
Za mu gabatar da shawararmu ga hukumar mako mai zuwa kuma za mu sabunta wakilai da ƙungiyoyi a kan matakai na gaba da zarar mun sami tabbatarwa.
Na gode da kungiyar APP don jagorancin ku a cikin wannan.
Yanayin ofishin, bayyanawa, da tsaftacewa
A makon da ya gabata, mun koyi cewa daya daga cikin abokan aikinmu na SF na iya fallasa cutar COVID-19.
Duk da haka, daga cikin gargadi mai yawa, mun yi amfani da ma'aikatan tsabtace kwayoyin cuta don tsabtace duk saman a ofishin San Francisco.
Sun yi amfani da maganin maganin maganin kwayar cuta na asibiti don tsabtace kowane saman, kazalika da bankunan lobby da lif da ke shiga bene.
Ginin yana amfani da ka'idar kula da kansa ta amfani da samfuran da ke tallafawa lafiyar masu hayarsu.
Muna jin daɗin cewa ofishin zai kasance a shirye don lokacin da muka yanke shawarar dawowa.
Ofishinmu na DC yana cikin WeWork, wanda ya raba yarjejeniyar COVID-19 tare da mu da dukan ma'aikatan DC.
Tun daga makon da ya gabata, ofishinmu na DC ya koma cikakken tsari mai nisa daidai da jagorancin da aka raba tare da San Francisco.
Kamar yadda wasu daga cikin abokan aikinmu na NYC sun sani, mun kuma yi tattaunawa game da hayar wuri a Brooklyn.
Wadannan tattaunawa suna ci gaba amma ana iya jinkirtawa.
Wasu abokan aikinmu suna aiki nesa a karon farko.
Abokan aikinmu na dogon lokaci sun san cewa zai iya zama gyara, kuma suna so su ba ku wasu shawara:
Rage tsawon tarurruka zuwa mafi yawan sa'a daya ko biyu.
Idan ana buƙatar tsawon zaman, la'akari da yadda za a rabu da su a cikin kwanaki da yawa.
A bayyane yake ƙayyade taron, samun shirin, kuma aika kayan karatu a gaba.
Yi bidiyo da tsohuwar, tare da kayan aiki kamar Google Docs da Zoom don sauƙaƙe haɗin gwiwa da haɗin kai.
Samun jagora don sauƙaƙe kowane taro, wani don saka idanu da tattaunawa don tambayoyi da kuma bin jerin masu magana, da kuma wani don taimakawa ɗaukar bayanan bayanai (ko yin haɗin gwiwar kulawa).
Aika imel don tallafawa fasaha idan kuna buƙatar sauti mai kyau.
Yi amfani da biyan kuɗin ku don abincin dare.
Ku shiga tashar #remoties a Slack don yin magana da abokan aikinku game da aikin rarraba
Kungiyar Ayyuka na HR tana bincika jagorancin ergonomics na yanar gizo don tallafawa karuwar aikin rarraba a fadin Gidauniyar.
A makon da ya gabata, mun nemi duk masu karɓar tallafin al'umma su soke abubuwan da ake gudanar da ayyukan jama'a na Wikimedia, irin su editathons, har sai WHO ta bayyana annobar ta kammala.
Mun sanar da su cewa mun fahimci cewa roƙonmu na sokewa da sauran ƙuntatawa na iya sa ba zai yiwu a kammala ayyukansu na ba da kyauta ba kuma cewa babu wanda zai azabtar da shi don jinkirin ko gyara waɗannan burin.
A wannan makon mai zuwa za mu ci gaba da ƙarin jagoranci a kan Wikimania da sauran taron yanki da jigogi na al'umma.
Babban ra'ayi daga kewaye da al'ummar duniya yana da alama yana da baƙin ciki a cikin rushewa amma taimako a cikin bayyanar da kuma ikon mai da hankali kan al'ummominsu, Wikimedia da sauransu.
Ci gaba, CRT yana aiki don kafa shafi a kan Meta-Wiki don samar da sarari ga al'umma don saka idanu da tasirin da kuma bin sadarwa tare da su.
Tattaunawa game da batutuwan da suka shafi COVID-19
Za mu aika gayyatar zuwa kalandarku na Alhamis mai zuwa, 14:00 UTC / 07: 00 PT don taron ma'aikata na musamman.
Za mu yi amfani da wannan lokaci don raba ƙarin sabuntawa, amsa tambayoyinku kuma ku ciyar da lokaci tare da juna.
Muna cikin wannan tare kuma a nan don taimakawa duk abin da za mu iya.
A halin yanzu, zaku iya ci gaba da samun bayanan daga wannan imel, da duk sauran abubuwan da suka shafi COVID-19, akan Ofishin Wiki.
CRT zai ci gaba da sabunta waɗannan shafukan da duk bayanan a wuri guda.
Muna kuma aiki don ci gaba da sadarwa na yau da kullum tare da ma'aikatan da ke zaune a ƙasashe waɗanda a halin yanzu suna da tasiri sosai.
Idan kana da wasu tambayoyi game da tafiye-tafiye, abubuwan da suka faru, babban aikin aiki, ko kalubale na rufewa, ko wani abu da zaku buƙaci taimako tare da shi, don Allah kada ku yi jinkirin sanar da kuma aiki tare da CRT.
Muna nan don taimakawa wajen tallafawa da sadarwa kamar yadda ake buƙata.
Idan kana da wani abu sirri ko m, don Allah imel Bryan Judan - Daraktan HR Global Operations.
Babu wani daga cikin wadannan canje-canje da za a yi la'akari da shi a matsayin rabuwa da aikinmu.
Maimakon haka, sun yarda cewa a halin yanzu, aikinmu da wajibi ne mu daidaita a hanyar da ba mu yi a baya ba.
Waɗannan su ne matakai da muke tsammani muna buƙatar tallafawa juna don mu ci gaba da aiki, samar da motsi tare da goyon baya da suke bukata, da kuma duniya tare da sabis da suke dogara da su.
Ayyukanmu za su kasance a can don jiran lokacin da ya zo.
A halin yanzu, lokaci ya yi da za mu tallafa wa juna da kuma ƙirƙirar sararin samaniya don muhimmancin aikin da zai zo a cikin makonni da watanni masu zuwa.
Muna buƙatar ku duka don yin hakan, don haka muna buƙatar ku duka don kula da kanku da iyalanku don ku kasance cikin mafi kyawun lokacin da ake bukata.
Yanzu, don Allah - wanke hannuwanku kuma kada ku taɓa fuskarka!
Katherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, da Tony S), da sauran ƙungiyar jagorancin (Grant I, Heather W, Jaime V, Janen U, Lisa S, Robyn A, Ryan M, da Toby N).
b'Angiotensin-maye gurbin enzyme 2 (ACE2) wani enzyme ne da aka haɗe da surface na waje (cell membranes) na kwayoyin a cikin huhu, arteries, zuciya, kirji, da ciki.
ACE2 yana magance ayyukan enzyme mai alaƙa da angiotensin-maye enzyme (ACE) ta hanyar rage adadin angiotensin-II da kuma ƙara Ang(1-7) sa shi manufar miyagun ƙwayoyi don magance cututtukan zuciya. ACE2 kuma yana aiki a matsayin wurin shiga cikin sel don wasu coronaviruses.
Sau da yawa ana kiran samfurin enzyme a matsayin hACE2.
Enzyme 2 mai canzawa na Angiotensin shine zinc wanda ke dauke da metalloloenzyme da ke kan saman endothelial da sauran ƙwayoyin cuta.
Protein ACE2 ya ƙunshi yanki na N-terminal peptidase M2 da kuma yanki na C-terminal collectorrin na karfe amino acid.
ACE2 wani nau'in furotin membrane guda ɗaya ne, tare da yankin enzymatically aiki da aka fallasa a kan surface na sel a cikin huhu da sauran nau'ikan.
An cire yankin ACE2 daga yankin transmembrane ta wani enzyme wanda aka sani da sheddase, kuma an saki furotin mai narkewa a cikin rafin jini kuma a ƙarshe an cire shi cikin fitsari.
ACE2 yana cikin mafi yawan ƙwayoyin: ACE2 yana da alaƙa da ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar enterocytes na ƙananan ƙwayar ƙwayar, ƙwayoyin endothelial da ƙwayoyin ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar a mafi yawan kwayoyin cuta.
Har ila yau, ana samun maganganun ACE2 mRNA a cikin kwakwalwa, striatum, hypothalamus, da ƙwayar kwakwalwa.
Babban aikin ACE2 shine yin aiki a matsayin daidaituwa ga ACE.
ACE yana dauke da hormone na angiotensin I a cikin vasoconstricting angiotensin II.
ACE2 a gefe guda yana dauke da carboxyl-terminal amino acid phenylalanine daga angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) kuma yana hydrolysis shi a cikin vasodilator angiotensin (1-7), (H-Asp-Arg-Val-Tyr-Ile-H-H-Pro-H-H-H-H-H-H-H-H-H-H-H-H-H-H-A-A-A-A-A-A-A-A-A-A-A-A-A-A-A-A-A-A-A-A-A-A-
ACE2 na iya rike wasu peptides ciki har da [des-Arg9]-bradykinin, apelin, neurotensin, dynorphin A, da ghrelin.
ACE2 kuma yana tsara fataucin membrane na mai ɗaukar amino acid SLC6A19 kuma an haɗa shi a cikin cutar Hartnup.
A matsayin furotin transmembrane, ACE2 yana aiki a matsayin babban wurin shiga cikin sel na wasu coronaviruses, ciki har da HCoV-NL63; SARS-CoV (virus da ke haifar da SARS); da SARS-CoV-2 (virus da ke haifar da COVID-19).
Musamman, haɗin furotin S1 na SARS-CoV da SARS-CoV2 zuwa yankin enzymatic na ACE2 akan saman kwayoyin yana haifar da endocytosis da translocation na kwayar cutar da enzyme cikin endosomes a cikin kwayoyin.
Wannan tsarin shigarwa kuma yana buƙatar yin amfani da furotin S ta hanyar TMPRSS2 serine protease wanda aka hana shi a karkashin bincike na yanzu a matsayin mai yiwuwar magani. Wannan ya haifar da wasu raguwa cewa rage matakan ACE2, a cikin sel, zai iya taimakawa wajen yaki da kamuwa da cutar.
Koyaya, ƙungiyoyi masu sana'a da hukumomin tsari sun ba da shawarar ci gaba da inhibitor na ACE da maganin ARB.
"Nazarin tsarin da aka wallafa a ranar 11 ga Yuli, 2012, ya gano cewa "" Amfani da masu hana ACE an haɗa shi da rage yawan kashi 34% na haɗarin ƙwayoyin cuta idan aka kwatanta da iko." "
Bugu da ƙari, an rage haɗarin ciwon huhu a cikin marasa lafiya da aka bi da masu hana ACE waɗanda ke cikin haɗarin ciwon huhu, musamman wadanda ke da ciwon zuciya da rashin lafiyar zuciya.
Har ila yau, amfani da magungunan ACE yana da alaƙa da ragewar mutuwar ƙwayoyin cuta, kodayake sakamakon sun kasance ƙasa da ƙarfi fiye da hadarin ƙwayar ƙwayar cuta gabaɗaya. "
An yi imanin cewa ACE2 na mutum (rhACE2) ya zama sabon magani don rauni na huhu, kuma ya bayyana ya inganta hemodynamics na huhu da kuma ciwon oxygen a cikin daji tare da ciwon matsalar numfashi mai tsanani wanda aka haifar da lipopolysaccharide.
Rabin rabi na rhACE2 a cikin mutane shine kimanin awanni 10 kuma fara aiki shine minti 30 ban da hanyar tasiri (duration) na awanni 24.
Sakamakon bincike da yawa sun nuna cewa rhACE2 na iya zama magani mai launin fata ga waɗanda ke da rashin haƙuri ga masu hana tsarin renin-angiotensin (mai hana RAS) ko a cikin cututtuka inda ake yada angiotensin II. An kimanta rhACE2 a gwaje-gwaje na asibiti don magance cutar numfashi mai tsanani.
aikace-aikacen b'COVID-19 aikace-aikacen software ne na wayar hannu wanda aka tsara don taimakawa ganewar haɗin gwiwa a mayar da martani ga cutar coronavirus ta 2019-20, watau tsarin gano mutane ("tallace-tallace") waɗanda zasu iya tuntuɓar mutum mai kamuwa da cutar.
An haɓaka aikace-aikace da yawa ko an gabatar da su, tare da goyon bayan gwamnati a wasu yankuna da hukumomi.
An kirkiro wasu tsare-tsaren don gina aikace-aikacen sadarwa na lambobin sadarwa.
An tayar da damuwa na sirri, musamman game da tsarin da ke dogara ne akan bin wurin yanki na masu amfani da aikace-aikace.
<0xC6><0x98>ananan zaɓuɓɓuka sun haɗa da amfani da siginar Bluetooth don yin rajista kusancin mai amfani ga sauran wayar salula.
A ranar 10 ga Afrilu, 2020, Google da Apple sun bayyana cewa za su haɗa aiki don tallafawa irin waɗannan apps na Bluetooth kai tsaye zuwa tsarin aiki na Android da iOS.
A kasar Sin, gwamnatin kasar Sin, tare da Alipay, ta shigar da aikace-aikacen da ke ba da damar 'yan ƙasa su duba ko sun kasance cikin hulɗa da mutanen da ke da COVID-19.
Ana amfani dashi a cikin biranen China fiye da 200.A Singapore, ana amfani da wani app mai suna TraceTogether.
"App an haɓaka ta gida IT al'ummar, da aka saki a matsayin bude tushe kuma za a mika shi ga gwamnati.North Macedonia kaddamar da ""StopKorona!"," wani Bluetooth tushen aikace-aikace don gano bayyanar tare da yiwuwar mutane da cutar da kuma samar da sauri amsa ga hukumomin kiwon lafiya. "
Ma'aikatar Sadarwa da Fasaha da Ma'aikatar Kiwon Lafiya ta samar da wannan app.
A ranar 14 ga Afrilu, 2020, app yana jiran amincewa da Google Play Store da Apple App Store.
"A ranar 12 ga watan Afrilu, gwamnati ta bayyana cewa aikace-aikacen binciken sadarwa yana cikin mataki na ci gaba, kuma za a samu don aikawa a cikin makonni.A irin wannan aikace-aikacen an shirya a Ireland, da kuma Faransa ("StopCovid").
Dukansu Australia da New Zealand suna la'akari da aikace-aikace dangane da aikace-aikacen TraceTogether na Singapore da yarjejeniyar BlueTrace.Russia tana nufin gabatar da aikace-aikacen geofencing ga marasa lafiya da ke da cutar COVID-19 da ke zaune a Moscow, wanda aka tsara don tabbatar da ba su fita gida.
Ross Anderson, farfesa na injiniyan tsaro a Jami'ar Cambridge, ya jera wasu matsaloli masu yiwuwa tare da tsarin app-tushen, ciki har da ingancin ƙarya da kuma yiwuwar rashin tasiri idan an iyakance amfani da aikace-aikacen zuwa ƙananan kashi kawai na yawan jama'a.
"Game da damuwa game da yaduwar aikace-aikacen da ke dauke da cutar coronavirus ko cutar," Apple ya kafa iyakance a kan irin ƙungiyoyin da za su iya ƙara aikace-aikacen da ke da alaƙa da coronavirus zuwa App Store, yana iyakance su zuwa kawai "official" ko kuma kungiyoyi masu daraja. "
Google da Amazon sun yi amfani da irin wannan takunkumi.
Masu zanga-zanga na sirri sun nuna damuwa game da tasirin sa ido na taro ta amfani da aikace-aikacen coronavirus, musamman game da ko kayan aiki na sa ido da aka kirkiro don magance cutar coronavirus za a warware shi da zarar barazanar ta wuce.
Amnesty International da sauran kungiyoyi sama da 100 sun ba da sanarwar kira ga iyakance irin wannan sa ido.
<0xC6><0x98>ungiyoyin sun bayyana yanayi takwas akan ayyukan gwamnati:
"Ya kamata kulawa ya zama "ya kamata, dole ne, da kuma daidaitawa";
Dole ne a sake dubawa da kuma saka idanu su kasance da ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan;
Dole ne a iyakance amfani da bayanai ga dalilai na COVID-19;
Dole ne a kiyaye tsaron bayanai da anonymousity kuma a nuna cewa an kiyaye su bisa shaida;
Dole ne a guje wa saka idanu na dijital don kauce wa ƙaruwar nuna bambanci da raguwa;
Duk wani raba bayanai tare da ɓangare na uku dole ne a bayyana a cikin doka;
Dole ne a sami kariya daga cin zarafi da haƙƙin 'yan ƙasa don amsawa ga cin zarafin;
"Ma'anar halartar dukkan masu ruwa da tsaki" za a buƙaci, ciki har da na masana kiwon lafiyar jama'a da ƙungiyoyi masu rauni.The Jamus Chaos Computer Club (CCC) da Reporters Without Borders (Reporter undefrents) (RSF) kuma bayar da jerin rajista."
Shirin Google / Apple yana nufin magance matsalar sa ido ta hanyar cire tsarin bincike daga tsarin aiki na na'ura idan ba a buƙatar shi ba.
Wasu ƙasashe sun yi amfani da hanyar sadarwa ta tushen wurin bin diddigin wuri maimakon apps, kawar da buƙatar sauke aikace-aikacen da ikon kauce wa bin diddigin.
A Isra'ila, an amince da bin diddigin hanyar sadarwa.
Matsalolin da ke da tushen hanyar sadarwa waɗanda ke da damar samun damar bayanai na asali na yanar gizo suna da matsaloli masu mahimmanci na sirri.
Duk da haka, ba duk tsarin tare da sabobin tsakiya ba suna buƙatar samun dama ga bayanan wurin sirri; an kirkiro wasu tsarin tsare sirri waɗanda ke amfani da sabobin tsakiya kawai don sadarwa (duba sashe a ƙasa).
A Koriya ta Kudu, an yi amfani da tsarin da ba a yi amfani da shi ba don yin bin diddigin haɗin gwiwa.
Maimakon amfani da sadaukar da aikace-aikace, tsarin ya tattara bayanan bin diddigin bayanai daga kafofin daban-daban ciki har da na'urar hannu bin diddigin bayanai da bayanan ma'amaloli na katin, kuma ya haɗu da waɗannan don samar da sanarwa ta hanyar saƙonnin rubutu ga mutane masu yiwuwa masu kamuwa da cutarwa.
Bugu da ƙari, amfani da wannan bayanin don gargadin hanyoyin sadarwa, gwamnati ta kuma samar da bayanan wuri a fili, wani abu da aka halatta saboda canje-canje mai nisa ga dokokin sirri na bayanai bayan barkewar MERS a wannan kasar.
Wannan bayanin yana samuwa ga jama'a ta hanyar apps da shafukan yanar gizo.Countries ciki har da Jamus da aka yi la'akari da amfani da tsarin tsare sirri da tsare sirri.
Tun daga ranar 6 ga Afrilu, 2020, har yanzu ba a saki cikakken bayani ba.
Binciken tuntuɓar sirri shine ra'ayin da ya dace, tare da babban rukuni na wallafe-wallafen bincike da suka dawo a kalla 2013.As na 7 Afrilu 2020, fiye da ƙungiyoyin gwani da dama suna aiki a kan hanyoyin da ke da kyau na sirri, kamar amfani da Bluetooth Low Energy (BLE) don yin rajista mai amfani da kusa ga sauran wayar hannu.
Koyaya, PEPP-PT shine kokarin haɗin gwiwa wanda ya ƙunshi hanyoyin tsakiya da marasa tsari, kuma ba shi da yarjejeniyar guda ɗaya ba. Yarjejeniyar <0xC6><0x98>arƙashin <0xC6><0x98>arƙashin <0xC6><0x98>arƙashin <0xC6><0x98>arƙashin <0xC6><0x98>arƙashin <0xC6><0x98>arƙashin <0xC6><0x98>arƙashin <0xC6><0x98>arshe (DP-DP-3T), Lambobin Lambobin Lambobin Lambobin <0xC6><0x98>i na <0xC6><0x98>i (Tungiyoyi, Lambobin <0xC6><0x98>, Lambobin <0xC6><0x98>, Lambobin <0xC6><0x98>, Lambobin <0xC6><0x98>, Lambobin <0xC6><0x98>, Lambobin <0xC6><0x98>, <0xC6><0x98>, <0xC6><0x98>).
A cikin waɗannan ƙa'idodi, bayanan sirri da za a iya ganewa bazai bar na'ura ba, kuma duk dacewa yana faruwa a kan na'ura.
Kungiyar sirri a MIT Media Lab tana haɓaka SafePaths, dandamali don amfani da dabarun kiyaye sirri yayin tattara da amfani da bayanan wurare ko hanyar haɗuwa don bin yaduwar COVID-19.
"Wannan ya dogara ne akan binciken daga fararen takarda "Apps ya tafi Rogue: kiyaye sirrin sirri a cikin annoba" da aka saki a watan Maris 2020.Wani irin wannan ƙoƙari shine dandamali na SafeTrace ta Enigma MPC, kamfanin da ke haɓaka fasahar sirri wanda aka samo asali a MIT Media Lab.
SafeTrace yana amfani da fasahar kayan aiki don ba masu amfani damar raba wurare masu mahimmanci da bayanan lafiya tare da sauran masu amfani da jami'an, ba tare da ɓata sirrin wannan bayanan ba.
A ranar 5 ga Afrilu, 2020, kungiyoyi da suka haɗu da haɗin gwiwar TCN na duniya sun kafa a kusa da abin da ya fi dacewa da wannan tsari kuma galibi ya haɗu da yarjejeniyar, tare da manufa don rage rarrabuwa, da kuma ba da damar haɗin gwiwa na duniya na ganowa da aikace-aikacen gargaɗin, babban bangare na cimma.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa ta bude ka'idar BlueTrace da aikace-aikacen gwamnatinta na hukuma.
A ranar 10 ga Afrilu, 2020, Google da Apple, kamfanonin da ke sarrafa dandamali na Android da iOS, sun sanar da shirin don bin hanyar sadarwa, wanda suka yi iƙirarin cewa zai kiyaye sirri, dangane da haɗin fasaha na Bluetooth Low Energy da kuma tsare sirrin sirri.
Hakanan sun wallafa bayanan fasahar da aka yi amfani da su a cikin tsarin.
A cewar Apple da Google, an tsara tsarin a cikin matakai uku:
<0xC6><0x98>irƙirar kayan aiki don ba da damar gwamnatoci ƙirƙirar aikace-aikacen bincike na sirri na sirri na hukuma
hade da wannan ayyuka kai tsaye a cikin iOS da AndroidGoogle da Apple shirin magance daukar-up da kuma m sa ido matsaloli ta farko rarraba da tsarin ta hanyar aiki updates, da kuma daga baya cire shi a hanya guda da zarar barazanar ya wuce.
B'Drug repositioning (wanda aka fi sani da magungunan sake farfadowa, sake farfadowa, sake yin aiki ko canzawa na magani) shine sake dawo da magani da aka amince da shi don maganin wata cuta ko yanayin likita daban-daban fiye da abin da aka samar da shi a farkon.
Wannan layin ne na binciken kimiyya wanda a halin yanzu ana gudanar da shi don haɓaka lafiya da inganci na maganin COVID-19.
Sauran hanyoyin bincike sun haɗa da ci gaban allurar rigakafi ta COVID-19 da kuma canja wuri na plasma.SARS-CoV-2 yana da kusan furotin magani 66, kowannensu yana da shafukan ɗakunan ɗakunan ligand da yawa.
Binciken waɗannan shafukan da ke da alaƙa suna samar da aikin da ya dace na haɓaka ƙwayoyi masu inganci akan furotin COVID-19.
Daga cikin mafi muhimmanci SARS-CoV-2 manufa suna kama da papain protease, RNA dogara RNA polymerase, helicase, S protein, da ADP ribophosphatase.
Hussein A A, et al ya yi nazarin wuraren da dama na dan takarar da sannan ya inganta da kuma bincika don kama da kwayoyin halittarsu tare da mafi girma irin wannan kwayoyi da aka amince da su don hanzarta ci gaban kwayoyi mai iko da SARS-CoV-2 a cikin bincikensa na farko don a ba da shawarar a cikin zane na asibiti.
Chloroquine magani ne na anti-malarial wanda kuma ana amfani dashi akan wasu cututtukan autoimmune.
A ranar 18 ga watan Maris, WHO ta sanar da cewa chloroquine da hydroxychloroquine masu alaƙa za su kasance daga cikin magungunan hudu da aka yi nazari a matsayin wani ɓangare na gwajin asibiti na Solidarity.
Gwamnan jihar New York Andrew Cuomo ya sanar da cewa gwajin jihar New York na chloroquine da hydroxychloroquine zai fara ne a ranar 24 ga Maris.A ranar 28 ga Maris, FDA ta ba da izinin amfani da hydroxychloroquine sulfate da chloroquine phosphate a karkashin iziniyar amfani gaggawa (US).
Ba a amince da maganin gwajin asibiti na FDA ba kuma an ba shi izinin a karkashin Amurka kawai a matsayin magani na gwaji don amfani da gaggawa a cikin marasa lafiya waɗanda ke asibiti amma ba su iya karɓar magani a cikin gwajin asibiti.
"CDC ya ce, "aiwatar da, sashi, ko tsawon tsawon lokaci na hydroxychloroquine don maganin ko maganin kamuwa da cutar SARS-CoV-2" ba a kafa shi ba.
"Doctors sun ce suna amfani da miyagun ƙwayoyi lokacin da 'babu wani zaɓi'."
Kungiyar binciken Turkiyya a Istanbul tana gudanar da karamin bincike kan amfani da chloroquine tare da zinc, bitamin A, bitamin C da bitamin D.
Ana gudanar da manyan karatu a Jami'ar Duke da Jami'ar Oxford.
Makarantar likita ta NYU Langone tana gudanar da gwaji kan aminci da inganci na amfani da hana hydroxychloroquine.
"Nazarin asibiti na kasar Sin a Wuhan da Shenzhen sun yi iƙirarin nuna favipiravir shine "ainihin tasiri"."
35 marasa lafiya a Shenzhen sun gwada mummunan a tsakiyar kwanaki 4, yayin da tsawon cutar ya kasance kwanaki 11 a cikin marasa lafiya 45 waɗanda ba su karɓa ba.
A cikin binciken da aka gudanar a Wuhan akan marasa lafiya 240 da ke da ciwon huhu, rabin rabin an ba su favipiravir kuma rabin an samu umifenovir.
Hukumar magunguna ta Italiya ta tunatar da jama'a cewa shaidar da ke yanzu don tallafawa miyagun ƙwayoyi ba shi da yawa kuma na farko.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta sayi miyagun ƙwayoyi daga Japan don adanawa, kuma ta yi amfani da sojoji don isar da miyagun ƙwayoyi ga asibitocin jami'a, inda za a yi amfani da miyagun ƙwayoyi don magance marasa lafiya na COVID-19.
A cewar kasar Sin ta Kudu Morning Post, Shinzo Abe ya yi wa gwamnatin Trump game da sayen miyagun ƙwayoyi.Magunguna na iya zama kasa da tasiri a cikin mummunan cututtukan cututtuka inda kwayar cutar ta riga ta ƙaruwa.
Wataƙila ba zai iya zama lafiya don amfani da mata masu ciki ko waɗanda suke ƙoƙarin yin ciki ba.
"Nazarin daya na lopinavir / ritonavir (Kaletra), haɗin kwayoyin cuta na lopinavir da ritonavir, ya kammala cewa ba a lura da amfani ba."
An tsara magunguna don hana HIV daga yin maimaitawa ta hanyar haɗa zuwa protease.
Kungiyar masu bincike a Jami'ar Colorado suna ƙoƙarin canza kwayoyi don neman mahaɗin da zai haɗu da protease na SARS-CoV-2.Akwai zargi a cikin al'ummar kimiyya game da jagorantar albarkatun don sake tsara kwayoyi musamman don HIV / AIDS.
WHO ta haɗa da lopinavir / ritonavir a cikin gwajin solidarity na duniya.
Kimiyyar Gilead ta kirkiro Remdesivir kuma ta haɓaka shi azaman maganin cutar Ebola da kamuwa da cutar Marburg . Daga baya Kimiyyar Gilead ta gano cewa Remdesivir yana da ayyukan kwayar cuta a cikin injiniya da yawa-, pneumo-, paramyxo-, da corona-viruses .
Ɗaya daga cikin batutuwan da maganin maganin rigakafi shine ci gaban juriya ta hanyar maye gurbin da zai iya haifar da mummunan cuta da watsawa.
Wasu nazarin farko na farko sun ba da shawarar cewa remdesivir na iya samun babban gwaje-gwaje na kwayoyin halitta don juriya. Akwai gwaje-gwajen asibiti da yawa a yanzu, ciki har da asibitocin Jami'ar Cleveland guda biyu; daya don mutanen da ke da matsakaicin cututtuka da kuma ɗayan ga waɗanda ke da mummunan cututtuka.
Akwai gwaje-gwaje na asibiti guda uku na bitamin C na ciki ga mutanen da ke asibiti kuma suna da ciwo mai tsanani tare da COVID-19; biyu placebo sarrafawa (China, Kanada) da kuma daya ba tare da iko ba (Italy).
Jihar New York ta fara gwaji na antibiotic acithromycin a ranar 24 ga Maris 2020.
Cibiyar National Center for Global Health and Medicine (NCGM) ta Japan tana shirya gwajin asibiti don Teijin's Alvesco (ciclesonide), corticosteroid mai ɗaukar hoto don asthma, don maganin marasa lafiya da ke dauke da cutar coronavirus.
Wani nau'i na angiotensin-converting enzyme 2, an gudanar da gwajin Phase II tare da marasa lafiya 200 da za a dauki su daga mummunan cututtuka, asibiti a Denmark, Jamus, da Austria don ƙayyade tasiri na magani.
Masu bincike daga Cibiyar Zuciya ta Montreal a Kanada a halin yanzu suna nazarin rawar colchicine a rage cin zarafi da rikice-rikice na huhu a cikin marasa lafiya da ke fama da cutar COVID-19.
Nazarin, mai suna COLCORONA, yana daukar manya 6000 da suka kai shekaru 40 da suka wuce wanda aka gano da COVID-19 kuma yana fuskantar alamun cutar da ba ta buƙatar asibiti.
Matan da ke da ciki ko maye gurbi ko waɗanda ba su da wata hanyar da ta dace da magani ba su cancanci.
Ana gwada wasu anticoagulants a Italiya.
Ana amfani da heparin mai nauyi mai yawa don magance marasa lafiya, yana haifar da Hukumar Magunguna ta Italiya don buga jagorancin amfani da shi.
An sanar da bincike mai yawa akan marasa lafiya 300 da ke bincike game da amfani da enoxaparin sodium a profillaxis da kuma magani a Italiya a ranar 14 ga Afrilu.
Tun da SARS-CoV-2 kwayar cutar ne, an mayar da hankali mai yawa a kimiyya kan sake mayar da hankali kan kwayoyin maganin kwayar cuta da aka amince da su waɗanda aka haɓaka don barkewar da suka gabata kamar MERS, SARS, da West Nile virus.
Ribavirin: An ba da shawarar ribavirin don maganin COVID-19 bisa ga umarnin bugu na 7 na kasar Sin
Umifenovir: an ba da shawarar umifenovir don maganin COVID-19 bisa ga jagorancin bugu na 7 na kasar Sin
Wasu antibiotics da aka gano su a matsayin mai yiwuwa a sake amfani da su a matsayin maganin COVID-19:
Tocilizumab (Anti-IL-6 mai karɓa): An amince da shi ta kasar Sin.
Har ila yau, gwaje-gwaje a Italiya da China. kuma duba Tocilizumab#COVID-19.
B'A COVID-19 allurar rigakafi ce ta rigakafin cutar coronavirus 2019 (COVID-19).
Kodayake babu rigakafin da aka kammala gwaje-gwaje na asibiti, akwai ƙoƙari da yawa a ci gaba don haɓaka irin wannan allurar rigakafi.
A ƙarshen Fabrairun 2020, Hukumar Kula da Lafiya ta Duniya (WHO) ta ce ba ta tsammanin rigakafin SARS-CoV-2, cutar da ke haifar da cutar, zai zama samuwa a cikin kasa da watanni 18.
A watan Afrilu, 'yan takarar allurar rigakafi biyar sun gudanar da binciken tsaro.
An gano COVID-19 a watan Disamba 2019.
Babban barkewar cutar ta yada a duk faɗin duniya a cikin 2020, wanda ke haifar da babbar zuba jari da ayyukan bincike don haɓaka allurar rigakafi.
Yawancin kungiyoyi suna amfani da genomes da aka buga don haɓaka yiwuwar allurar rigakafin SARS-CoV-2.
An bayyana a watan Afrilu, abubuwan da ake bukata na shirin CEPI don haɓaka allurar rigakafi sune sauri, ikon masana'antu, aiwatarwa a sikelin, da kuma samun damar duniya.
A watan Afrilu, masana kimiyyar CEPI sun ba da rahoton cewa dandamali 10 daban-daban na fasaha suna ƙarƙashin bincike da ci gaba a farkon 2020 don ƙirƙirar ingantaccen allurar rigakafin COVID-19.
Major dandamali manufofin ci gaba zuwa mataki na I nazarin tsaro sun hada da:
Nucleic acid (DNA da RNA) (Phase I developer da kuma rigakafin dan takarar: Moderna, mRNA-1273)
Viral vector (Phase I developer da kuma rigakafin dan takarar: CanSino Biologics, adenovirus type 5 vector)
Kamar yadda masana kimiyyar CEPI ta ruwaito a watan Afrilu, jimillar 'yan takarar allurar rigakafin 115 ne a farkon matakai na ci gaba, tare da 78 sun tabbatar a matsayin ayyukan aiki (79, a cewar Cibiyar Milken), da wasu 37 sun sanar, amma tare da ƙananan bayanan jama'a da ake samuwa (wanda ake tsammani a shirin shirin ko an tsara su).
Gwajin Phase I-II yana gudanar da tsaro na farko da gwajin immunogenicity, yawanci ana sarrafa shi, sarrafa placebo, da kuma a shafukan yanar gizo masu yawa, yayin da yake ƙayyade ƙarin ƙwayoyi masu mahimmanci, masu inganci.
Gwajin mataki na III yawanci sun haɗa da ƙarin mahalarta, ciki har da ƙungiyar kulawa, da gwajin tasiri na allurar don hana cutar, yayin da sa ido ga mummunan sakamako a mafi kyawun kashi.
"Daga cikin 'yan takarar allurar rigakafi 79 a ci gaban aiki (an tabbatar da su a farkon Afrilu 2020), 74 ba su kasance a cikin kimantawa na ɗan adam ( har yanzu a binciken "preclinical").
Kimanin 24 ga Janairun 2020 a Australia, Jami'ar Queensland ta sanar da cewa tana bincika yiwuwar rigakafin kwayoyin cuta wanda zai canza ƙwayoyin cuta na kwayoyin halitta don motsawa da kwayoyin cuta.
Kimanin 24 ga Janairun 2020 a Kanada, Cibiyar rigakafi ta Duniya (VIDO-InterVac) a Jami'ar Saskatchewan ta sanar da fara aiki akan allurar rigakafin, wanda ke nufin fara gwajin ɗan adam a 2021.
An sanar da ayyukan ci gaban ƙwayar cuta a Cibiyar Kula da Cututtuka ta China a ranar 26 ga Janairun 2020, da Jami'ar Hong Kong a ranar 28 ga Janairu.
Kimanin 29 ga Janairu 2020, Kamfanonin Janssen Pharmaceutical, wanda Hanneke Schuitemaker ya jagoranci, ya sanar da cewa ta fara aiki a kan haɓaka allurar rigakafi.
Janssen yana hade da inganta allurar rigakafi ta baka tare da abokin tarayyarta na fasaha, Vaxart.
A ranar 18 ga Maris 2020, Emergent BioSolutions ya sanar da haɗin gwiwa na masana'antu tare da Vaxart don haɓaka allurar rigakafin.
A ranar 8 ga Fabrairun 2020, dakin gwaje-gwaje na OncoGen a Romania ya wallafa takarda kan ƙirƙirar allurar rigakafi tare da irin wannan fasahar da aka yi amfani dashi don maganin allurar rigakafi na neoantigen.
A ranar 25 ga watan Maris, shugaban cibiyar bincike ya sanar da cewa sun kammala aikin rigakafin kuma sun fara gwajin.
A ranar 27 ga watan Fabrairun 2020, kamfanin generex, NuGenerex Immuno-Oncology, ya sanar da cewa suna fara aikin allurar rigakafin don ƙirƙirar allurar peptide ta Ii-Key da COVID-19.
"Sun so su samar da wani dan takarar allurar rigakafin da za a iya gwadawa a cikin mutane a cikin kwanaki 90."
A ranar 5 ga Maris, 2020, Jami'ar Washington a St. Louis ta sanar da ayyukanta don haɓaka allurar rigakafi.
A ranar 5 ga watan Maris, 2020, Binciken Likitanci da Kwamandan Material a Fort Detrick da Cibiyar Nazarin Sojojin Walter Reed a Silver Spring, duka a yammacin Maryland, sun sanar da cewa suna aiki a kan allurar rigakafi.
Kimanin 10 Maris 2020, Emergent Biosolutions ya sanar da cewa ta haɗu da Novavax Inc.
Yadda za a ci gaba da samar da allurar rigakafi?
Abokan cinikin sun ƙara sanar da shirye-shiryen gwaji na farko da gwajin na asibiti na mataki na farko a watan Yuli 2020.
A ranar 12 ga watan Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar da cewa suna aiki tare da makamai 11, kuma koda a kan hanya mai sauri zai ɗauki akalla shekara daya da rabi zuwa biyu don haɓaka allurar rigakafi.
A ranar 12 ga Maris 2020, Medicago, wani kamfani mai fasahar ilimin kimiyya a birnin Quebec, Quebec, ya ba da rahoton ci gaban wani ɓangare na coronavirus a karkashin kudade daga Cibiyoyin Nazarin Kiwon Lafiya na Kanada.
Mai neman allurar rigakafin yana cikin binciken dakin gwaje-gwaje, tare da gwajin ɗan adam da aka shirya don Yuli ko Agusta 2020.
"A farkon wannan makon, The Guardian ya ba da rahoton cewa Shugaban Amurka Donald Trump ya bayar da CureVac "kudi masu yawa" don samun damar samun allurar rigakafin Covid-19," wanda gwamnatin Jamus ta yi zanga-zangar.
A ranar 17 ga Maris 2020, kamfanin masana'antu na Amurka Pfizer ya ba da sanarwar haɗin gwiwa tare da kamfanin BioNTech na Jamus don haɓaka allurar rigakafin mRNA.
Dan takarar allurar rigakafin mRNA na BNT162, a halin yanzu a gwajin pre-clinic tare da gwaje-gwaje na asibiti ana sa ran farawa a watan Afrilu 2020.
A Italiya a ranar 17 ga Maris 2020, Takis Biotech, wani kamfanin fasaha na Italiya ya sanar da cewa za su sami sakamakon gwajin gwaji a watan Afrilu 2020 kuma dan takarar allurar rigakafin su na iya fara gwajin ɗan adam da fadi.
A Faransa a ranar 19 ga Maris 2020, <0xC6><0x98>ungiyar Tattalin Arziki (CEPI) ta ba da sanarwar saka hannun jari na dala miliyan 4.9 a cikin haɗin gwiwar bincike na allurar rigakafin COVID-19 wanda ya hada da Institut Pasteur, Themis Bioscience (Vienna, Austria), da Jami'ar Pittsburgh, wanda ke kawo jimlar sakancin sakancin sakancin CEPI a ci gaban COVID-19 a ci gaban allurar.
Sauran abokan zuba jari na CEPI don ci gaban allurar rigakafin COVID-19 sune Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford, da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, jami'an kiwon lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin dabbobi guda shida daban-daban.
Masu binciken Kwalejin Imperial London sun sanar a ranar 20 ga Maris 2020 cewa suna haɓaka allurar rigakafin RNA na COVID-19.
An kirkiro dan takarar allurar rigakafin a cikin kwanaki 14 bayan karbar jerin daga kasar Sin.
A ƙarshen Maris, gwamnatin Kanada ta sanar da $ 275 miliyan don tallafawa ayyukan bincike na 96 kan matakan magani na likita da COVID-19, ciki har da 'yan takarar allurar rigakafi da yawa a kamfanoni da jami'o'i na Kanada, irin su Medicago da Jami'ar Saskatchewan.
"A lokaci guda, gwamnatin Kanada ta sanar da $ 192 miliyan musamman don haɓaka allurar rigakafin COVID-19, tare da shirye-shiryen kafa "bank na kasar" na sababbin allurai da za a iya amfani da su idan wani cutar coronavirus ta faru."
A ranar 2 ga watan Afrilun 2020, masu bincike a Makarantar Magunguna ta Jami'ar Pittsburgh sun ba da rahoton gwajin PittCoVacc, wataƙila allurar COVID-19 a cikin yara, yana mai cewa "MNA ya ba da allurar rigakafin SARS-CoV-2 S1 wanda ya haifar da amsoshin maganin antigen na musamman [a] wanda ya bayyana farkon makon makonni biyu bayan rigaka."
A Kanada a ranar 16 ga Afrilu 2020, Makarantar Jami'ar Waterloo ta Makarantar Pharmacy ta ba da sanarwar ƙirƙirar wani dan takarar allurar rigakafin DNA a matsayin mai yiwuwa a cikin ƙanshi.
Amfani da bacteriophages, za a tsara DNA don samar da kwayoyin cuta a cikin ɗan adam don samar da kwayoyin cuta marasa lahani, wanda zai iya motsa tsarin rigakafi don samar da kwayoyin cuta da kwayar cutar SARS-CoV-2.
A watan Maris na 2020, gwamnatin Amurka, masana'antu, da jami'o'i uku sun tattara albarkatun don samun damar supercomputers daga IBM, haɗe da albarkatun ƙirar girgije daga Hewlett Packard Enterprise, Amazon, Microsoft, da Google.
Wasu allurai suna da tasiri na heterological, wanda kuma ake kira tasiri ba na musamman ba.
Wannan yana nufin za su iya samun fa'idodi fiye da cutar da suke hanawa.
Wani gwaji a Australia yana neman shiga ma'aikatan kiwon lafiya 4,170.
Ana iya samun allurar rigakafi a cikin ci gaba bazai zama lafiya ko tasiri ba.
Nazarin farko don tantance ingancin allurar rigakafi ta amfani da samfuran dabba na musamman na COVID-19, irin su ƙwararrun ƙwararrun ACE2, sauran dabbobi na gwaje-gwaje, da kwayoyin da ba mutane ba, suna nuna buƙatar matakan ƙuntatawa na matakin biosafety 3 don sarrafa ƙwayoyin cuta masu rai, da daidaitattun ƙasashen duniya don tabbatar da hanyoyin aminci.
An gwada allurar rigakafin SARS da MERS a cikin samfuran dabbobi marasa mutum.
Tun daga shekarar 2020, babu magani ko rigakafin kariya ga SARS wanda aka nuna cewa yana da lafiya da tasiri a cikin mutane.
A cewar takardun bincike da aka buga a shekarar 2005 da 2006, ganowa da haɓaka sabon allurai da magunguna don magance SARS ya kasance fifiko ga gwamnatoci da hukumomin kiwon lafiya na jama'a a duk faɗin duniya.
Lokacin da MERS ya zama yadu, an yi imanin cewa binciken SARS na yanzu na iya samar da samfurin amfani don haɓaka allurar rigakafi da magani akan kamuwa da cutar MERS-CoV.
Tun daga watan Maris 2020, akwai allurar MERS daya (tushen DNA) wanda ya kammala gwaje-gwaje na asibiti a cikin mutane, da kuma wasu uku waɗanda ke ci gaba, dukkansu sune allurar rigakafin da aka samu, biyu adenoviral-vectored (ChAdOx1-MERS, BVRS-GamVac), da MVA-vectored (MVA-MERS-S-S-S).
Shafukan kafofin watsa labarun sun inganta ka'idar haɗin gwiwa da ke da'awar cewa an san kwayar cutar a bayan COVID-19 kuma an riga an sami allurar rigakafin.
Lambar da aka ambata ta hanyar posts daban-daban na kafofin watsa labarun sunyi la'akari da launin fata na yanzu don jerin kwayoyin halitta da allurar rigakafi ga sauran nau'ikan coronavirus irin su SARS coronavirus.
Cutar Coronavirus ta b'2019 (COVID-19) cuta ce mai kamuwa da cuta da ke haifar da mummunan cututtukan numfashi na coronavirus 2 (SARS-CoV-2).
Alamun cututtuka na yau da kullum sun haɗa da zazzabi, ciwo, da gajeren numfashi.
Sauran alamomi na iya haɗawa da gajiya, ciwon tsoka, ciwo, ciwon makogwaro, rashin zafi, da kuma ciwon addominal.
Lokacin daga bayyanar cututtuka zuwa farkon alamu yawanci yana kusa da kwanaki biyar amma yana iya kasancewa daga kwanaki biyu zuwa goma sha huɗu.
Duk da yake mafi yawan lokuta suna haifar da alamun cututtuka masu sauƙi, wasu ci gaba zuwa ƙwayoyin cuta da gazawar ƙwayoyin cuta.
Tun daga ranar 17 ga Afrilu, 2020, an ba da rahoto fiye da mutane miliyan 2.24 a cikin ƙasashe da yankuna 210, wanda ya haifar da mutuwar fiye da 153,000.
Fiye da mutane 568,000 sun warke. Kwayar cutar tana yadawa tsakanin mutane yayin tuntuɓar kusanci, sau da yawa ta hanyar ƙananan ƙananan ƙananan ƙananan da aka samar ta hanyar ciwo, ƙishirwa, ko magana.
Duk da yake ana samar da waɗannan ƙananan lokacin numfashi, yawanci sun fadi a ƙasa ko a kan saman maimakon su kasance masu kamuwa da cuta a tsawon nisa.
Hakanan mutane na iya kamuwa da cutar ta hanyar taɓa surface da aka ƙazantar sannan kuma taɓa idanunsu, hanci ko bakinsu.
Ciwon kwayar cutar zai iya tsira a sararin samaniya har zuwa awanni 72.
Yana da mafi kwayar cuta a cikin kwanaki uku na farko bayan farawar alamun, kodayake yana iya yiwuwa yaduwar cututtuka kafin ya bayyana kuma a cikin matakai na ƙarshe na cutar. Hanyar ganowa ta hanyar sashin sarkar polymerase (rRT-PCR) daga nasopharyngeal swab.
Ana ba da shawarar yin amfani da masks ga waɗanda suke zargin cewa suna da kwayar cutar da masu kula da su.
Shawarwari don amfani da abin rufe fuska ta jama'a sun bambanta, tare da wasu hukumomi suna ba da shawara game da amfani da su, wasu suna ba da shawarar amfani da su, kuma wasu suna buƙatar amfani da su.
A halin yanzu, babu allurar rigakafi ko takamaiman magani ga COVID-19.
An yi rikodin yaduwar cutar a yawancin ƙasashe a duk yankunan WHO shida.
Wadanda suka kamuwa da cutar na iya zama marasa alama ko ci gaba da alamun cutar kamar zazzabi, ciwo, gajiya, da gajiyawar numfashi.
Alamun gaggawa sun haɗa da wahalar numfashi, ciwon kirji ko matsa lamba, rikice-rikice, matsaloli na farkawa, da fuskar blue ko lebe; ana ba da shawarar kula da lafiya nan da nan idan waɗannan alamu sun kasance.
Sau da yawa, ana iya ganin alamun numfashi na sama kamar hanci, hanci mai tsanani ko ciwon makogwaro.
An lura da alamun gastrointestinal kamar nauyi, ciwon daji da ciwon daji a kashi daban-daban.
Wasu lokuta a kasar Sin sun gabatar da kawai tare da ƙarfin zuciya da palpitations.
A wasu, cutar na iya ci gaba zuwa huhu, gazawar jiki da yawa, da mutuwa.
Wannan ana kiran lokacin incubation.
Lokacin shigarwa na COVID-19 yawanci kwanaki biyar zuwa shida amma yana iya kasancewa daga kwanaki biyu zuwa 14.
97.5% na mutanen da ke haifar da alamun za su yi haka a cikin kwanaki 11.5 na kamuwa da cutar.
Har yanzu ba a san rawar da waɗannan masu ɗaukar hoto ba a cikin watsawa; duk da haka, shaidu na farko sun nuna cewa suna iya ba da gudummawa ga yaduwar cutar.
A halin yanzu ba a san yawan mutanen da ba su nuna alamun cututtuka ba kuma ana nazarin su, tare da cibiyoyin kula da cututtuka na Koriya (KCDC) sun ba da rahoton cewa kashi 20% na duk wadanda aka tabbatar sun kasance marasa alama a lokacin da suke asibiti.
Hukumar kiwon lafiya ta kasar Sin ta fara haɗa da lokuta marasa alamu a cikin shari'ar ta yau da kullun a ranar 1 ga Afrilu; daga cikin kamuwa da cutar 166 a wannan rana, 130 (78%) ba su da alama a lokacin gwajin.
Dukansu sputum da saliba na iya ɗaukar manyan nau'ikan ƙwayoyin cuta.
Magana mai ƙarfi yana saki ƙananan ƙananan ƙananan fiye da tattaunawa na al'ada.
Wani binciken da aka gudanar a Singapore ya gano cewa ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwa na iya haifar da ƙananan ƙafa har zuwa mita 4.5 (15 feet).
Kodayake kwayar cutar ba ta cikin iska ba, Kwalejin Kimiyya ta Kasa ta ba da shawarar cewa bioaerosol yana iya yiwuwa kuma masu tattara iska suna sanyawa a cikin dakin a waje da ɗakunan mutane sun ba samfurori masu kyau don RNA na kwayar cutar.
Wasu hanyoyin likita kamar intubeation da karfin zuciya resuscitation (CPR) na iya haifar da numfashi aerosolized kuma hakan ya haifar da yaduwar iska.
Duk da yake akwai damuwa da za a iya yada ta hanyar zubar da ciki, ana zaton wannan haɗarin ya zama ƙananan. Kwayar cutar tana da kamuwa da cutar lokacin da mutane ke da alamun cutar; yayin da yaduwar zai yiwu kafin a bayyana alamun, haɗarin yana da ƙananan.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ce yayin da ba a bayyana yadda cutar ta yadu da sauƙi ba, mutum ɗaya gabaɗaya yana kamuwa da wasu biyu zuwa uku.
Musamman, an gano kwayar cutar don kwana ɗaya a kan kartani, har zuwa kwanaki uku akan roba (polypropylene) da bakin karfe (AISI 304), kuma har zuwa awanni hudu akan 99% jan.
Duk da haka, wannan ya bambanta dangane da zafi da zafin jiki.
Sabulu da detergent kuma suna da tasiri idan aka yi amfani da su daidai; samfuran sabulu sun rage lakabin kariya na faty virus, dakatar da shi, da kuma 'yantar da su daga fata da sauran surface.
Sauran hanyoyin, irin su benzalkonium chloride da chlorhexidine gluconate (wanda ke cirewa na kiwon lafiya), ba su da tasiri. A wani binciken Hong Kong, an dauki samfurori na saliva a matsakaicin kwanaki biyu bayan fara asibiti.
A cikin marasa lafiya biyar daga cikin marasa lafiya shida, samfurin farko ya nuna mafi girman kaya na kwayar cutar, kuma mai haƙuri na shida ya nuna mafi girman kaya na kwayar cutar a rana ta biyu da aka gwada.
Cutar numfashi mai tsanani ta 2 (SARS-CoV-2) wani sabon ciwon numfashi mai tsanani ne na numfashi mai tsanani, na farko ya ware daga mutane uku da ke da ciwon huhu da alaka da cututtukan cututtukan numfashi masu tsanani a Wuhan.
Dukkan siffofin kwayar cutar SARS-CoV-2 suna faruwa a cikin kwayoyin coronavirus masu alaƙa da yanayi.
A waje da jikin mutum, kwayar cutar ta kashe ta hanyar sabulun gida, wanda ke fashe da bubble.SARS-CoV-2 yana da alaƙa da asalin SARS-CoV.
Huhuntawa sune gabobin da COVID-19 ya fi shafa saboda kwayar cutar tana samun damar kwayoyin masu karɓa ta hanyar enzyme angiotensin-converting enzyme 2 (ACE2), wanda yake da yawa a cikin kwayoyin alveolari na nau'i na II na huhu.
Kwayar cutar tana amfani da glycoprotein na musamman da ake kira "spike" (peplomer) don haɗa zuwa ACE2 kuma shiga cikin kwayar mai karɓa.
An gano raunin zuciya mai tsanani a cikin kashi 12 cikin 100 na mutanen da ke dauke da cutar a asibiti a Wuhan, China, kuma ya fi sau da yawa a cikin mummunan cututtuka.
Rahotanni na cututtukan zuciya suna da yawa, saboda amsawa na tsarin wutar lantarki da cututtukan tsarin rigakafi a lokacin ci gaban cututtuka, amma raunin myocardial kuma na iya dangantawa da masu karɓar ACE2 a cikin zuciya.
ACE2 masu karɓa suna nunawa sosai a cikin zuciya kuma suna shiga cikin aikin zuciya.
Babban adadin thrombosis (31%) da thromboembolism (25%) an samu a cikin marasa lafiya na ICU da kamuwa da cututtukan COVID-19 kuma ana iya danganta su da mummunan ra'ayi.Autopsis na mutanen da suka mutu daga COVID-19 sun sami lalacewar alveolar mai zurfi (DAD), da kuma limfocyte-wanda yana daukar ciki a cikin hututtura.
Kodayake SARS-COV-2 yana da tropism don kwayoyin epithelial na hanyar numfashi na ACE2, marasa lafiya da ke da mummunan COVID-19 suna da alamun hyperframmedic tsarin.
Musamman, an nuna kwayoyin T-cell masu ɓoye GM-CSF masu ɓoyewa don dangantawa tare da ɗaukar monocytes masu ɓoyewa na IL-6 da cututtuka masu tsanani na huhu a cikin marasa lafiya na COVID-19.
Har ila yau, an ba da rahoton limfocytic infiltrations a cikin autopsy.
WHO ta wallafa ka'idojin gwaji da dama don cutar.
Hanyar gwaji na yau da kullum shine ainihin lokaci-lokaci mayar da rubutun polymerase sarkar martani (rRT-PCR).
Ana yin gwajin galibi akan samfurori na numfashi da aka samu ta hanyar swab nasopharyngeal; duk da haka, ana iya amfani da samfurin nasa ko samfurin sputum.
Gabaɗaya ana samun sakamako a cikin 'yan sa'o'i zuwa kwanaki biyu.
Ana iya amfani da gwajin jini, amma waɗannan suna buƙatar samfuran jini guda biyu da aka ɗauka makonni biyu kuma sakamakon yana da ƙananan darajar nan take.
Masana kimiyya na kasar Sin sun sami damar ware wani nau'i na coronavirus da kuma buga jerin kwayoyin halitta don haka gwaje-gwaje a duk faɗin duniya na iya haɓaka sarkar sarkar polymerase (PCR) don gano kamuwa da cutar.
Tun daga ranar 4 ga Afrilu 2020, gwaje-gwaje na kwayoyin cuta (wanda zai iya gano kamuwa da cuta mai aiki da kuma ko mutum ya kamu da cutar a baya) sun kasance a ci gaba, amma har yanzu ba a yi amfani dashi da yawa ba.
Kwarewar China tare da gwajin ya nuna daidaito ne kawai 60 zuwa 70%.
FDA a Amurka ta amince da gwajin farko na kulawa a ranar 21 ga Maris 2020 don amfani a ƙarshen wannan watan. Jagoran binciken da Asibitin Zhongnan na Jami'ar Wuhan ya fitar ya ba da shawarar hanyoyin gano kamuwa da cututtuka bisa fasali na asibiti da haɗarin annoba.
Biladelate multilobar ƙasa-glass opacities tare da wani m, asymmetric da kuma rarraba daga baya ne kowa a farkon kamuwa da cuta.
Subpleural mallakar, crazy paving (lobular septal kauri tare da m alveolari cika), kuma karfafawa na iya bayyana yayin da cutar ta ci gaba.
Ana samun bayanai kaɗan game da rauni na microscopic da ƙwayoyin cuta na COVID-19.
Babban abubuwan da ke faruwa a cikin autopsy sune:
Macroscopy: pleurisy, pericarditis, haɓaka huhu da kuma pulmonary oedema
Ana iya lura da nau'ikan hudu na cutar pneumonia:
pneumonia mai sauƙi: pulmonary oedema, pneumocyte hyperplasia, babban pneumocytes atipical, wutar lantarki tare da limphocytic shigarwa da kuma multinucleated giant cell samar
Mai tsanani pneumonia: lalacewar alveolari (DAD) tare da alveolari exudates.
DAD shine dalilin cutar cutar numfashi mai tsanani (ARDS) da hypoxemia mai tsanani.
Cutar pneumonia: ƙungiya na exudates a cikin alveolar cavities da pulmonary interstitial fibrosis
jini: yada intravascular coagulation (DIC); leukoerythroblastic martani
Matakan karewa don rage yiwuwar kamuwa da cutar sun haɗa da kasancewa a gida, guje wa wurare masu yawa, wanke hannuwa da sabulu da ruwa sau da yawa kuma don akalla 20 seconds, yin aikin tsabtace numfashi mai kyau da kuma guje wa taɓa idanu, hanci ko bakin hannu ba tare da wanke hannu ba.
CDC ya ba da shawarar rufe bakin da hanci tare da nama yayin da ake cike ko cikewa kuma ya ba da shawarar yin amfani da ciki na katako idan babu nama.
Ana karfafa tsaftace hannu mai kyau bayan kowane nau'i ko nau'i.
CDC ta ba da shawarar yin amfani da rufin fuska a cikin saitunan jama'a, a wani ɓangare don iyakance watsawa ta mutane marasa alama. dabarun nesa na zamantakewa suna nufin rage tuntuɓar mutane masu kamuwa da manyan kungiyoyi ta hanyar rufe makarantu da wuraren aiki, ƙuntata tafiya da soke manyan taron jama'a.
Har ila yau, ƙa'idodin nisa sun haɗa da cewa mutane suna zama aƙalla ƙafa 6 (1.8 m) bambanci.
"Babu wata magani da aka sani da tasirin hana COVID-19.A matsayin allurar rigakafin ba a sa ran har zuwa 2021 a farkon ba, wani muhimmin ɓangare na gudanar da COVID-19 yana ƙoƙarin rage yawan annobar, wanda aka fi sani da "flattening the curve" .
CDC kuma ya ba da shawarar cewa mutane suna wanke hannayensu sau da yawa tare da sabulu da ruwa na akalla 20 seconds, musamman bayan tafiya zuwa wanka ko lokacin da hannayensu suke marmari, kafin cin abinci da kuma bayan busa hanci na mutum, ciwo ko ƙashi.
Bugu da ƙari, yana ba da shawarar yin amfani da tsaftace hannu mai tushen giya tare da akalla 60% barasa, amma kawai lokacin da sabulu da ruwa ba a samuwa ba. Ga yankunan da ba a samuwa ba na kasuwanci, WHO ta samar da gyare-gyare biyu don samar da gida.
A cikin waɗannan nau'ikan, aikin antimicrobial ya fito ne daga ethanol ko isopropanol.
"Hydrogen peroxide ana amfani dashi don taimakawa wajen kawar da ƙwayoyin kwayoyin cuta a cikin barasa; ba abu ne mai aiki ba don antisepsis."
An ƙara Glycerol a matsayin Humectant.
Ana sarrafa mutane tare da kulawa masu goyon baya, wanda zai iya haɗawa da jiyya na ruwa, goyon bayan oxygen, da tallafawa sauran mahimman gabobin da suka shafi.
CDC ta ba da shawarar cewa wadanda suke zargin daukar kwayar cutar suna dauke da abin rufe fuska mai sauƙi.
An yi amfani da oxygenation (ECMO) don magance batun rashin numfashi, amma har yanzu ana la'akari da fa'idodinsa.
An ba da shawarar tsaftacewa na sirri da salon rayuwa mai kyau da abinci don inganta rigakafi.
Magunguna masu tallafawa na iya zama da amfani ga waɗanda ke da alamun cutar mai sauƙi a farkon mataki na kamuwa da cutar.WHO da Hukumar Lafiya ta China sun wallafa shawarwari don kula da mutanen da ke asibiti da COVID-19.
Masana kimiyya da masana ilimin kimiyya a Amurka sun tattara shawarwarin magani daga hukumomi daban-daban zuwa wani albarkatun kyauta, IBCC.
Tun daga Afrilu 2020, babu wani takamaiman magani na COVID-19.
Ga alamun cututtuka, wasu kwararrun likita suna ba da shawarar paracetamol (acetaminophen) a kan ibuprofen don amfani dashi na farko.
Dole ne a dauki kulawa don rage haɗarin watsa kwayar cuta, musamman a cikin saitunan kiwon lafiya yayin aiwatar da hanyoyin da zasu iya samar da aerosols, irin su intubetion ko iska na hannu.
Ga kwararrun kiwon lafiya da ke kula da mutanen da ke da cutar COVID-19, CDC ya ba da shawarar sanya mutumin a cikin ɗakin rufi na kamuwa da cutar (AIIR) ban da amfani da ka'idoji na yau da kullun, kula da kulawa da ka'idojin iska.
A shawarar kaya ne: PPE tufafi, numfashi ko facemasks, kariya ido, da kuma likita takalma.Idan akwai, numfashi (maimakon facemasks) an fi so.
An amince da masu numfashi na N95 don saitunan masana'antu amma FDA ta ba da izinin yin amfani da abin rufe fuska a ƙarƙashin izinin Amfani na Gaggawa (USA).
An tsara su don kare daga ɓangarorin da ke cikin iska kamar ƙura amma tasiri akan takamaiman wakilin halittu ba a tabbatar da amfani da su ba.
Lokacin da ba a samu abin rufe fuska ba, CDC ta ba da shawarar yin amfani da garkuwa na fuska ko, a matsayin mataki na ƙarshe, abin rufe fuska na gida.
Yawancin lokuta na COVID-19 ba su da matukar tsanani don buƙatar iska ko madaidaiciya, amma yawancin lokuta sun kasance.
Nau'in goyon bayan numfashi ga mutanen da ke da alaƙa da gazawar numfashi na COVID-19 ana nazarin shi sosai ga mutane a asibiti, tare da wasu shaidar cewa ana iya guje wa intubewa tare da matsi na hanci mai zurfi ko matsa lamba na iska mai kyau na mataki.
Ko ɗaya daga cikin waɗannan biyun yana haifar da amfani ɗaya ga mutanen da ke da rashin lafiya sosai ba a san su ba.
Wasu likitoci sun fi son kasancewa tare da fannin injiniya lokacin da yake samuwa saboda wannan fasaha tana iyakance yaduwar ɓangarorin aerosol idan aka kwatanta da babbar ƙananan ƙananan ƙananan ƙananan ƙananan.
Yawancin ƙasashe masu ci gaba ba su da isasshen gado na asibiti na kowa, wanda ke iyakance ikon tsarin kiwon lafiya don magance haɓaka ba zato ba tsammani a yawan lokuta na COVID-19 da ke da tsanani sosai don buƙatar asibiti.
Wani bincike a kasar Sin ya gano cewa an shigar da kashi 5% cikin ma'aikatan kulawa masu tsanani, 2.3% suna buƙatar goyon bayan injiniya na iska, kuma 1.4% sun mutu.
A kasar Sin, kimanin kashi 30 cikin 100 na mutanen da ke asibiti tare da COVID-19 a karshe ana shigar da su zuwa ICU.
Injin iska ya zama mafi rikitarwa yayin da cutar numfashi mai tsanani (ARDS) ta ci gaba a cikin COVID-19 kuma oxygenation ya zama wuya.
Ana buƙatar fansa da za su iya sarrafa yanayin matsa lamba da kuma PEEP mai girma don inganta isar da oxygen yayin da rage haɗarin raunin huhu mai haɗin gwiwa da pneumotorax.
Babban PEEP ba za a iya samuwa a kan tsofaffin fan.
Bincike a kan yiwuwar magani ya fara ne a watan Janairu 2020, kuma wasu magunguna masu yawa suna cikin gwaje-gwaje na asibiti.
Remdesivir yana da alama cewa shine mafi kyawun sada zumunta.
Kodayake sabbin magunguna na iya ɗaukar har zuwa 2021 don haɓaka, yawancin magunguna da ake gwadawa an riga an amince su don wasu amfani ko kuma sun riga sun kasance a gwajin ci gaba.
Ana iya gwada maganin maganin antivirus a cikin mutanen da ke da cuta mai tsanani.
WHO ta ba da shawarar masu sa kai su shiga gwaji na tasiri da amincin magani.FDA ta ba da izinin wucin gadi don warkar da plasma a matsayin magani na gwaji a cikin lokuta inda rayuwar mutum ta kasance mai tsanani ko nan da nan cikin barazana.
Ba a samu nazarin asibiti da ake buƙata don nuna cewa yana da lafiya da tasiri ga cutar.
A watan Fabrairun 2020, kasar Sin ta kaddamar da aikace-aikacen wayar hannu don magance barkewar cutar.
Ana buƙatar masu amfani su shigar da sunan su da lambar ID.
A aikace-aikacen zai iya gano "saduwa kusa" ta amfani da sa ido bayanai da kuma saboda haka yiwuwar haɗarin kamuwa da cuta.
Kowane mai amfani zai iya duba matsayi na sauran masu amfani guda uku.
Idan an gano wata hadari mai yiwuwa, app ba kawai bayar da shawarar kai-quarantine, shi kuma gargadi ma'aikatan kiwon lafiya na gida.Big data analytics a kan wayar hannu data, fasahar gane fuska, mobile wayar hannu tracking da artificial intelligence amfani to tracking mutane da kuma mutanen da suka tuntube a Koriya ta Kudu, Taiwan Taiwan da Singa.
A watan Maris na shekarar 2020, gwamnatin Isra'ila ta ba da damar hukumomin tsaro su bincika bayanan wayar hannu na mutanen da ake tsammani suna da coronavirus.
An dauki matakin don aiwatar da kwararowar da kuma kare wadanda zasu iya tuntuɓar 'yan ƙasa masu kamuwa da cutar.
Har ila yau, a watan Maris 2020, Deutsche Telekom ta raba cikakken bayanan wurin wayar hannu tare da hukumar gwamnatin tarayya ta Jamus, Robert Koch Institute, don bincike da hana yaduwar cutar.
Rasha ta yi amfani da fasahar ganewar fuska don gano kwararru.
Kwamishinan kiwon lafiya na yankin Italiya Giulio Gallera ya ce an sanar da shi daga masu aiki da wayar hannu cewa "40% na mutane suna ci gaba da motsawa ko ta yaya."
Gwamnatin Jamus ta gudanar da hackathon na sa'o'i 48 a karshen mako tare da mahalarta sama da 42,000.
Har ila yau, Shugaban Estonia, Kersti Kaljulaid, ya yi kira a duniya don hanyoyin kirkiro kan yaduwar coronavirus.
Mutane na iya fuskantar damuwa daga keɓewa, ƙuntatawa ta tafiye-tafiye, sakamakon magani ko tsoron kamuwa da cutar kanta.
"BBC ta ambaci Rory O'Connor a cewar, "<0xC6><0x98>arin warewar zamantakewa, kaɗaici, damuwa na kiwon lafiya, damuwa da tattalin arziki sune hadari mai kyau don cutar da lafiyar mutane da lafiyarsu."
Cutar na iya ɗaukar hanya mai sauƙi tare da ƙananan alamu ko babu alamun, kamar sauran cututtukan numfashi na sama kamar sanyi na kowa.
Yawancin lokuta masu sauƙi suna warkewa a cikin makonni biyu, yayin da waɗanda ke da cututtuka masu tsanani ko masu muhimmanci na iya ɗaukar makonni uku zuwa shida don warkewa.
Mata masu ciki na iya kasancewa cikin haɗarin kamuwa da cuta mai tsanani tare da COVID-19 dangane da bayanai daga wasu kwayoyin cuta irin su SARS da MERS, amma bayanai na COVID-19 ba su da kyau. A wasu mutane, COVID-19 na iya shafi huhu da ke haifar da ciwon huhu.
A cikin waɗanda suka fi mummunan rauni, COVID-19 na iya ci gaba da sauri zuwa cutar numfashi mai tsanani (ARDS) wanda ke haifar da gazawar numfashi, zazzabi na wucin gadi ko gazawar ƙungiyoyi masu yawa.
<0xC6><0x98>ananan da ke da alaƙa da COVID-19 sun haɗa da sepsis, hawan jini da lalacewar zuciya, koda da hanta.
An bayyana rashin daidaituwa, musamman karuwar lokaci na prothrombin, a cikin 6% na waɗanda aka shigar da su asibiti tare da COVID-19, yayin da ana ganin aikin koda mara kyau a cikin 4% na wannan rukuni.
Kimanin 20-30% na mutanen da ke da COVID-19 sun nuna enzymes na hanta (transaminases).
A cewar wannan rahoto, tsakiyar lokaci tsakanin farawar alamun cutar da mutuwar kwanaki goma ne, tare da shan da aka kashe a asibiti.
Duk da haka, marasa lafiya sun canza zuwa ICU suna da matsakaicin lokaci na kwana bakwai tsakanin asibiti da mutuwa.
A cikin binciken farkon lokuta, tsakiyar lokaci daga nuna alamun farko zuwa mutuwa shine kwanaki 14, tare da cikakken kwanaki shida zuwa 41.
A cikin binciken da Hukumar Lafiya ta Kasa (NHC) ta kasar Sin ta yi, maza suna da kashi 2.8% na mutuwa yayin da mata ke da kashi 1.7% na mutuwa.
Nazarin ilimin kimiyya na samfuran huhu na bayan mutuwar mutum ya nuna lalacewar alveolar tare da fibromyxoid na kwayoyin halitta a cikin huhu duka.
An lura da canje-canje na cytopathic na Viral a cikin pneumocytes.
Hoton huhu ya yi kama da cutar numfashi mai tsanani (ARDS).
A cikin 11.8% na mutuwar da Hukumar Lafiya ta Kasa ta China ta ruwaito, an lura da lalacewar zuciya ta hanyar haɓaka matakan troponin ko tsagewar zuciya.
A cewar bayanai na Maris daga Amurka, kashi 89% na waɗanda ke asibiti suna da yanayi na dā.Availability na albarkatun likitanci da tattalin arzikin zamantakewa na wani yanki na iya shafar mutuwar.
Tabbatar mutuwar mutuwa daga yanayin ya bambanta saboda waɗannan bambance-bambancen yanki, amma kuma saboda matsalolin hanyoyin.
<0xC6><0x98>addamar da ƙananan cututtuka na iya haifar da yawan mutuwar da za a iya ƙididdige su.
Koyaya, gaskiyar cewa mutuwar ita ce sakamakon shari'o'in da aka kwangila a baya na iya nufin adadin mutuwar yanzu ba a ƙididdige shi ba.
Masu shan taba sun kasance sau 1.4 mafi yiwuwar samun mummunan alamun COVID-19 kuma kusan sau 2.4 mafi yiwuwar buƙatar kulawa mai tsanani ko mutuwa idan aka kwatanta da wadanda ba masu shan taba ba.
Hukumar asibitin Hong Kong ta gano raguwar 20% zuwa 30% a cikin ƙwayoyin cuta a wasu mutanen da suka warke daga cutar, kuma binciken huhu ya nuna lalacewar jiki.
Hakanan yana iya haifar da ciwon lafiya bayan dawowa.
Tun daga watan Maris 2020, ba a san ko kamuwa da cutar da ta gabata ta ba da rigakafi mai inganci da na dogon lokaci a cikin mutanen da suka warke daga cutar.
Ana ganin rigakafi a matsayin mai yiwuwa, dangane da halayyar sauran coronaviruses, amma lokuta da aka bi daga COVID-19 ta hanyar gwaje-gwaje masu kyau na coronavirus a wani lokaci daga baya an bayar da rahoton.
Wadannan lokuta sun yi imanin cewa cututtukan cututtuka sun fi karfi maimakon sake kamuwa da cutar.
An yi imanin cewa kwayar cutar ta zama na halitta kuma tana da asalin dabba, ta hanyar kamuwa da cuta.
Ainihin asalin ba a san shi ba, amma a watan Disamba 2019 yaduwar kamuwa da cutar ta kusan gaba ɗaya ta hanyar watsawar mutum zuwa mutum.
Wani bincike na shari'ar 41 na farko da aka tabbatar da COVID-19, wanda aka buga a cikin Janairu 2020 a The Lancet, ya bayyana ranar farko ta fara alamun cututtuka a ranar 1 ga Disamba 2019.
Rubutun hukuma daga WHO sun ba da rahoton farkon bayyanar cututtuka a ranar 8 ga Disamba 2019.
Yawancin matakai ana amfani da su don adana mutuwar mutane.
Wadannan lambobi sun bambanta da yankin da kuma tsawon lokaci kuma suna tasiri da girman gwaji, ingancin tsarin kiwon lafiya, zaɓin magani, lokaci tun farkon fashewa da halayen jama'a kamar shekaru, jima'i da lafiyar gaba ɗaya.
A ƙarshen shekarar 2019, WHO ta ba da lambar ICD-10 na cututtuka ta gaggawa U07.1 don mutuwa daga kamuwa da cutar SARS-CoV-2 da kuma U07.2 don mutuwa daga asibiti ko annobar da aka gano COVID-19 ba tare da kamuwa da cutar SARS-CoV-2 da aka tabbatar da ita ba.
Bisa ga ƙididdiga na Jami'ar Johns Hopkins, rabo na mutuwar duniya shine 6.9% (153,822/2,240,191) tun daga 17 ga Afrilu 2020.
Adadin ya bambanta da yankin.Wasu matakai sun haɗa da yawan mutuwar mutum (CFR), wanda ke nuna kashi ɗaya daga cikin wadanda aka gano wadanda suka mutu daga cutar, da kuma kashi na kamuwa da cutar (IFR), wanda ke nuna kashi na mutanen da aka kamuwa da cutar (wanda aka gano da ba a gano su ba) wadanda suka mutu daga cutar.
Wadannan ƙididdiga ba su da lokaci kuma suna bin takamaiman yawan jama'a daga kamuwa da cuta ta hanyar warware shari'a.
Duk da yake ba duk mutanen da aka kamuwa da cutar ba su haɓaka kwayoyin cuta, kasancewar kwayoyin cuta na iya ba da bayani game da yawan mutane da aka kamuwa da cutar.
A cikin cibiyar barkewar cutar a Italiya, Castiglione d'Adda, ƙananan ƙauyen 4600, 80 (1.7%) sun riga sun mutu.
A Gangelt, an yada cutar ta hanyar bukukuwan Carnival, kuma ya yada ga matasa, yana haifar da raunin mutuwar COVID-19, kuma ba duk mutuwar COVID-19 ba za a iya rarraba su a matsayin wannan ba.
Bugu da ƙari, tsarin kiwon lafiya na Jamus ba ya damu da yawa.
A cikin Netherlands, kusan kashi 3% na iya samun kwayoyin cuta, kamar yadda aka kiyasta daga masu ba da gudummawa da jini.
An tabbatar da cewa 69 (0.004% na yawan jama'a) sun mutu daga COVID-19.
Tasirin annobar da yawan mutuwarsa sun bambanta ga maza da mata.
Mutuwa ya fi girma a cikin maza a cikin binciken da aka gudanar a China da Italiya.
Mafi kyawun haɗari ga maza shine a cikin shekarun 50, tare da bambancin tsakanin maza da mata ya rufe kawai a 90.
A kasar Sin, adadin mutuwar ya kai kashi 2.8% ga maza da kashi 1.7% ga mata.
Ainihin dalilai na wannan bambancin jima'i ba a san su ba, amma abubuwan kwayoyin halitta da hali na iya zama dalilai.
Bambance-bambancen rigakafi na jima'i, ƙarancin yawan shan taba a cikin mata da maza suna haɓaka yanayin haɗin gwiwa irin su hypertension a ƙarami fiye da mata na iya taimakawa ga mafi girman mutuwar maza.
A Turai, kashi 57% na mutanen da suka kamu da cutar sun kasance maza kuma kashi 72% na wadanda suka mutu da COVID-19 maza ne.
Tun daga watan Afrilun 2020, gwamnatin Amurka ba ta bin bayanan cututtukan COVID-19 da ke da alaƙa da jima'i ba.
Bincike ya nuna cewa cututtukan kwayar cutar kamar Ebola, HIV, Influenza da SARS suna shafar maza da mata daban-daban.
Yawancin ma'aikatan kiwon lafiya, musamman ma ma'aikata, mata ne, kuma suna da babbar dama na fallasa cutar.
Hukumar Lafiya ta Duniya ta sanar a ranar 11 ga Fabrairu 2020 cewa sunan hukuma na cutar zai zama "COVID-19."
Shugaban WHO Tedros Adhanom Ghebreyesus ya bayyana cewa CO yana tsaye ga corona, VI don kwayar cutar, D don cutar, da kuma 19 don lokacin da aka fara gano barkewar: 31 ga Disamba 2019.
An zaɓi sunan don kauce wa ambaton wani wuri na musamman (misali China), nau'ikan dabbobi ko rukuni na mutane, bisa ga shawarwari na sunaye na duniya da ke nufin hana stigmatization.The virus da ke haifar da COVID-19 an kira shi mummunan cutar numfashi ta coronavirus 2 (SARS-CoV-2).
"WHO kuma tana amfani da ""virus COVID-19"" da ""virus da ke da alhakin COVID-19"" a cikin sadarwa na jama'a.
"Dukkanin cutar da cutar ana kiran su "coronavirus"."
"A lokacin barkewar farko a Wuhan, China, ana kiran kwayar cutar da cutar da aka fi sani da ""coronavirus"" da ""Wuhan coronavirus""."
A watan Janairun 2020, WHO ta ba da shawarar cutar numfashi ta 2019-nCov da 2019-nCoV a matsayin sunaye na wucin gadi na kwayar cutar da cutar bisa ga jagorancin 2015 game da amfani da wurare a cikin cututtuka da sunayen kwayar cuta.
An bayar da sunayen COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu 2020.
Saboda iyakancewar damar a cikin ka'idojin samar da kayayyaki, wasu masana'antun dijital suna buga kayan kiwon lafiya kamar nau'i na hanci da sassa na fan.
A daya misali, lokacin da wani asibiti na Italiya ya buƙaci bawul na fan, kuma mai ba da kaya bai iya isar da shi a cikin tsawon lokaci da ake buƙata ba, wani kamfani na gida ya sake tsarawa kuma ya buga bawuloli 100 da ake buƙata a daren.
Bayan fashewar farko na COVID-19, ra'ayin haɗin gwiwa, bayanai na yau da kullun da rashin bayanai sun fito game da asalin, sikelin, rigakafin, magani da sauran bangarorin cutar da yada sauri a kan layi.
Mutane suna iya yada kwayar cutar zuwa wasu dabbobi.
Nazarin ya kasa gano shaidar kwayar cuta a cikin aladu, ducks, da kaji.
Babu wani magani ko magani don magance cutar.
Ana gudanar da bincike na kasa da kasa game da allurai da magani a cikin COVID-19 ta ƙungiyoyin gwamnati, kungiyoyin ilimi da masu binciken masana'antu.
"A watan Maris, Hukumar Lafiya ta Duniya ta kaddamar da gwajin "SOLIDARITY" don tantance tasirin magani na kwayoyin maganin kwayar cuta huɗu tare da mafi yawan alkawarin inganci."
Babu rigakafin da ake samu, amma hukumomi daban-daban suna haɓaka 'yan takarar allurar rigakafi.
Ana amfani da aikin da ya gabata akan SARS-CoV saboda SARS-CoV da SARS-CoV-2 duka suna amfani da mai karɓar ACE2 don shiga sel na mutum.
Ana bincika hanyoyin allurar rigakafi guda uku.
Na farko, masu bincike suna da niyyar gina allurar rigakafi gaba ɗaya.
Amfani da irin wannan kwayar cutar, ko ba shi da aiki ko mutuwa, yana nufin samar da amsar rigakafi mai sauri daga jikin mutum ga sabon kamuwa da cutar COVID-19.
Wata dabarun na biyu, allurar rigakafi, yana nufin ƙirƙirar allurar rigakafi wanda ke jin dadin tsarin rigakafi ga wasu ƙungiyoyi na kwayar cutar.
A cikin yanayin SARS-CoV-2, irin wannan binciken ya mayar da hankali kan furotin S-spike wanda ke taimakawa kwayar cutar ta shiga mai karɓar enzyme ACE2.
Hanya ta uku ita ce na allurar nucleic acid (DNA ko RNA rigakafin, sabon dabarar don ƙirƙirar allurar rigakafi).
A ranar 16 ga Maris 2020, gwajin asibiti na farko na allurar rigakafin ya fara tare da masu sa kai hudu a Seattle.
rigakafin ya ƙunshi kwayar halitta mara lahani da aka kwafa daga kwayar cutar da ke haifar da cutar.Antibody an ba da shawarar ingantawa a matsayin ƙalubale mai yiwuwa don ci gaban rigakafin SARS-COV-2, amma wannan yana da rikice-rikice.
Ana gudanar da gwaje-gwajen asibiti sama da 300 masu aiki tun daga watan Afrilu 2020.
Gwaje-gwaje bakwai suna kimanta maganin da aka riga aka amince da su don malaria, ciki har da nazarin hudu game da hydroxychloroquine ko chloroquine.
Magungunan maganin kwayar cutar na kasar Sin sun kasance mafi yawan binciken kasar Sin, tare da gwaje-gwajen mataki tara na uku akan remdesivir a fadin kasashe da dama saboda rahoton da za a yi a karshen watan Afrilu.
Ana gudanar da bincike mai mahimmanci game da ci gaban asibiti don allurar rigakafin COVID-19 da 'yan takarar miyagun ƙwayoyi, har zuwa Afrilu 2020. Ana kimanta wasu magungunan antivirus da ke yanzu don maganin COVID-19, ciki har da remdesivir, chloroquine da hydroxychloroquine, lopinavir / ritonavir da lopinavir / ritonavir tare da interferon beta.
Akwai hujjoji na gwaji don inganci ta remdesivir, har zuwa Maris 2020.
An lura da ingantacciyar asibiti a cikin marasa lafiya da ake bi da remdesivir mai amfani da tausayi.
Ana gudanar da gwaje-gwaje na asibiti na mataki na III a Amurka, China da Italiya. An yi nazarin Chloroquine, wanda aka yi amfani da shi a baya don magance cutar cutar, a China a watan Fabrairu 2020, tare da sakamakon farko.
Duk da haka, akwai kira don bincika binciken na biyu.
Hukumomin kiwon lafiya na Koriya da China sun ba da shawarar yin amfani da chloroquine.
Duk da haka, Cibiyar Kiwon Lafiya ta Wuhan, yayin da yake ba da shawarar kashi na yau da kullum na gram ɗaya, ya lura cewa sau biyu wannan kashi yana da haɗari sosai kuma zai iya zama mai lahani.
A ranar 28 ga Maris 2020, FDA ta ba da izinin amfani na gaggawa don hydroxychloroquine da chloroquine bisa ga tunanin likitoci da ke kula da mutanen da ke da COVID-19. Jagoran bugu na 7 na kasar Sin sun haɗa da interferon, ribavirin ko umifenovir don amfani da COVID-19.
Bayanai na farko sun nuna cewa yawancin nau'ikan ribavirin suna buƙatar hana SARS-CoV-2 a cikin invitro.
An ba da shawarar nitazoxanide don ci gaba da bincike a cikin vivo bayan nuna ƙananan ƙaddamarwa na SARS-CoV-2.Studies sun nuna cewa farkon spike protein priming ta transmembrane protease serine 2 (TMPRSS2) yana da muhimmanci don shiga SARS-CoV-2 ta hanyar hulɗa tare da mai karɓar ACE2.
Nazarin chloroquine da hydroxychloroquine tare da ko ba tare da azithromycin ba suna da manyan iyakancewa waɗanda suka hana al'ummar likita daga ɗaukar waɗannan magani ba tare da ƙarin bincike ba. Oseltamivir ba ya hana SARS-CoV-2 a cikin injiniya kuma ba shi da wani rawar da aka sani a maganin COVID-19.
Tsarin Cytokine na iya zama rikice-rikice a matakai na ƙarshe na COVID-19.
Akwai hujjoji cewa hydroxychloroquine na iya samun kayayyakin hadari na anti-cytokine.Tocilizumab an haɗa shi a cikin jagorancin magani ta Hukumar Lafiya ta Kasa ta China bayan an kammala karamin bincike.
Ana gudanar da gwajin gwaji na mataki na 2 a matakin ƙasa a Italiya bayan ya nuna sakamako mai kyau a cikin mutanen da ke da cuta mai tsanani.
Tare da gwajin jini na ferritin don gano guguwa na cytokine, ana nufin magance irin wannan ci gaba, wanda ake tsammani shine dalilin mutuwa a wasu mutanen da suka shafa.
FDA ta amince da antagon mai karɓar interleukin-6 dangane da nazarin hali na baya don maganin steroid refractory cytokine release syndrome wanda ya haifar da wata dalilai daban-daban, maganin CAR T cell, a cikin 2017.
Har zuwa yau, babu wata shaida mai mahimmanci, mai sarrafawa cewa tocilizumab magani ne mai inganci ga CRS.
Canja wurin tsarkakewa da mayar da hankali kwayoyin halitta da tsarin rigakafi ya samar da wadanda suka warke daga COVID-19 ga mutanen da suke buƙatar su ana bincika su azaman hanyar rigakafin cutar da ba ta dace ba.
An gwada wannan dabarun don SARS tare da sakamakon da ba a kammala ba.
Viral neutralation shine tsarin da ake tsammani na aiki wanda maganin antibody na iya tsara tsaro a kan SARS-CoV-2.
Sauran hanyoyin, duk da haka, irin su cytotoxicity na kwayoyin halitta da / ko phagocytosis, na iya yiwuwa.
Sauran nau'ikan maganin antibody, alal misali, ta yin amfani da ƙwayoyin monoclonal da aka kera, suna cikin ci gaba.
Samar da serum na convalescent, wanda ya ƙunshi ɓangaren ruwa na jini daga marasa lafiya da aka warke kuma yana dauke da kwayoyin halitta na musamman ga wannan kwayar cutar, za a iya ƙara shi don sauri.
cututtuka na coronavirus, wani rukuni na cututtuka masu dangantaka
Li Wenliang, likita a Asibitin Tsakiya na Wuhan, wanda daga baya ya yi kwangila kuma ya mutu daga COVID-19 bayan ya kara fahimtar yaduwar cutar.
